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I NTRODUCT I ON 
Propi oni c  ac i demia  i s  an autosoma l recess i vely i nheri ted d i s order 
of organic  ac id  meta bol i sm cau sed by defi c i ent  acti v i ty of prop i onyl 
GoA carboxyl ase . Thi s enzyme is requ i red for the catabol i sm of the 
odd -cha in  fatty ac i d s, the s i de cha in  of chol esterol and the amino 
ac i d s: i sol euc ine ,  methi onine , and threon ine . Al thoug h the c l i n i ca l 
express i on of thi s d i sorder i s  var i abl e ,  affec ted c hildren u s ua l l y  d e­
vel op ketoac idos i s  and hyperammonemi a  whi ch may progress  to s e i zures , 
coma and poss i bly death . Some pati ents may exh i b i t  vomi t ing , l ethargy 
and hypotoni a in  the fi rst few weeks of l i fe whereas others may rema i n  
a symptomati c for months o r  even years . ( l ) The degree of res i dua l  
enzyme acti v i ty in  the  t i ssues  from these pati ents does  not  correl a te 
to th i s  apparent cl in ica l  heterogenei ty .  The rel ati on sh i p between the 
c l in ica l  var iat ion observed among propi onyl CoA carboxyl a s e  defi c i ent  
pa t i ents and the correspond ing geneti c and b i ochemi cal ma ke up ,  i s  not 
yet understood . The a im of thi s project is  to study the b i ochem i ca l  
and immunol og ical  properti es  of propi onyl CoA carboxyl ase i n  l iver 
homogena tes and fi brobl ast  sampl es from severa l  pati ents wi th prop i onic 
ac idemi a , to gain a better understand ing of the nature of the defect in 
th i s  d i sorder. 
Prev i ou s  compari sons of propi onyl CoA carboxyl ase  from f i bro­
b l a sts of pati ents with  th i s  enzyme def i c i ency and unaffec ted ind i v i ­
dual s have suggested that propi onyl eoA carboxyl a se i s  s tructural ly  
al tered in  t he  pati ents wi th prop i on i c  ac idemi a .  The fi brobl a s t  l ines 
from these pati ents can be categori zed i nto two majo r  genet i c  
2 
compl ementation groups , pccA and pccBC , based on the i ncrea se i n  
acti v i ty observed i n  heterokaryons formed by pa i rwi se  cel l fus i on s . ( 2 ) 
I n  add i ti on ,  the defec ti ve propionyl CoA carboxyl a se  can be  d i fferen­
ti a ted bi ochemica l ly  from the norma l enzyme and from each compl ementa­
tion  group. ( 3 ) These d i fferences suggest that the a l terat ion s  i n  
propi onyl CoA carboxyl a se  structure i n  each compl emen tation  g roup  
represent mutations  i n  d i fferent s u bun i ts .  I n  add i t ion , mutat ions  
wi thi n a s i ng l e  gene  resu l t i ng s l i ghtly d i fferen t enzyme structures , 
woul d  expl a i n  the c l i n i ca l  vari ation  �l i th i n  a compl ementation  grou p . 
Therefore , biochemica l  differences among mutant propionyl CoA carboxy­
l a se s  from the same compl ementat ion group were i nvest i gated . 
To prov ide further ev idence that prop i on i c  ac i demi a  i s  the resu l t  
of s tructura l a l terati ons  i n  propi onyl CoA carboxyl ase , immunol og i c  
techn iques were u sed t o  determ i ne  i f  equa l  quanti t ies  o f  c ro s s -reacti ng 
ma ter i a l  ( CRM ) were present i n  l i ver and fi brobl ast homogenates from 
propi onyl CoA carboxyl a s e  defi c i en t  pati ents from the var i o u s  genet ic  
compl emen ta ti on groups . Anti serum prepared aga i n st  puri f ied p i g  heart  
prop i onyl CoA carboxyl ase  whi ch  cros s -reacts wi th human propi onyl CoA 
carboxyl ase  and another anti serum prepared aga i nst  the human b i oti n ­
conta i n i ng enzymes, were compared u s i ng immunoti trati on techn iques .  
These tests demonstrated that there are equa l  quanti ti es of cro s s -re­
acting ma teria l in  the  ti s sue  homogenates of propion i c  a c i demi a  
pati ents . ( 4, 5) 
Investigations were undertaken to b i oc hemi cal ly  c haracter i ze and  
eva l uate the heterogene i ty wi th i n  the  pccBC  genet i c  compl ementati on 
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grou p .  Th i s  group was chosen because prev i ou s  compl ementation  and 
b i ochemical  s tud i es wi th fi brobl asts  from the pccBC subgroups have 
suggested the ex i stence of i n tera l l el i c compl ementati on in thi s  g roup .  
( 6 ) Spec i fic  b i ochemica l  d i fferences among propi onyl CoA carboxyl a ses  
from cel l s  bel ong i ng to  pa ti ents in  th i s  group  cou l d  identi fy hetero­
genei ty and characterize the compl ementation  pa ttern . Normal and  
mutant  propi onyl CoA carboxyl a se  from the  pccBC comp l ementati on group 
were h i ghly puri f ied and the i r  bi ochemica l  properties  were compared u s ­
i ng the i r  i soel ectr i c  po i nt. thermostab i l i ty ,  a n d  enzyme affi ni ty for 
su bstrates. The properties of the purified enzymes were then compared 
wi th propi onyl CoA carboxylase  from other mutants in th i s  grou p .  These 
compari sons demonstrated b i ochemi cal  heterogene i ty wi th i n  the pccBC 
compl ementat ion grou p . (7 ) 
The resu l ts prov ide  compel l i ng evidence that the defect  in pro­
p i on i c  acidemia  represents a structural a l terati on of propi onyl CoA 
carboxyl ase  i n  the pccA and pccBC compl ementa ti on groups . In add i t i on . 
the b i ochemical  heterogene i ty demonstrated wi thi n the pccBC compl emen­
tation  group suggests that several di fferent s tructural mu tat i ons , 
pos s i bl y of the same subun i t ,  are invo l ved that resu l t i n  s l ightly 
d i fferent bi oc hemica l  parameters for each mutant enzyme . These s tru­
tura l a l tera ti ons may expl a i n  the compl i cated compl ementat i on map for 
the pccBC subgrou ps . S i nce i nteral l e l i c  compl ementation i s  based on 
the heteropol ymer be i ng s l ightl y more acti ve than the homopolymer , 
d i fferent s tructural al teration s i n  the muta nts may i nterfere wi th 
their  abil i ty to parti c i pa te in i n tera l l el i c compl ementation . 
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Furthermore , b i ochemical  d i fferences wi thi n the group may be reflected 
i n  the c l i n i cal  phenotype of the d i sease and may be an  i n d i ca tor of 
the c l i n ica l  vari at ion  wh i ch has  been observed i n  these patients . 
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L ITERATURE REV I EW - CL INICAL REV I EW 
A .  I denti ficati on o f  the Syndrome 
Prop ion ic  aci dem ia  was i n i ti a lly one of a group of metabol i c  d i s ­
orders whi ch was c haracteri zed by the c l i n i ca l  f i nd i ng of hyperg lyc i n ­
emi a . (8 ) I n  1961 , Ch i l d s  e t  a l .  ( 9 ) descri bed a pati ent with  
" id i opa thi c  hypergl ycenemi a" who presented i n  i nfancy wi th vomi t i ng, 
l ethargy , and ketoac idos i s. Ami no ac id  ana lys i s  of hi s s erum revealed 
el evated g l yc i ne concen trati on s  as wel l as modera te elevations  i n  the 
concentrations  of l euci ne , i sol euc i ne ,  and val i ne .  The admi n i s trati on 
of loading doses o f  l eucine. isoleucine , valine o r  threonine, precipi­
tated a ttacks  of ketos i s  and vomi t i ng , whereas g l yc i ne fa i l ed to 
i nduce symptoms . 
Subsequently , another patient  wa s descri bed wi th the cl i n i ca l  
f ind i ngs o f  hyperglyc i nemi a  and se i zures but wi thout ketos i s . ( lO ) 
Thi s patient  cou l d  a l so  be d i fferenti ated from the first  case  by h i s  
respon se  to the l oad i ng tests. Infu s i on of l oading doses o f  i sol euc i ne 
had n o  effect , however , the i nfus i on of g lyc i ne d i d  resu l t i n  aggre­
vati on of the cli n i ca l  symptom in the absence of ketos i s . ( l O ) These 
two cases  demonstrate the cl i n i cal  vari at ion  seen among the hyperg l y­
c i nem i a  syndromes , the presence and absence of ketos i s  and they are , 
therefore ,  des ignated a s  the ketot i c  and n on ketot ic  forms , respect i ve­
l y. ( l l ) � v i vo s tud i es of  patients with the  n onketot i c  form of  
hyperglyc i nemia demons tra te a defect i n  t he  convers i on of g lycine to  
seri ne . The catabol i sm of glyc i ne-1-14C wa s mea sured by  14C02 exp i red 
and glyc i ne _2_14C ut il i za tion was measured by i ts incorporation into 
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ser i ne .  Both functi ons were shown to be impa i red in these pati ents . 
( 12 ) 
For several years , i nvestigators searched fu ti l el y  for a defect 
of g lyc i ne metabol i sm in the ketoti c  form of hyperg l yci nem i a .  I n  1968 . 
Hommes et a l . ( 13 ) observed a pati ent wi th th i s  d i sease who a l so had 
el eva ted propi onate excreti on and , therefore , thi s form of the syn­
drome became known as  prop i on i c  ac i demi a .  Autopsy exam i nati on of the 
l i ver from thi s pati ent showed i ncreased concentrations of ClS- and 
C17 -odd-cha i n  fatty ac i d s . To expl a i n  these find i ngs , Hommes proposed 
that these patients had a metabol i c  defect in prop;onyl CoA carboxy­
l a se whi ch  woul d  prevent propi onyl Cop. from bei ng cata bol ized to 
methyl mal onyl CoA . Thi s defect accounts for the e l evated serum con­
centrati ons of  i sol euc i ne and  the presence of  i ncreased odd -c ha i n  
fatty ac ids  s i nce both are degraded v i a  the propi onate degradation 
pa thway . 
Concurrentl y ,  Rosenberg et a l.( 14 ) reported another pati ent  w i th  
a nother form of hyperg lyc i nemi a who i n  add i ti on to  prop i on i c  ac idur ia  
excreted el eva ted concentrati ons of  methylma l on i c  aci d .  The mass i ve 
excreti on of methylma l on i c  ac id  in this chil d led Rosenberg and his 
col l eages to postu l ate that h is  patient had a defect i n  the propi on a te 
catabol i c  pathway whi c h  prevented the convers i on of methyl mal onyl CoA 
to succ i nyl CoA expl a i n i ng the bu i l d  u p  of methylma l on i c  a ci d .  Re­
studyi ng Chi l d s ' or i g i na l  pa t ient  fa i led to revea l i ncreased 
methylmal on i c  excreti on .  The c l  i n i cal simi l ar i ty of these blo pat ients 
conv i nced the authors that the ori g i na l  proband m i ght have a defect i n  
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the previ ou s  s tep of the s ame pathway , the carboxyl at ion .of propi onyl 
CoA to methylma l onyl CoA . Aga i n , the ident i fi ca tion  of a new ketot i c 
hypergl yci nem i a  syndrome , methylmal on i c  ac idemi a ,  i nd icated further 
heterogeneity among the hyperg lyc i nem i a s  and suggested the pos s i b l e  
d efect i n  a s i mi l ar syndrome. 
I n  197 0 ,  H s i a  et a l . ( 1 5 ) demonstrated a b l ock i n  propionate 
metabol i sm i n  the l eu�cytes from the affected s i bl i ng of Ch i l d s' 
ori g i na l  pati ent and i n  the proband wi th  methylma l on i c  aci dem i a .  
Leukocytes from both patients  and contro l s were i ncuba ted wi th e i ther  
3-14C-propi onate, 14C-methylmal onate o r  14C-succinate. The quantity 
of 14C i ncorporated i nto tri ch l oroacetic ac i d  prec i p i ta tabl e materi a l  
wa s measured a s  an  i nd i ca t i on of meta bo l i sm through  the propi onate 
pathway . The propi on ic  ac idem ic  patient was not a bl e  to meta bol i ze 
the l abel l ed propi onate but cou l d  u ti l i ze both methyl ma l onate and 
succi nate normal l y .  The methy lma l on i c  ac i dem i a  pati ent ' s cel l s  cou l d  
nei ther ut i l ize  l abel l ed propi onate nor methylma l onate but cou l d 
meta bol ize  the l a bel l ed succi nate norma l ly .  S i nce thi s i s  the major 
pathway by wh ich  propi onate i s  metabol i zed , any s ubsta nces enteri ng 
thi s pathway pri or to a b l ock cannot be metabol i zed further . Thi s 
experiment ,  therefore , l oca l i zed the bl ock i n  thi s pathway for eac h  
d i sorder. The bl ock i n  the d i sorder , prop ion i c  a c i demi a ,  occurred a t  
the enzyme prop i onyl CoA carboxyl a se a s  prev i ous ly  postu l ated. The 
b l ock in methyl ma l on i c  ac i demi a is  in methyl ma l onyl CoA muta s e, 
methylmal onyl CoA racemase  or coba l am i n  metabol i sm .  The defec t i n  
propi on i c  ac idemi a was confi rmed by Gompertz e t  a l  .(16) who measured 
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propi onyl CoA carboxyl a s e  acti v i ty d i rectly i n  a l i ver mi tochondria l  
preparation from a d eceased pati ent wi th  prop ion ic  ac idemi a and con­
fi rmed a defi c i ency of thi s enzyme . Thi s fi nd i ng was l a ter  confi rmed 
in fi broblas ts from the ori g i na l  proband and h i s  affected sib l i ng who  
were found to  have l es s  than  2% of normal carboxyla se  acti v i tY . ( 1 7) 
Prop i onyl CoA carboxylase acti v i ty i n  fi brobl asts from eac h  parent 
showed approx imately 50% of norma l acti v i ty .  Because  there was more 
than one affected s i bl i ng wi thi n th i s fami l y  and becau se the parents  
demons trated propi onyl CoA carboxylase acti v i ty i n termed i a te between 
the d efi cient and control val ues . the disorder was considered to be 
i nheri ted as an autosomal reces s i ve cond i t i on . ( 17) Further ev i dence 
for autosomal recess i ve i n heri tance was prov ided by several fami l i e s  
wi th  multi ple affected sibli ngs and documented parental consang u i n ­
i ty . ( 16 . 18) 
B .  Cl i nical Manifestat ions  
The c l i n i ca l  features of prop i on i c  aci demi a are extremel y  vari abl e .  
The c l a s s i ca l  mani festa tions of thi s d i sorder i nc lude severe metabo l i c  
a c i dosis . vomi t i ng . dehydrat ion and l ethargy whi c h  may progress to 
coma if untreated . B i ochemi cal analys i s  may show h i g h  concentrati ons  
of propionate, ammoni a, and glyci ne in  the serum or ur i ne but these  
l atter find i ng s  are not  constant . The i ncidence of comprom i s ed metab­
ol i sm i s  u sually  episodic and must  be trea ted aggress i ve ly  wi t h  fl u i d s . 
glucose, and bicarbonate replacement  to minimi ze the effect o n  the 
patient.(19) 
Many patients wi th propion ic acidemia have presented wi t h  keto s i s 
9 
earl y i n  the neonata l , others  have not exh i b i ted symptoms unti l 
severa l months of age . Some of the vari a bi l i ty i n  the age  of onset  of 
symptoms may be expl a i ned by d i fferences in d i etary protei n  i n ta ke or 
the occurrence of i nfec ti ons . These two factors often i n tera c t  to 
prec i p i tate a cri s i s  by cau s i ng an overl oad of endogenous prote i n  
catabol i sm not tol erated by the pati ent . ( 20 ) 
The mode of presentati on of th i s  d i sorder i s  a l so var i a b l e. 
Ketoaci do s i s s i gnal s i mmed i atel y  that the probl em may be metabol i c ;  
however , recently some pa ti ents have been reported who have not  pre­
sen ted with acidosis . Non-specifi c symptoms such as vomiting, 
dehydrati on and l ethargy can m im i c  commonly occurr i ng probl ems s uch  as  
seps i s ,  gastroi ntest i nal  obstruct i on , card i opul monary probl ems or 
b i rth trauma mak i ng d i agnos i s d i ffi cu l t . (21 ) The only cons i s tent  b i o­
chem i ca l  f ind i ng i s  e l evated s erum propi onate whi c h  wou l d not  be 
detected by rout ine  testi ng. 
Rap i d  d i agnos i s  of th i s  d i sorder i s  essenti a l  for proper treat­
ment because  the ac i d os i s  i n  these ch i l dren may be pers i s tent and 
requ i re agress i ve treatment . ( 21 ) The reduc t ion  in prote i n  i ntake  to a 
tol erabl e l evel i s  a major factor i n  restori ng metabol i c  bal ance . 
Severa l pati ents have been mi sd i agnosed a s  non-ketoti c hypergl yc i nem i a  
( 22 , 23 ) because  o f  the a bsence o f  ketos i s o r  a s  a dysautonom i a and  
subsequently, a urea cyc l e  defect because  of the presence of hyper­
ammonem i a  i n  the absence of hypergl yc i nem i a. ( 24 ) A further demon stra� 
t i on of the c l ini ca l  heterogene i ty i s  the report of a tota l l y  asymto ­
ma t i c  patient who has a comparable enzyme deficiency to other 
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prop i on i c  ac i demia  pati ents i nc l u d i ng her  brother who  c l i n i ca l l y  man i ­
fests  the d i sorder . Thi s pati ent has never been ketoti c ,  even when 
chal l enged wi th an  i sol euc i n e  l oad i ng tes t . ( 25 ) Cl earl y ,  the c l i n i cal 
var i ab ili ty seen in th i s  d i sorder makes d i agnos i s  d i ffi cul t i n  many 
cases  as wel l as resu l ts i n  affected symptomatic  or a symptomat i c  
i nd i v i dua l s who a r e  never d i a gnosed . 
Hyperglyci nemi a ,  frequently  observed during  cri ses has  been a 
major d i agnostic i nd i cator of prop i o n i c  ac idemi a and suggests further 
defi n i ti ve testi ng . Perturbati on i n  propionate metabol i sm cau sed by 
the enzyme defect may also result in hyperammonemia especially during 
meta bol i c  cri ses . ( 26 ) These two b i ochemica l  features are proba bl y  
secondary to the pri mary defect because  they are frequently found i n  
pati en ts wi th other metabol i c  d i s orders such  a s  methyl ma l on i c  ac i dem i a  
and i sova l er i c  acidemi a .  Several stud i e s  have been performed t o  e l u ­
c i date the eti ol ogy o f  hypergl yci nemi a .  The c l eavage of 1 _14C-g l yc i n e  
i n  v i vo a s  measured by 14C02 expi red , h a s  been s hown to b e  impa i red. 
( 27 , 28 , 29 ) However , the ab i l i ty of 2 _14C-gl yci ne to be converted to 
l a bel l ed seri ne seems to be normal in prop i on i c  acidemi a pati ents i n  
contra s t  to the findings i n  nonketoti c hyperg lyc i nemi a . ( 30 ) A s econd-
ary i nh i b i t i on of the g l yci ne c l eavage system by propi onate or i ts 
metaboli tes may account for the el evated g l yci ne concentrati ons  
observed i n  prop i on i c  acidemia. 
There i s  growi ng evi dence that the i ncrea se concentrat i on of pro­
p i onate or i ts metabolites whi c h  occurs in body ti ssues  of these 
pati ents causes a secondary hyperammonemia. Serum concentrations of 
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ammon i a  have been shown t o  b e  d i rectly proporti onal t o  the i nc reased 
l evel s of serum prop i onate. ( 3 1) The observat ion of a decrea s e  i n  car­
bamyl phosphate syntheta se acti v i ty in  two prop i on i c  ac i demi a pati ents 
suggests that propi onate concentra ti ons may i nfl u ence th i s  enzyme . ( 32. 
24) Al though, propi onate does not i n h i bi t carbamyl phosphate synthe­
tas e ,  the CoA deri vati ves t i g lyl CoA , propi onyl CoA , and methylmal onyl 
CoA a s  wel l a s  free Coen zyme A i n h i b i t  the acti v i ty of carbamyl 
phosphate synthetase from norma l human l i ver up to 70% . ( 33) An a l ter­
nate mechani sm by wh i c h  propi onyl CoA may i nfl uence carbamyl phosphate 
synthetase acti v i ty is sugges ted by its ability to inhibit N-acetyl­
g l u tamate syntheta se . N-acetyl g l u tamate i s  an acti vator of carbamyl 
phosphate synthetase; therefore , a decrease i n  i ts synthes i s  wou l d  
resu l t i n  a decrease i n  the acti v i ty o f  carbamyl phosphate synthe­
tas e . ( 34) A thi rd mechani sm i mpl i cates the depleti on of ATP by h i g h  
l evel s o f  propi onate wh i c h  i n  turn i nh i b i ts carbamyl p hosphate synthe­
tase . The  i nh i b i ti on of thi s enzyme i s  rel i eved by the  add i t i on of 
excess ATP to the system . (35 ) 
Another mechani sm for urea cycl e i n h i b i ti on has been proposed by 
Wi l l i amson et a l .  (36) wh ich  i nvol ves the tyi ng u p  of free acetyl -CoA 
by the acyl i ntermed i a tes whi c h  bu i l d  up  al ong the pathway . The 
decl i ne in free cel l u l ar acetyl -CoA i nh i bi ts pyruvate carboxyl ase  which 
has  been shown to d ecrease both g l uconeogenesis and urea synthes i s by 
50% i n  i sol a ted rat l i ver cel l s .  Th i s  mechan i sm may a l s o  exp l a i n  the 
hypoglycemia  often accompanyi ng thi s d i s order . 
Other f ind ings  which have been descri bed i n  assoc i a tion with 
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prop i on i c  acidemi a i ncl ude neutropen i a  a n d  i ntermi ttent thrombocyto ­
pen i a  which  may pos s i bl y  account  for t h e  frequent  infecti ons i n  
affec ted c h i l dren . Chron i c  features such a s  se izures a n d  mental 
retardati on have been descri bed frequentl y i n  thi s d i sorder but  may b e  
secondary to the acute early i nc idences o f  ac i dos i s  whi ch  are accom­
pan i ed by hyperammonemia  whi ch  i s  probably i njur ious  to bra i n  
development and functi on. ( 2I ) There i s  hope that wi th earl i er recog ­
n i tion  and better metabol i c  control , many of these problems can be 
averted . 
C .  Abnormal Metabol i tes  
The  defi c i ency of propi onyl CoA  carboxyl ase  acti v i ty in  these 
patients causes an accumu l ati on of propi onate i n  body ti s sues  resu l t ­
i ng i n  the metabol i sm o f  propi onate by a l ternate mi nor pathways . Many 
of these pathways have been i denti fi ed by el uc ida ti ng abnormal metabo­
li tes in the serum or uri ne of pati ents wi th thi s d i s order . The u s e  
o f  i sotopes to identi fy abnormal metabo l i tes  h a s  a l so  contri buted t o  
o u r  knowl edge o f  normal human metabol i sm by i denti fying  reacti ons  
which  had not been  previ ously descri bed in  man . 
The first  observat ion of propi onate bei ng shunted through  an  
alterna te pathway was made  by  Hommes et  a l . (13 ) in  one o f  the ori g i nal 
proband wi th the f i nd i ng of i ncrea sed Cl5 and CIl odd -cha i n  fatty 
ac id s . These fatty ac i d s  can be g enerated by substi tuting propi onyl 
CoA for acetyl CoA in fatty ac id  synthes i s  cau s i n g  the add i ti on of 
three carbon u n i ts rather than two carbon un i ts. Thi s proces s  wou l d  
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occur even though the affi n i ty of the enzyme for prop ionate may be l ow .  
due to the h i g h  concen trations  o f  propionyl CoA i n  the cel l s. 
Compos i t ion of the ketones found i n  propion ic  aci demi a pati ents 
are d i fferen t from those found i n  other ch i l dren wi th keto si s .  
Menkes (37) compared the ketone found i n  the keto ti c  cri s i s o f  Ch i l ds' 
or i g i nal  patient to five other chi l dren wi th varyi ng causes  of  ketos i s. 
I n  the chi l dren wi th ketos i s from other causes , acetone formed approx ­
imately 95% of the i r  ketone . Duri ng ketoti c cri ses, 60% of the ketone 
from pa ti ents wi th prop ion i c  acidemia  were acetone whereas the rema i n ­
der consisted of four or more carbon units . Three unusual ketones 
were found , 2-bu tanone . 2-pentanone and 2-hexanone . The 2-bu tanone 
whi ch  formed 25% of the patients' ketones had not prev ious ly  been 
descri bed in human s .  Thi s fi ndi ng was confi rmed by Sweetman et a l . 
(38) u s i ng ga s -l i q u i d  chromatography and mas s  spectroscopy ( GC/MS ) who 
postu l a ted that thi s ketone was deri ved throug h i sol euc i ne metabol i sm 
from the i ntermed i a te 2-methyl acetoacetyl CoA a s  shown i n  step 4 of 
the pathway in  fi gure 1 .  
The most a bundant abnorma l metabol i te found i n  the uri ne of  pro­
p ion i c  aci demia pati ents i s  methyl c i trate . This substance was found 
i n  the ur ine  of a patient  after be i ng fed 1-14C-propi onate and i denti ­
fi ed by GC/MS . Methyl c i trate i s  formed by the consol i dati on of 
prop i onyl CoA wi th oxa l oacetate by c i trate synthetase. ( 3 9 ) S tudies of 
thi s en zyme from p i g  heart s how that it  can u se  propi onyl CoA approx i­
mate ly  1/1000 as  effi c i entl y  as  acetl y CoA . (40 ) 
Another pathway metabolises propionate byf -oxi dat ion to 
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3-hydroxyprop ionate. (4 1 ) The f ind ing that a l abel ed 14C -val i n e  can be 
converted to hydroxyprop i onate i nd icated that va l i ne  mus t  be normal ly 
meta bol i zed throug h  propi onate . 
Other metabol i te s  of i sol eucine  cata bol i sm are found i n  the ur i ne 
of prop i on i c  aci dem i a  pati ents . The most  a bundant is  ti g l ic acid . (42 ) 
Two prev i ous ly  unrecognized ur i nary metabol i tes , 2-methyl butyr i c  ac i d  
a nd  2 -methyl -3-hydroxybutyri c  ac id , are der i ved from the i r  CoA i n ter­
med i a tes  in  the  i sol euc i ne  degradative pathway . ( Steps 1 ,  2, and 3 in  
fi gure 1 ) ( 38 ) These  metabol i c  i ntermed i ates accumu l ate becau se  the  
block in  propionate u tili zation causes  a shift i n  the equilibrium 
al ong the pathway . 
A general mechani sm for detox i fyi ng CoA deri vatives  i s  thei r con­
jugation wi th g lyc i n e . Propi onyl g lyc i ne ( 43 ) , t i g lyl gl yc i ne ( 44 ) , and 
2 -methyl butyryl g l yc i ne ( 38 ) have a l l been i denti fi ed . It  has  been 
postu l a ted that the high g lyc i ne l evel s in  this syndrome stimu l ates 
detox i f i cation . The high g l yc i n e  concentrations  s hou l d  then resu l t i n  
a decrease in propi onate concentrati ons and b e  i nverse l y  proporti onal 
to the propi onate concentrati on i n s tead of d i rectly proporti ona l , as 
has been observed . (43 ) 
Two condensation  p roducts of propionyl CoA and acetyl CoA have 
been observed�3-oxova l er i c  acid and 3-hydroxyva l eri c  aci d .  ( Steps 6 
and 7 i n  f igure 1 ) The thi ol a se  from p i g  heart wh i c h  normal l y  cata­
l yzes the condensation  of two acetyl CoA mol ecu l es has been s hown to 
use propi onyl CoA at about 2% of i ts maximal  effi ci ency . ( 38 ) The 
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ABNORMAL METABOL ITES 
I SOlrCine  
2 -oxo -3 -methyl val eri c acid  
URI NARY METABOLITES 
I _____ 2-methyl butyl"i c ac id  
2 -methyl butYl"yl COA _______ 
I 
2 -methyl butyryl g lyc i n e  
�Ti9liC acid 
Tig lyl CoA 
I Tig lyl g lyc i ne 
2 -melthYl -3-hYdrOXYbutyr�A 
;2-methyl -3 -hydoxybu tyr i c  ac id  
2-methyl acetoacetyl CoA -- 2 -methyl acetoaceti c a c i d  . 
1 
methyl ethyl ketone (2-butanone ) 
5 Acetyl CoA Propi onyl CoA - Propi onic aci d V.:--k 3==::::'Propi onyl g lyc i n e  �. � -- 3-hydroxypropi on i c  acid Methyl mal onyl CoA�ethyl c i trate 
6 3 -oxo,alerYl CoA 3�oxoval eric a c i d  
7 3-hydroxyval eryl CoA�· --- 3-hydroxyva l er i c  ac id  
Fi gure 1 - Abnormal uri nary metabol i tes. A proposed pa thway for  the  
producti on of abnorma l ur i nary metabol i tes . (38) 
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condensation of acetyl  CoA in  man  may occur i n  norma l metabol i sm s i nc e  
the enzyme must  be presen t .  
The uri nary metabol i te excretion patterns i n  prop ion i c  aci d em i a  
a r e  s imi l ar t o  those found i nj?-methyl crotonyl CoA carboxyl a s e  
defi c i ency and methyl ma l on i c  ac idemi a ,  but they d i ffer s i gn i ficantl y 
from those  seen i n  n on-ketoti c hyperg l yc i nemi a . (45 , 46 ) 
D .  Treatment 
The major method of treati ng thi s d i sorder has been to p ermi t 
norma l protei n  synthes is  wi thout causi ng endogenous protei n  catabolism. 
Thi s i s  accompl i s hed by restr i cting  d i eta ry prote i n  thereby l im i t i ng 
potenti a l ly harmfu l ami no aci ds  i sol euc i ne , val i ne ,  meth i on i ne and  
threon i n e .  The  restricted prote i n  i ntake ranges from 1 to 1 . 5  grams 
per k i l ogram body wei g ht per day whi l e  norma l ca l or i c  req u i rements a re 
made up  l argely  from foods r i ch  i n  carbohydrates . Thi s d i et requ i re s  
a del i cate ba l ance between the amoun t  o f  prote i n  these  chi l dren can 
tol erate wi thout devel opi ng symptoms and the amoun t  requ i red for nor­
mal mental and phys ica l  growth . Even mi nor chi l d hood i nfecti ons can 
alter body protein catabolism and compromise these pat i ents . (20 ) 
The success of thi s form of therapy has been variab l e .  Manage­
men t of these pa ti ents seems to  be most  d i ffi cu l t betwee n  b i rth and  
two years , when the  metabol i c  demands of the  body are h i g h  and the  
amount of prote i n  requ i red exceeds the  amount tol era ted by  the prop i ­
on i c  acidemic  pati ent . ( 24 ) During that cri ti ca l  peri od , many patients  
devel op severe metabol i c  compromi se , i rreversa ble bra i n  damage  or  d i e . 
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Pati ents surv i v i ng th i s  peri od seem to  be eas i er to  control . The  
earl i er l i terature i ndi cates that  mos t  pati ents d i ed in  the fi r st  few 
months of l i fe , even w ith  ear ly  d i etary treatment . ( 2 1 ) However , with  
earl i er recogn i tion , d i agnos i s and  i nst i tu t i on of appropri ate therapy , 
the prognos i s  i s  somewhat improved . 
E .  B i oti n Respons i ve-Propi on i c  Ac i demi a 
Another exampl e of c l i n i cal  heterogenei ty wi th i n  th i s  d i sorder 
was the i denti fication  of a growi ng number of  pati ents who demons tra­
ted c l i n i ca l  improvement after the adm in i strati on of pharmacol og i c  
concentrations of the v i tami n ,  b iot in. In the simi l ar disorder 
methyl mal on ic  ac idemi a ,  the v i tam i n  B 12 which i s  requ i red for acti v i ty 
of methyl ma l onyl eoA mutase has been s hown to amel i orate the symptoms 
i n  a proporti on �f the cases . ( 47 ) Thi s f indi ng l ed to the specu l at ion  
tha t b i oti n ,  the  coenzyme for propionyl eoA carboxyl a s e  cou l d  be  u se­
ful i n  the  treatment of  prop i on i c  aci demi a .  The importance o f  b i oti n 
i n  the treatment of some of these ch i l dren was confi rmed when Barne s  
et a l . ( 48 ) reported a chi l d  who exh i b i ted marked c l i n i ca l  improvement 
after being treated wi th 5 mg. of  b iot in  dai l y .  Subsequently ,  two 
other pati ents have been reported who, in add i t ion to the ur i nary 
metabol i tes  prev ious ly  found i n  propionic aci demi a ,  hadj3-methyl ­
crotonylglycine.(49, 50 , 5 1 ) Thi s abnormal  uri nary metabo l i te 
s i gnal l ed a second defect i n  the enzyme;e-methylcrotonyl eoA carboxy­
l a s e . Stud i es of the fibroblasts from one of these  pati ents 
demonstrated that both propionyl eoA carboxylase and ;B -methyl crotonyl 
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GoA carboxyl ase  acti v i ti e s  were defi c i en t .  Enzyme acti v i t ies i ncreased  
to norma l when fi brobl asts  were i ncubated in  h i g h  concentra ti ons  of  
bi oti n . ( 50 ) Thi s f i nd i ng l ead to the hypothes i s that the enzyme 
defi c i enci es were s econdary to a defect i n  a common hol ocarboxyl a s e  
syntheta se whi c h  attaches b i oti n t o  both enzymes or , an a l terna te 
hypothes i s ,  that there was a defect i n  i nterce l l u l ar b iot i n tran s port. 
Recen tly , fi brobl asts  from two of thes e  pati ents have been res tud i ed 
and have been s hown to have a defi ci ency of a thi rd m i tochondri a l  
carboxyl ase , pyuvate carboxyl ase . ( 52 ) Two add i t i onal  pati ents have 
been reported in whom all three fibroblast mitochondrial carboxylase 
defi c i enc ies  were s hown to be bi oti n respon s i v e . ( 53 , 54 ) I n  add i ti on , 
e i g h t  pati ents have been reported i n  whom the b ioti n respon s i ve mul ­
t i p l e carboxyl ase defi c i ency was demonstrated i n  l eu�ocytes . ( 5 5 , 56 , 
57 , 58 ) Al opec i a  and dermatit i s seem to accompany the syndrome . I n  
one fami l y  a defect i n  i mmune response has been reported wh i c h  may 
account for a cand ida  type s k i n  rash  whi c h  i s  frequently observed . ( 56 ) 
An unusua l  case has been reported where the patient had typ i ca l  fi nd ­
ings for a mu l t i pl e carboxyl ase  defi ci ency , i ncl udi ng a l opec i a , 
dermati ti s ,  hypoton i a  and l arge quant it ie s  of 3-hydroxyisovaleric 
a ci d ,�-methyl crotonyl g l yc i ne , and 3-hydroxyprop i onate i n  the ur i ne . 
But  the enzyme assay of the three carboxyl a ses i n  fi brob l a sts  from 
thi s pat ient  showed norma l activ i ty .  The pat ient  responded c l in i ca l l y  
t o  h i g h  doses  o f  b i oti n and therefore the tran sport of b i oti n was 
apparentl y defecti ve i n  thi s pati ent . ( 59 ) A case of b i oti n respon s i ve 
propionyl eoA carboxyl ase  def i c i ency wi th normal ji-methylcrotonyl eoA 
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carboxyl ase  acti v i ty h a s  a l s o  been reported . ( 60) Th i s  may represent  
sti l l  another form of the  b iot in  respons i ve d i sorders . 
For pati ents wi th the v i tam i n  respon s i ve carboxyl ase  defi c i enc i e s , 
the admi ni strat ion of  b i oti n doses as  h i g h  a s  50 mg . per day i s  nece­
ssary to amel i orate the symptoms . I n  contrast , for mos t  prop i on i c  
aci dem ia  pati ents , the admi n i stration  o f  h i g h  doses o f  b i o t i n  does not  
i ncreas e  t he  enzyme ' s  act i v i ty even though �-methyl crotonyl CoA 
carboxyl ase  acti v i ty in these pati ents  i s  i ncreased s l i ghtly a bove 
normal  i nd i cati ng that  b i oti n i s  enteri ng these c el l s . (61 ) 
F .  Prenata l  Detecti on 
Prenata l  d i agnos i s of th i s  d i sorder has been a ttempted u s i ng 
severa l  d i fferent methodol ogi es . Di rect measurement of prop i onyl CoA 
carboxyl ase  act i v i ty in cu l tured amn i on i c  cel l s  i s  a very sen s i t i ve , 
exact method a l though con s i derab l e time i s  requ i red to cul ture enough  
cel l s  for  the enzyme a s say . Thi s techni que  was u sed by Gompertz e t  al e 
( 62 ) to d i agnose the f irst  case of prop i on i c  ac idemi a i n  u tero by com­
par i ng the acti v i ty of cul tured amn i on i c cel l s  obta i n ed by amni ocen ­
tes i s  wi th cel l s  obta i ned from e i ght other pregnanci es whi c h  were not  
a t  ri s k .  
A method has been proposed by H i l l  e t  a l . ( 63 ) that does not re­
qu i re cul tur i ng of the  fi brobl a s t  cel l s .  I n s tead , the fi brob l asts  
obtai ned a t  amn i ocentes i s  are  i ncubated wi th 14C-prop i onate for  10 
hours , then was hed and exam i ned by autorad i ograph i c  techn i ques . Thi s 
method i s  rap id  and can iden t i fy both prop i on i c and methyl mal on i c  
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ac i dem ia  s i nce nei ther can i ncorporate l a be l l ed prop i onate . A qua n ta ­
tat ive  var iati on of thi s method was devi sed u ti l i zi ng t h e  tri c h l oroace­
t i c  ac id  prec i p i tab l e mater i a l  whi ch i s  counted in  a sc i nt i l l a ti on 
coun ter to determine  prop i onate i ncorpora ti on . ( 64 ) Wi l l ard and 
col l eagues  ( 65 ) u sed thi s method i n  four a t  r i s k  pregnanc i es for 
methylma l on i c  ac idemi a .  They pred i c ted the outcome correctly i n  a l l 
ca ses  and ident if i ed one affected fetu s .  
Another method of i denti fyi ng a fetu s a t  r i s k  for prop i on i c  
aci demi a i s  ana lys i s o f  amn ion ic  fl u i d  for two u n i que  meta bol i tes  o f  
prop i on i c  ac i demi a methyl c i tra te a n d  3-hydroxypropi onate b y  GC/MS . ( 66 ) 
Thi s procedure i s  rap i d  permi tti ng d i agnos i s  wi th i n  48 hours . 
The importance of rap id ly  i denti fying  an affected fetus i s  
e s pec i a l l y  cruc i a l  i n  the v i tami n respon s i ve d i sorders s o  that pre­
nata l  v i tami n treatment can be i n i t i ated . 
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A .  Propi onate Metabol i sm 
Propi onate i s  produced by the oxi dation  of the branch-cha i n  ami no 
ac ids , v a l i n e , methi on i n e , and i sol euc i n e , (Fi gure 2 ) , theft-oxida­
t i on of odd-cha i n  fa tty ac ids  and  the  s i de cha i n  of chol estero l . 
Prop i onate i s  further catabol i zed to methyl mal onyl CoA and subsequen t­
l y ,  succi nate where i t  enters the tri carboxyl i c  ac id  cyc l e .  
Prior to 1950 , the catabol i sm o f  propi onate wa s thought  to occur 
by d i rect convers i on of another three carbon i n termed i ate such a s  
pyruva te . { 47) Lorber et  a l . (48) f irst  suggested an a l ternative  meta ­
bol i c  pathway , after observ i ng that when 0( o r p -l abel l ed propi onate 
wa s i nfu sed i n to a rat , both the 0( and f3 carbon s of the pyruvate 
i sol ated were equa l l y  l a bel l ed .  I n  order to expl a i n  the randomi zati on 
of  the l abel , the i nvesti gators postu l a ted that the convers i on of pro­
pi ona te to pyruva te wa s occurri ng throu g h  a symetr i cal  four-carbon 
i n termed i ate such as succ i nate . Lardy (49) observed that the 14C02 -
fi xat ion reaction requ i red the presence of propi onate and ATP i n  crude 
ra t l i ver mi tochond ri a .  Thi s  product was extrac ted and i denti fi ed as 
succ i nate by paper chromatography .  ( 50 , 5 1 ) Flavi n et a l . ( 52 ) , u s i ng 
an enzyme prepara t i on from p i g  heart , found tha t the C14-l a be l l ed 
product of  carboxyl ati on co-migra ted wi th succi nate i n  the i r  c hromato ­
graphi c system , but i t  wa s not converted to fumara te or ma l a te when 
i ncu bated wi th succ i nox i dase . Us i ng several so l vent sys tems , they 
demon strated that the actual l a bel l ed product wa s methyl ma l on i c  acid . 
2. 2  
F IGURE 2 
DEGRADAT I ON OF METH I ON I N E , VAL I NE , AND ISOLEUC I N E  TO PROP I ONYL CoA 
from-Leni nger , A . L .  i n  B i o c h e Pl i s t ry p 5 7 7 . W o r t h  P u b l i s h e r s  
I n c  . •  N e w Y o r k . 1 9 7 8 . 
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This observation was confirmed in rat l iver by Katz and C haikoff ( 53 ) ,  
al though  in rat .  the majority of the product  was quickly c onverted to 
succina te . I f  propionyl CoA was u sed a s  the substrate , the a ctivity 
increased substantia l l y ,  suggesting tha t it was the actua l  s ubstrate 
for the enzyme . ( 54 , 55 ) The propionate carboxyl a tion reaction there­
fore required propionyl CoA , ATP , and Mg�+ .  The reaction was further 
enhanced by g l u ta thione which s tabil ized the thio�g roups  and thereby 
indicated their importance in the carboxyl ation reaction . (49 ) 
Since other carboxyl a tion reactions have been shown previous l y  to 
be b iotin-dependent ,  Lardy and Adl er ( 5 1 )  s tudied prop ionyl C oA 
dependent 14C02 -fixa ti on in a series of rats made b i oti n deficient by 
adding avidin to their diets . Carboxyl ation of propionyl CoA was 
reduced to approximately 1 0% o f  normal which cou l d  be res tored and  
even  enhanced a bove normal l evel s after three days of ora l  biotin 
suppl ementation . These resu l ts suggested that biotin wa s an e s sen tia l 
cofactor for propionyl CoA carboxyl a se activ i ty .  
By 1957 , the propionate degradati 'Ie pathway , incl uding the fac ­
tors necessary for optima l  activity was known a s  fol l ows : 
Mg*r 
Propi onyl CoA + ATP + CO2 �----� methylmal onyl CoA �---) Succinyl CoA bioti n B1 2  ADP + Pi 
B .  Enzyme Character i zation 
The compartmental i zat i on of propi onyl CoA carboxyl a s e  in rat l iver 
reveal ed tha t 75% of the enzyme acti v i ty was l ocal ized in the mitochon-
dr i a . ( 56 ) Prop i onyl CoA carboxyl ase  has  been purifi ed from many 
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organ i sms and the enzymat ic  propert ies  of the enzyme from a var i e ty of 
sources s hows remarkabl e s im i l ari ty .  For exampl e .  the Km val u es for 
the various  s ubstrates l i sted i n  Tabl e I are very s i mi l a r ,  i f  not 
iden t i ca l . I n  add i ti on to catabol i z i ng propionyl CoA , the enzyme can  
a l s o  cata l yze the carboxyl ati on of severa l of acyl compounds i nc l ud i ng 
acetyl CoA , butyryl CoA and va l eryl CoA but  uses  these 1 . 03 .  4 . 7 1 . and 
0 . 49% respectively a s  effi c iently  a s  prop ionyl CoA . ( 57 ) 
Prop i onyl CoA carboxyl ase  acti v i ty i s  extremel y  sen s i t ive  to i n ­
hi b i t i on by avid i n .  the whi te prote i n  whi c h  b i nd s  b iot i n and b i o ti n ­
conta i n i ng enzymes a lmost  i rrevers lb ly . ( 64 . 6 5 )  The add i ti on of 
excess  b i oti n to av i d i n  pri or to i ncubation wi th prop i onyl CoA carbox ­
yl a se  protects the enzyme from av i d i n  i nactivat ion . ( 65 ) Puri f i ed p i g  
heart propi onyl CoA conta i ns four  mol ecu l es of b i o ti n  for every 
700 . 000 mol ecu l ar  wei g ht mol ecu l e  of the enzyme a s  determi ned by gel 
fi l trati on . 
The carboxyl ati on reaction  was a l so  shown to be sensi ti ve  to 
su l fhydryl reagen ts such a s  para -chl oromeri cu� benzoate , i adoacetam ide  
a nd  N -ethyma l eimide a nd  i s  protected from i nactivat ion by g l uta ti one . 
(66 , 67 ) Pre - i nc u ba t i n g  wi t h  pro p i onyl CoA prevents the i nacti vation 
by these s u l fhydryl reagents . Moreover , add i t i on of ei ther of the 
su l fhydryl reagents causes  a change in  the Km of prop i onyl CoA but 
does not a l ter the Km ' s  for ATP or b i carbonate i nd i ca t i ng that a cys ­
ti ene res i due  i s  i nvol ved i n  or near the b i nd i ng s i te of  prop i onyl 
CoA on the enzyme . ( 68 ) 
Propi onyl CoA carboxyl a se has a l so  been s hown to be a c t i v a ted by 
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1 X 1 0 -4 
2 X 10 -4 
1 . 6 X 10-3 
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8 
8 X 1 0-5 
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3 X 10-3 
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8 .  F .  Ka l ousek , M . Dari go , and L .  E • .  Rosenberg . J .  B i o1 . Chern . 255 : 60-65 , 1980 . ( 63 ) 
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monova l ent cations  such  a s  pota ss i um .  Pota s s i um ha s been reported to 
s l i g htly l ower the Km for b icarbonate . ( 69 ) Gi org i o  a nd Pl au t  did not 
fi nd a l owered Km for b icarbonate but rather a n  i ncrease  in the 
vel oci ty of the react i on . ( 59 ) 
C .  Mechani sm 
Kaz i ro et a l . (70) and Lane et a l . ( 71 ) i ndependentl y proposed 
the fol l owing two s tep carboxyl at ion  reaction  for propi onyl CoA 
ca rboxyl ase : 
Parti a l  Reaction 1 
( EnZ  - B i o t i n ) + ATP + HC03 - -�g�� - ( EnZ-B i o ti n  -C02 ) + A �P + P i  
Parti a l  Reacti on 2 
( Enz  - B i oti n - CO2 ) + Propi onyl CoA - ----- Methyl ma l onyl CoA + ( Enz  - B i oti n ) 
Net Reaction  
ATP + HC03
- + Propi onyl CoA ---------- Methylmal onyl CoA + ADP  + P i  
Thi s concerted P i ng -Pong mechan i sm was proposed , ba sed on s everal 
observati ons  whi c h  were cons i stent only with thi s mechan i sm . ( 72 ) The 
first parti a l  reaction wh ich  requ i red Mg++ was supported by the  fol ­
l owi ng two o bservati on s .  F i r st , Kaz i ro et a l . (73 ) s howed that the 
exchange of l abel  between ADP32  and ATP or P i 32 a nd ATP requi red the 
presence of both ADP and P i . Second l y ,  the exchange of l abel l ed ADP3 2  
with ATP o r  P i 32 wi th ATP wa s CO2 dependen t . (74 ) The second revers i bl e 
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parti a l  react ion was deomonstrated by the prop i onyl CoA carboxyl a s e  
med i a ted cata lys i s  of an exchange reacti on between methyl mal onyl CoA 
and 14c_ propi onyl CoA whi ch was i ndependent of ATP , ADP or Mg++ . ( 67 ) 
( 7 0 , 7 1 , 7 5 ) The reverse react ion has  a l so  been demon s trated by the 
exc hange of 3 -14C -methylmal onyl CoA wi th propi onyl CoA . (67 ) Both 
partia l  reacti ons  are a v i d i n  sens i tive  i nd i cati ng that b i oti n i s  re­
qu i red . The rates for the two parti a l  reactions  have been determ i ned 
by Kaz i ro et a l . (76 ) and are s hown i n  Ta bl e I I . 
Stud ie s  of these  reacti ons u s i ng l a be l l ed oxygen showed that one 
oxygen from HC03
- was necessary for the ATP cl eavage and wa s i ncor ­
porated i n to orthophosphate , whereas ,  two l abel l ed oxygens  were found 
in the free carboxyl group  of methylmal onyl CoA . S i nce both oxygens  
in  the carboxyl group of methyl mal onyl CoA were l abel l ed ,  the reacti ve 
spec i es mu st  be HC03 - rather than CO2 wh i ch  wou l d  have on l y  l a be l l ed a 
s i ng l e oxygen of methylmal onyl CoA . ( 73 )  
The s i te o f  carboxyl ati on o n  the enzyme ha s been shown t o  b e  the 
I -N -pos i t i on of the b i oti n miety . ( 72 ) Chromatograp h i c  stud i e s  of  the 
hydro lys i s  of the puri f i ed beef l i ver mi tochondr ia l  enzyme has i denti ­
f i ed on (-N-I-N-carboxy( + ) bi oti nyl lysyl res idue . ( 77 ) Thi s i nd i cates 
that the b i oti n bi nds to the enzyme via the [-am i no group of l ys i ne . 
D .  B i oti n a s  a Cofactor for Propi onyl CoA Carboxyl a se 
B i ot i n  i s  the coenzyme for the four known human carboxyl a s e  
enzymes : acetyl CoA carboxyl a s e , f -methyl crotonyl CoA carboxyl a s e , 
pyrvate carboxyl a se and propi onyl CoA carboxyl a s e . The b iot i n 
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TABLE I I  
RATE OF REACT IONS CATALYZ ED BY P ROP I ONYL CoA CARBOXYLASE 
Reacti on 
Overa l l ,  forward 
Overa l l ,  backward 
P i
32_ATP exchange 
Propi ony1 CoA _1 _C1 4_ 
Methy1ma1 0ny1 CoA exchange 
Rate ( 2 50 ) 
moles/mi n/Un i t  forward 
1 . 000 
0 . 01 5  
0 . 002 
0 . 600 
From - Y .  Kaz i ro and S .  Ochoa . Adv . Enz . 26 : 283-378 , 1 964 . (V6 ) 
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mo l ecu l e con s i s ts of  a ureido  r i ng  fu sed to  a tetra hydrothrophene r i ng 
wi th a f ive  carbon a l i phati c s i d e  cha i n  as  shown i n  F i gure 3 . (47 ) 
B i oti n cannot be synthes i sed i n  man and i s  therefore suppl i ed by d i et 
and by rud imentary bacter i a . A d i etary defi c i ency of b iot i n causes  a 
severe i l l ne s s  whi ch  i s  a phenocopy of the mul ti pl e carboxyl a s e  
defic i ency s i nce  b i oti n i s  requ i red t o  tran sform the four carboxyl a ses  
i nto the i r  act i ve  forms . B i oti n seems to be coval ently attached to 
eac h  of the carboxyl a ses via i ts a l i p hat ic  s i de cha i n  by the act i on  of 
a common hol ocarboxyl a s e  syntheta se . The react i on requ i res  ATP and 
Mg++ and i s  spec i fi c  for d-bi oti n .  ( 78 ) T h e  proposed mecha n i sm fOI' 
hol ocarboxyl ase  synthes i s i s  repre sented by the fol l owi ng two parti a l  
reacti ons : (7 9 ,  80 ) 
Part i a l  1 
Part ia l  2 
�lg++ 
d -B i oti n + ATP --synthetase-- R-�-O-S-O-Adenos i ne b 
d-bi  oti  nyl -6 ' -A t4 P 
o 
d-B i oti nyl -5 ' AMP +Enz-l ysyl -(-NH2 ------------Enz-l ysyl -{-NH-f-R+5 ' AMP apoenzyme syntheta se hol oenzyme 
Net Reacti on 
Mg++ d-B i oti n + ATP + apoenzyme ------ Hol ocarboxyl ase  + AMP + PP i 
The reaction  i nvol ves  the formati on of a n  amide  l i n kage  between the 
a l i p hati c s i d e  c ha i n  of bi oti n and the e -am i no  group of a l ys i ne res i ­
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by  demonstrat i ng the formati on of  b i ocyt i n  ( b i oti n -lys i ne ) from enzyme 
d i g ests  of puri fi ed carboxyl ases  and seems to be a common feature of  
a l l four carboxyl a se s . (80 ) 
Once a ttached to the enzyme , the ureido  r i ng of b ioti n  accepts a 
carboxyl group by nuec l eophyl i c  a ttac k  i n  the f irst  part i a l  reac ti on . 
( Figure 4 ) I n  the second part ia l  carboxyl a tion  reaction , b i oti n trans­
l ocates to  t he  acceptor s i te and rel ea ses  t he  carboxyl to  t he  receptor 
substrate . B i oti n acts then , to transfer the carboxyl from one s i te 
on the mol ecu l e to another . (81 ) 
E .  Av i d i n  
Av i d i n  i s  an  egg wh i te prote i n  wh ich  h a s  a very h i g h  affi n i ty a nd 
spec i f i c i ty for b i ot i n  of 101 5 . (82 ) I t  ha s been a u sefu l tool , there­
fore , in ident ifying  b i oti n-conta i n i ng enzymes . Avi d i n is a g l ycopro ­
tei n that has a mol ecu l ar wei g ht of 67 , 000 wi th four i denti ca l s ub­
u n i ts , each  wi th a mol ecu l ar  wei ght of  1 6 , 000 . Each subun i t  b i nds  one 
mol ecu l e of b i oti n a nd con s i sts of 129  ami no ac id  res i dues , fou r 
res i dues  of mannose and three res i dues of g l ucosamine . (83 , 84 ) C hemi ­
cal  modi fication  stud i es u s i ng bromosucc i n im i de . demons tra ted that 
b i o ti n protects three to four tryptophan mol ecu l es i n  each s ubun i t  from 
ox idat ion  impl i cati ng these res i dues  in the b i oti n -av i d i n  i nteracti on . 
(85 ) These tryptophan s  proba b ly  form a non -cova l ent attachment to the 
ureido  g rou p of bi oti n .  The i d enti ficati on of tryptophan in  b i oti n 
b i nd i ng expl a i n s  the red s h i ft i n  the av i d i n  a bsorpti on  s pectrum whi c h  
i s  observed after b i oti n b i nd i ng . Al thoug h , there a re fou r  b i nd i ng 
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F IGURE 4 
MECHAN ISM FOR B I OTIN  CARBOXYLATI ON 




Frorn- Y .  Kaz i ro ,  L .  F .  Has s , P .  D. Boyer , and S .  Ochoa . J .  B i ol . 
Chern . 237 : 1460-1468 , 1962 . ( 7 3 )  
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s i te s  for b i oti n on the a v i d i n  mol ecule , there i s  no  evi dence of co­
opera t i v i ty between the  s i tes . (86 ) 
Av i d i n  ha s been u s ed by several i nvest igators to b i nd and i so l a te 
bi oti n -conta i n i ng prote i n s . Swack  et a l . (87 ) u sed an  a ffi n i ty co l umn 
of av i d i n -coupl ed to Sepharose  to remove carboxyl ases  from av ian  and 
ra t l i ver homogenate s . E l u t i on from the col umn requ i red 6�1 quani d i ne 
hydrochl oride  whi c h  unfortunatel y d enatu red the enzymes . Th i s  method 
was mod i f i ed by Green and Toms (88 ) us i ng av id i n �onomers coup l ed to 
�pharose whi c h  bound b i oti n -conta i n i ng prote i n s  l es s  t ight ly  and  
a l l owed the i r  el u ti on wi thou t denaturati on . Th i s  l a tter col umn wa s 
u s ed by Gravel et a l . (89 ) for the puri ficati on of prop i onyl CoA car­
boxyl a s e .  Av i d i n  ha s a l so been  coupl ed to  fl uorescent dyes such  as  
fl uorescam i ne and u s ed for the  l oca l i zat ion of b i oti n -conta i n i ng pro­
tei ns or subu n i ts . (87 ) 
F .  S tructu re of the Normal EnzJme 
The mol ecu l ar wei g ht of pur if i ed p i g  heart propi onyl CoA carboxy­
l a se was i n i t i a l l y  e stima ted by g el fi l trat i on to be  a pprox imate l y  
700 . 000 da1 ton s . ( 6o ) T h e  l arge s i ze of the mol ecu l e and  the  d emon­
stra t i on that i t  conta i n ed fou r b i oti ns  per mol ecu l e ,  suggested that 
the enzyme via s proba bly a tetramer . Lau et  a 1 . ( 90 ) descri bed the 
phys i ca l  properti es  of thi s enzyme after pur i f i cat i on from bov i ne 
k idney and demonstra ted that i t  wa s composed of two non - identica l  s ub­
un i ts w i t h  mol ecu l ar wei g hts 58 , 000 and  74 , 000 a s  determ i n ed by SDS­
pol ya cryl amide gel  e1 ectrophores i s . (Ta b1 e I I I ) T he  l arger subun i t  was 
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TABL E  I I I  
NOLECULAR I�E I GHT OF PROP I ONYL CoA SUBUN ITS FROM D I FFERENT SPEC I ES 
! I I AV IAN BOV I N E  I HUMAN 
! ; , 
I i 1 2 3 4 
a. 7 6 , 000 I 74 , 000 72 , 000 7 5 , 000 
B 42 , 000 58 , 000 56 , 000 60 ,000 
I 
1 .  J .  A .  Swa c k ,  G .  L .  Zander , & r� . F .  U tter . Anal . B i ochem .  87 : 1 14-
126 , 1 978 . (87 ) 
2 .  E .  P .  Lau , B .  C .  Cochran , L .  Munson , & R .  R .  Fa l l .  Proc . Nat .  Acad . 
Sc i .  76 : 214-2 1 8 ,  1972 . ( 90 ) 
3 .  F .  Ka l ousek , M . D .  Dar igo , & L .  E .  Rosenberg . J .  B i ol . Chern .  2 55 : 60 -
65 , 1980 . (63 ) 
4 .  R .  A .  Gavel , K .  F .  Lam , D .  Mahuran , & A .  Kron i s .  Arch . B i ochem . 
B i phy .  201 : 669-673 , 1 980 . (89 ) 
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cons i dered t o  con ta i n  b i ot in  because  o f  i ts a bi l i ty t o  b i nd av id i n .  
S i nce  the nat i ve mol ecu l e  conta i n s  four b i o ti n mol ecul e s , t ne s truc­
ture ( a�4  was propos ed to expl a i n  the na t i v e  mol ecu l ar weight  of 
540 , 000 . S imi l a r  resu l ts have been reported for the enzyme from av ian  
l i ver . ( 87 ) 
The human enzyme was pur i f i ed 20-fo l d  from normal human l i ver  a nd 
showed s i mi l ar properti es  and Km ' s to .  a v i a n  and other mamma l i a n  pro­
p i onyl CoA carboxyl a s e . ( 9 1 ) As pred icted , the enzyme was acti va ted by 
monova l ent  cations  a nd i nacti vated by av id i n  a nd parachl oromercu� ,ben­
zoa te . 
Recentl y ,  Ka l ou sek  et a l . ( 63 ) puri f ied the enzyme u p  to 3000-fo l d 
from human l i ver by u s i ng col umn separat i on s  and a 'ffi u e  Sep harose  
affi n i ty res i n  whi ch  b i nd s  t he  ATP fol d  of t he  enzyme . The  homogen ­
eou s enzyme shows very s i mi l ar characte r i s t i c s  to the  bov i ne  k idney 
enzyme . The nat ive  enzyme has a mol ecu l a r  wei g ht  of 540 , 000 wi th two 
non - i denti cal  subu n i ts w ith  mol ecu l a r  wei ghts  of 72 , 000 and 56 , 00 0 .  
T h e  l arger subu n i t  a ppears t o  conta i n  o n e  b i o t i n  mol ecu l e .  The appar­
ent  Km ' s for propi onyl CoA , ATP and bi carbonate are s im i l ar to thos e  
reported for other mammal i an propi onyl CoA carboxyl ases  a n d  those r e ­
ported for t h e  human enzyme i n  crude fi brobl a st  homogenates . (Tab l e I ) 
U s i ng the property of av id i n  to b i nd b iot i n-conta i n i ng carboxy­
l ases , Gravel  et  a l . (89 ) have devi sed a two step procedure  to i so l a te 
propi onyl CoA carboxyl a s e  from human  ti ssu e . The procedure  i nvol ves  a 
carbon tetrachl or ide  ti ssue  extra c t i on and a n  a v i d i n -monomer- �pharo s e  
aff i n i ty col umn . S i nce the av i d i n -monomer b i nds  the b i oti n-con ta i n i ng 
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carboxyl ase  l ess  t ig htl y than the av id i n  tetramer , the enzyme can be  
e l u ted from the  col umn by the  add i ti on of excess  free b ioti n .  The  
enzyme prepared i n  thi s manner was  puri f i ed to  homogenei ty and d emo n ­
strated s im i l ar s tructure t o  the other pur i fi ed enzymes . Est imates of 
the subuni ts ' mol ecu l a r  wei g hts were 75 , 000 and 60 , 000 . (Tabl e I I I ) 
Over-al l ,  the structure of propi onyl CoA carboxyl ase  seems to be  
simi l ar i n  the  enzyme from bov i ne ,  av i an , rodent and  human sources . ( 92 ) 
The bas i c  s tructure of the enzyme seems to have been con served through­
ou t s pec i e s  evol u t ion . 
Mutan t  Enzyme 
The mutant enzyme was purifi ed 200-fol d from normal fi brobl a s ts 
and those of severa l mutant l i nes . The mutant  cel l l i ne s  had between 
1 - 5% of  norma l propi onyl CoA carboxyl ase acti v i ty .  The s i ze of the 
norma l and the mutant enzyme , as mea sured by sucrose d en s i ty grad i en t  
centrifugati on , was 700 , 000 s imi l ar to that prev ious ly  reported . The 
Km val ues of the normal and mu tan t  enzyme were a l so  s im i l ar to those  
reported as compared in  Tabl e I .  These  stud i es were confi rmed by 
D ivry et a l . (62 ) who a l so  fa i l ed to demon s trate a d i fference i n  the 
Km val ues f o r  s u b s trates i n  t h e  en zyme from mutant fi brobl ast l i nes . 
However , the mu tant  enzyme wa s extremel y  un stab l e even when frozen a t  
-800C . The enzyme from the mu ta n t  fi brobl a s ts s howed greater thermo l ­
abi l i ty wi th a t� of 3 mi nutes a t  450C where the normal enzyme had a 2 
tl /2 of 1 5 minutes . ( 61 ) The i nstabi l i ty of the mu tan t  enzyme has  mad e  
i ts s tudy more d i ff i cu l t .  
G.. Other Human Carboxyl a se s  
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In add i ti on to prop i onyl CoA carboxyl a s e , there are three other 
human carboxyl a se s : pyruvate carboxyl a se , S -methyl crotonyl CoA 
ca rboxyl ase  and acetyl  CoA carboxyl a se . Al l of the carboxyl ases  have  
the same ba s i c  carboxyl a t i on mechani sm wi th two biotin  dependent .  
However , each  enzyme recogn i zes a d i fferent acceptor subs trate for the  
carboxyl group . ( 47 ) 
Partia l  1 
Enz - B i oti n 
Part i a l  2 
+ CO2
- + ATP - -��:: - - Enz b l· otl· n  CO - + ADP + P - - 2 i 
ENZ - b i ot i n  - CO2
- + Acceptor ------ Enz-B i o ti n  + Product  
Net  Reacti on 
CO2 + ATP + Acceptor - --------- Product + ADP + P i 
Pyruvate carboxyl a se  i s  a m i tochondr i a l  enzyme whi c h  i s  i mporta n t  
i n  the regu l at i on  of g l uconeogenes i s .  T h e  enzyme recog n i zes  pyruvate 
and forms oxa l oacetate . Acetyl CoA i s  a n  a l l o s ter i c  cofa c tor for the 
enzyme and manganese i s  an act ivator cati on . ( 47 ) Thi s enzyme h a s  not  
been  i so l a ted from man  bu t the  rat mi tochondri a l  enzyme has been  shown 
to be a tetramer con s i st i ng of four i dent i ca l  b i o t i n -conta i n i ng s ub­
u n i ts w ith  a mol ecu l ar wei ght  of 1 25 , 000 . ( 87 ) 
Another mi toc hondri a l carboxyl a se , S -methyl crotonyl CoA carboxy-
l ase i s  necessary for the cata bo l i sm of l eu c i ne . The enzyme converts 
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S -methyl crotonyl CoA to S -methyl g l  u taconyl �oA . When thi s enzyme i s  
defecti ve a s  i n  mul ti pl e carboxyl ase  defi c i ency ,  S -methyl crononyl ­
g l yc i ne and �hydroxyi soval eri c acid  accumu l a te and are excreted i n  
the ur i ne  of these pati ents . The structure of human S -methyl crotonyl 
CoA carboxyl ase  has not been determi ned but the enzyme from bov i ne 
kidney con s i s ts of a tetramer c omposed of two non-ident ica l  s u bu n i ts 
of 62 , 000 and 80 , 000 mol ecul ar wei ght wi th  the l a rger  s ubu n i t  conta i n ­
i ng the b i oti n moi ety . ( 90 ) The s tructu re i s  s imi l ar to tha t of 
prop i onyl CoA carboxyl ase  however the ev idence suggests that the s u b ­
u n i ts a re n o t  common t o  both enzymes . ( gO ) 
Acetyl CoA carboxyl a se i s  the only cytosol i c  carboxyl a s e  enzyme . 
I t  converts acetyl CoA to mal onyl CoA whi ch  consti tu tes the fi rst  
comm i tted step of fatty ac id  synthe s i s . ( 93 ) C i tra te i s  a powerfu l 
acti vator of thi s enzyme a nd may reg u l a te fatty ac id  synthes i s .  The 
s tructure of the human enzyme has not been reported ; however , in rat 
� i ver the enzyme s eems to be composed of a protomer of 2 1 5 , 000  mol ecu ­
l ar wei ght whi ch  cons i sts of two non-i dent ica l  s u bu n i ts wi th mol ecu l ar 
weight  of 118 , 000 a nd 125 , 000 , one of whi c h  conta i n s  the b i ot i n  
mo i e ty . ( 94 ) The protomers form l 1 near polymers w1 th mol ecul ar  we1 ghts 
of severa l mi l l i on wh i c h  have a f i ber-l i ke appearance u nder the e l ec ­
tron microscope . The f i ber s tructures may b e  importa n t  i n  cytopl a sm 
u l tras tructure . ( 47 ) 
K. Compl ementati on 
Geneti c compl ementa t i on i s  a soma t i c  ce l l tec h n i que  whi c h  has  
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recently been u sed t o  i denti fy a n d  i nvesti gate t h e  genetic  heterogen ­
ei ty of human metabol i c  d i sorders . Th i s  techn i qu e  was i n i ti a l l y  
devel oped i n  bacteri a l  systems i n  order t o  determi ne whether a defect  
was the  resu l t of muta ti on s  i nvol v i ng separate genes or a l l el es .  
Homozygou s mu tant bacter i a  were crossed and i f  the i r  defects were the  
resu l t  of two d i fferen t  genes or gene  un i ts . the g enomes wou l d  compl e­
ment  one another a nd g i ve a wi l d  type phenotype . ( 95 ) 
An exten s i on of  th i s  techn ique  to human fi brob l a s ts was dev i sed 
by fu s i ng two popu l ati ons of fi brobl a sts carryi ng i ndependent ly  
der i ved mu tati ons u s i ng i nacti vated senda i v i r u s  a n d  tes t i ng for 
correction  of the defect . ( 96 ) I f  two d i fferent gene products a re i n ­
vol ved i n  the enzyme defi c i ency . then the genome o f  one cel l shou l d 
compl ement that of the other cel l and the enzyme acti vi ty wou l d  be 
i ncrea sed . Th i s  process  i s  cal l ed i ntergen i c  compl ementat i on . Even 
when d i fferent defects occur wi th i n  the same gene l ocus , there i s  
occas i onal l y  some degree o f  compl ementati on . Thi s  occurs sometimes i n  
mul timeri c  prote i n s  becau se heteropolymers of the two di fferent 
defective su bu n i ts are sometimes more active  than the respect ive  homo­
pol ymers ,  probabl y due to ster i c  i nteracti on . ( 97 )  Thi s compl ementa­
ti on i s  u sua l l y  of a l esser  mag n i tude and i s  ca l l ed i n tera l l el i c 
compl ementat ion . Thi s techn i que  has  been u s ed to e l u c i date geneti c 
heterogene i ty i n  several human metabol i c  d i sorders s uch  a s  methylmal ­
on i c  ac i dem i a  and xeroderma p i gmentosum . ( 98 . 9 9 ) 
I n  1 97 7 . Gravel  et a l . ( 2 ) i denti f ied two majo r  compl ementa ti on 
grou ps  by consecut ive  pa i rwi s e  fu s i on s  of seven mutant f i brobl a s t  
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l i nes  from pa ti ents wi th c l i n i ca l l y  i nd i sti ngu i s ha bl e prop ion ic  acid­
emi a .  These groups  were des i gnated pccA and pccBC .  Thu s , when  cel l s  
from pccA were fu sed to cel l s  from the pccBC grou p , propi onyl  CoA 
carboxyl ase acti v i ty i ncreased marked ly  over unfu sed cel l s  as mea s u red 
by the 14C_ propi onate i ncorpora ti on demonstrated by a utorad i og raphy.  
When the cel l s  from d i fferent compl ementa t i on groups were mixed and 
not  fu sed or when cel l s  were fu sed to themsel ves , n o  i ncrease  in  l a be l ­
l ed prop i onate i ncorporat i on was observed . The compl ementat ion  
p i c tu re became more compl i cated when fi brobl a s ts l i nes from the pccBC 
grou p were fu sed to each otheL There w e r e  s om e  cel l 5 wh i c h  d i d  not 
compl ement wi thi n the group whi c h  compr i sed s u bgrou p ,  pccBC . There 
were some cel l s  whi c h  compl emented each other by s howi ng a s l i g h t  i n ­
creas e  i n  gra i n  count .  These fel l i nto two su bgrou ps  desi gna ted pccB 
and pcc C . Nei ther pccB nor pccC compl emen ted pccBC . A compl emen ta ­
ti on map ,  i nd i cati ng the d i fferent compl ementa t ion g roup s , i s  s hown i n  
Fi gure 5 .  The demonstra tion  o f  more than one compl ementation  gro u p  
\'/a s t h e  f i r s t  i nd i cat ion that more than o n e  gene wa s probab ly  i nvol v ed 
i n  propi onyl CoA carboxyl a se defi c i ency . 
A thi rd maj or compl ementati on group has  been establ i shed wi th 
cel l s  from patients wi th b i oti n -respons i ve mu l ti p l e  carboxyl a s e  
defi c i ency . Th i s  group des i g na ted , b i o ,  compl ements a l l  other pro­
p i onyl CoA carboxyl ase  mutants whi ch  supports the theory that thi s 
defect i nvol ves  a d i fferent  gene l ocus , pos s i bl y  respons i b l e  for hol o ­
ca rboxyl ase  syn thetase  o r  a b i ot i n  transport protei n . (52 ) 




COMPLEMENTAT I ON MAP 
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b io  
From- 11 . Saunders , L .  Sweetman ,  B .  Rob i n son , K .  Roth , R .  Cohn  and  
R .  A .  Gavel . J .  C l in .  I nves t .  64 : 1 695-1702 , 1 979 . ( 52 } 
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carboxyl a s e  defi c i ency depend s on �Ihether the compl ementati on between 
the s e  groups was i n tergen ic  or i n tera 1 1 e1 i c .  Stud i e s  on  the ki neti c s  
o f  compl ementation  were underta ken o n  po 1yethy1 eneg1yco1 -fu sed cel l s  
u s i ng a quanti t i ve prop i onate fixa t i on a ssay i n  order to c hoos e  be­
tween these a l ternative s . The resu l ts of thes e  stud i e s  revea l ed tha t  
compl ementat ion between pccA or pccC wi th b i o  had the same ki net ics  a s  
fu s i ons  o f  two unre l a ted gene defects . The compl emen tat ion  o f  pccA 
and pccC was much s l ower , a l though  it ach i eved the same mag n i tude of 
enhanced ac ti v i ty a s  did the b i o  X pccA crosses . Thi s suggested that 
pccA X pccC compl ementa ti on may be due to s u bu n i t exchange or de � 
su bu n i t  synthes i s .  The magn i tude of th i s  compl ementat i on a l so 
suggested an i n tergen ic  compl ementa ti on consi s te. nt  wi th a two non ­
identica l  subu n i t  model . Compl ementa ti on of the pccB and pccC s ub­
groups  revea l ed on l y  a sma l l i ncrea se  i n  prop i onyl CoA  carboxyl a s e  
acti v i ty compared t o  the other cro s ses a n d  pos s i bl y  represents i nter­
a l l el i c comp1 ementation . (6 ) 
Further ev idence for the mechan i sm of compl ementati on was o btai ned 
by determi n i ng whether de � prote i n  synthes i s was neces sary for 
compl ementati on . Cycl ohexam i d e  added a fter fu s i on of b i o  cel l s  wi th 
e i ther pccA or pccC cel l s  did  not a l ter compl emen tat ion . (I OO ) 
S tud i e s  were i n i t i ated to try and determi ne  the s i g n i ficance of 
the two compl ementa ti on groups  by i den t i fy i ng b i ochemica l  d i fferences  
between them . The  enzymes from several fi brobl a s t  l ines  i n  each  group 
were compared for thermostabi l i ty ,  for s ubstrates , Km ' s  and for a v id i n  
i n terac t i on s . I n  most parameters the mu tan t  enzymes were s im i l a r  to  
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the enzyme in n orma l fi brobl a st  extracts . However , prop i onyl CoA car­
boxyl a se from the  d i a lyZed pccA group fi brobl a s t  extracts demons trated 
an i ncreased Km for potass i um i o n s , wherea s , that i n  pccC extracts  wa s 
s im i l ar to normal cel l extracts . I n  add i t i on ,  the acti v i ty from pccA  
fi brobl a s t  extracts was l ess  s tab l e a t  450C than  wa s e i ther the n o rmal 
or pccC fi brobl a st  acti v i ty .  The pccC acti v i ty wa s i ntermed iate to 
that of n ormal and pccA . (6 ) These  s tud i es demon strated a few d i ffer­
ences between the c ompl ementati on group s  a l though on ly  a few cel l 
l i nes  i n  each  group were s tud i ed .  The d emonstra t i on of two i denti f i ­
abl e compl ementa t i on groups  a l so  ra i se s  the possi bi l i ty of two 
d i fferent s u bu n i ts i n  these enzymes .  
Sti l l  another d i fference between the pccA a nd pccC groups  was 
d i sc l osed i n  s tud i e s  of obl i ga te carri ers of prop i on i c  ac i demi a .  The  
prop i onyl CoA carboxyl a s e  acti v i ty in  f i brobl a s t  extracts from pccA 
heterozygotes was 52% of that of con trol s as expected in a rece s s i ve 
d i sorder . However , pccC heterozygotes had prop ionyl CoA carboxyl a s e  
acti v i ty wh i ch  was i n  t h e  normal range . There a r e  several pos s i b l e 
explanations  for thi s p henomenon . One expl ana t i on i s  that a hetero­
polymer of normal s ubu n i ts and  mu tan t  pccC reta i n  norma l acti v i ty .  
Another expl ana t i on i s  that there i s  a d i fferenti a l  rate o f  synth es i s  
o f  one  s u bu n i t ,  s o  tha t enou g h  norma l enzyme i s  formed t o  compensate  
for  the defective  enzyme . (IO I ) 
Further s tud i es on the mi nor compl ementati on group s  pccB and  
pccBC s hOvled them to be i nd i st i ngu i s habl e from the pcc C  group  when 
compared for heat stabi l i ty and Km val u es . (I 02 ) The data s upports the 
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hypothe s i s that pccB , pccBC and pccC represent  at  l ea st  three i nter­
a l l el i c mutat ions  a nd part of  a s i ng l e compl ementat i on group now 
des i gnated pccBC . Thi s wou l d  be expected i f  the add i ti on of a m i s s i ng 
enzyme such as hol ocarboxyl a se syntheta se i s  needed to acti vate pro­
p ionyl CoA carboxyl ase  and therefore only the m ix i ng of cel l contents 
wou l d  be necessary for enhanced prop i onyl CoA carboxyl ase  acti v i ty .  
However , when cyc l ohexamide  wa s added after fu s i on o f  pccA and pcc C , 
very l i ttl e i nc rea se  i n  acti v i ty was observed , i nd i cati ng that de  !!.Q.YQ. 
prote i n  synthe s i s was requ i red . I t  i s  pos s i bl e  that prote i n  synth e s i s 
i s  needed i n  order for subu n i t s  from both compl emen ta t i o n  groups to be 
i ncorporated i nto the enzyme to i ncreas e  propi onyl CoA carboxyl a se 
act i v i ty .  
MATERIALS AND METHODS 
A .  Ti s sue  Procurement and Preparat ion 
L i ver and k idney ti ssue  was obta i ned one to e i ght  hours postmor­
tem from i nd i vidual s rang i ng i n  age from newborn to 55 years o l d ,  who 
d i ed suddenly  from various  non -metabol i c  causes . Permi ss i on for a l l 
t i s su e  procurement was obta i ned u s i ng  consent  s ta tements a pproved by 
the Med i ca l  Col l ege  of V i rg i n i a  human research commi ttee and s i g ned by 
l egal  respon s i bl e  part ie s . (Append i x  I ) The pat i ent ' s  h i story and 
cau se  of death was obtai ned from med i ca l  records and for the purpose  
of confidenti a l i ty the  l i ver s ampl e wa s a s s i gned a spec i fi c  i dent i fi ­
cation  n umber . At the time of pr-ocur'ement , 1 i vers were s l  i ced i n to 
one centimeter secti ons and immedi ate ly  stored at  -BOoC .  No dete r i or ­
a t i on i n  propi onyl CoA carboxyl a s e  acti vi ty was noted wi th s torage u p  
to three years . Norma l human pl acentas were obta i ned immed i a te ly  
after del i very ,  pl aced on i ce  a nd  frozen . 
Four l i ver sampl e s  were obtai ned from pati ents wi th pro p i on i c  
ac idemi a who d i ed because  o f  compl i cati ons  of the d i sea s e .  Geneti c 
compl ementati on s tud i e s  u s i ng fi brobl a st s  from the same pat i ents 
a s s i gned these cel l l i nes  to the pccA , pccBC .  and pccC (2 ) compl emen ­
tat i on groups . One pl acenta was obta i ned from the pregnancy of a 
s econd affected offspri ng wi th prop ion i c  ac i demi a .  The fi brobl a sts  of 
th i s  pat ient  were a s s i gned to the pccBC compl ementation  g rou p . These 
ti ssues  were frozen and sent to the Med i ca l  Col l ege of V i rg i n i a  in  dry 
i c e  and stored su bsequently a t  -80oC .  
Var i ou s  ti s sues  were homogen i zed i n  100mM Tr i s -HCl , 0 . 5% .  p H  B . O  
( 1 0% w/v ) at  40C u s i ng a Potter-El vehj em homogeni zer . Fo l l owi ng 
46  
homogen i zat ion , cel l debri s was  removed by centr i fugat i on a t  1 0 , 000xg 
at 1 00C for 20 m i n utes . Homogenates of ti s sues  from affected i nd i v i d ­
ua l s were prepared s imi l arly except that i n  s everal i ns tances 2M 
sucrose was added to the homogen iz i ng sol u t ion to stab i l i ze the muta n t  
enzyme . Mi tochondr i a  were i sol a ted for severa l experiments by homog e ­
n i z i ng l i ver ( l O%w/v ) i n  0 . 2 5M sucrose-l OmM Hepes , pH 7 . 4 and 
cen tr i fu g i ng a t  7200xg for 1 5  m i n u tes a t  2oC .  The mi tochondr i a l  
pel l et was resuspended a nd  recentri fuged before lys i s by  son i cati on . 
Control fi brobl a s t  cu l tures were deri ved from s k i n  bi ops i es ob­
ta i ned from vol unteers or from i nd i v i d ua l s tested for other abnorma l ­
i ti e s  and determi ned to be norma l . F i brobl ast  cu l tures were grown a nd 
i ncubated i n  Eagl es ' m i n imum essentia l  med i um wi th gl u tami ne conta i n ­
i ng 10% feta l cal f serum and 1%  Kanamyci n .  Mutant  cel l l i nes o f  the 
pccA ( 2 ) , pccBC , pccB , pccC ( 2 ) , a nd b io  genetic  compl ementation  
grou ps  �/ere grown to  confl uency and harvested us ing  1 %  trysi n -0 . 2% 
EDTA i n  Hank ' s phosphate bal anced sa l t buffer . The c el l s  were washed 
three times in Han k ' s  buffer and centri fuged a t  1000xg a t  27°C for 1 0  
mi nutes . Cel l pel l ets were d i srupted by a 1 5  mi nu te i ncuba ti on i n  
100mM Tri s -HC1 , 0 . 5% Tri ton ( pH 8 . 0 ) u s i ng a pasteur p i pet . Cel l 
extracts  were then centri fug ed a t  1 0 , 000xg at 1 50C to remove cel l 
debri s .  
B .  Enzyme Assays 
Propi onyl CoA carboxyl ase  acti v i ty wa s measured by determi n i ng 
the i ncorporation  of 14C -bi carbonate i nto methylmal ony l  CoA u s i ng the 
procedure of I�o lf  et a l . ( 3 ) wher e i n  50 u l . of enzyme -conta i n i ng 
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sampl e wa s mi xed wi th 50u l . of buffer -subs ta te m ixture and i ncuba ted 
in a 370C shaki ng water bath for up to 30  m i nutes . The f i na l  a s say 
mi x ture conta i ns : 50mM Tri s -Hcl , pH 8 . 0 ,  1 0mM  MgC12 , 2mM sod i um 
adenos i ne tri phosphate (ATP ) ( S i gma ) , 1 00mM KCl , l mM prop ionyl CoA 
( S i gma ) , 5mM reduced g l u tat ione  ( S i g  m � a nd IOmM sod i um 14C_ bi carbo n -
a te ( New Engl and Nucl ear , Boston , Ma s s . ;  fi nal  spec i f i c  a c ti v i ty 1 2 . 2  
mC i /mmol ) . The bl ank  i nc l uded a l l reactan ts except propi onyl CoA i n  
order to determine  nonspec i f i c  l abel l ed b icarbonate i ncorpora ti on . I n  
a l l cases  the react i on was i n i ti a ted by the add i t i on of l abel l ed 
bi carbonate to the reaction m i xture . The rea c t i o n  wa s term i na ted by 
the add i ti on of 50u l of 1 0% tri chl oroacet ic  ac id  and the dena tured 
prote i n  was removed by centr i fugation  at 2000xg a t  room temperature 
for 1 0  mi nutes . A 100u l a l l i quot of the supernata n t  was p l aced i n  a 
sc i nti l l a t i on v i a l  and dr i ed u nder heat l amp l i bera t i ng 1 4C02 whi c h  
wa s not i ncorporated i nto methyl ma l on i c  ac id . The res i due  wa s s o l u b ­
l i zed i n  0 . 2ml o f  deion i zed water ;  four ml  of Aqu a -sol  ( New Eng l and  
Nucl ear ) was added and  sampl es  were counted i n  a Bec kman LS 7 500 
l i qu i d  s c i nt i l l at ion counter . I n  ear l i er experiments , l i bera ted 14C 02 
wa s trapped by methyl benzethon i um hydroxide i n  an enc l osed ves sel and 
an a l l i quot of the a s say mixture was counted d i rect ly  i n  Aqua -sol . 
Iden t i f i ca ti on of the f i na l  reacti on product , by h i g h  vol tage paper 
chromatography , demon strated that the 1 4C- l a be l l ed product  ran i den­
t ica l l y  wi th methyl ma l o n i c  ac id  i n  0 . 5M Acet ic  ac i d - Form i c  a c i d , 
pH 2 . 9  sol vent system . I n  a l l cases  1 4C02 i ncorporat i on i nto non ­
vol a ti l e  mater i a l  wa s l i near for per i ods  up  to 30 mi nutes wi th enzyme 
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preparat ions  conta i n i ng u p  to 20mg of prote i n  per m i l l i l i ter . 
Th i s  a s say system wa s mod i f i ed to measure the acti v i t i e s  of  two 
other carboxyl a ses , 8 -methyl c rotonyl CoA carboxyl a s e  a nd pyruvate car­
boxyl a s e . I n  the  �methyl crotonyl CoA carboxyl a s e  a s s ay 3mM (fi na l  
concentrati on ) B -methyl crotonyl CoA was s ubst i tu ted for prop i onyl CoA . 
I n  the pyruvate carboxyl a s e  a s s ay fi nal  concentrat i ons of 0 . 7 5mM 
acetyl CoA , an activator of thi s enzyme , and 3mM pyrvate were s ub st i ­
tu ted for propi onyl CoA . The b l a n k  for the pyruvate carboxyl a se a s say 
conta i ned acetyl  CoA in the a bsence of pyruvate . 
G l u tami c  dehydrogena se  act i v i ty was u sed a s  a reference m i tocho n ­
dri a l  matr ix -enzyme in  several exper imen ts . The  reaction  was moni tored 
spec trophotometer ica l l y  ( Beckman D . U .  w ith  G i l ford Components ) a t  
3400nm to detect the ox idati on o f  n i coti nam i d e  aden i ne  d i nucl eoti de , 
reduced form ( NADH ) . The fi nal  reacti on m ixture of one m i l l i l i ter  
conta i ned : 33 . 5mM tri ethanol ami ne-2 . 6mM EDTA , pH 8 . 0 ,  O . lM ammon i um 
aceta te ,  0 . 1 5mM NADH ( S i gma ) , 6mM ADP ( S i gma ) , 8mM sod ium a-ketog l u ta ­
rate , and 50u l o f  enzyme conta i n i ng - sampl e .  L i ver homogenates were 
d i l u ted one to one hundred for thi s a s say that was i n i t i ated by the 
add i t i on of �ketog l utarate . The vel oc i ty wa s mea sured a s  the change 
in  opti ca l  dens i ty over t ime at 230C .  
Al l enzyme acti v i ti es are reported i n  pmol e s  or umol e s  product  
formed per m i n u te per mi l l i gram of prote i n .  The prote i n  concentra t i ons  
were determi  ned  by  the method of  LO\,lry et a 1 . ( 1 23 ) Deta i 1 ed a s say pro­
cedures  are i nc l uded in Append i x  II . 
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C .  Anti body Preparati on 
The un ique  property of b i o t i n  and b i oti n-conta i n i ng enzymes  to 
bond spec i f i ca l l y  and e s senti a l l y  i rrevers i bl y  to av i d i n  was u s ed to 
i sol a te anti bod i e s  to the human carboxyl ases . An av i d i n  affi n i ty 
col umn synthes i zed a s  descr i bed by Landman and Landman ( 124 ) wa s u s ed 
to sel ectively  remove carboxyl a ses  from a human l i ver preparati on . 
Thi s s ,epharose-av i d i n -carboxyl ase  compl ex wa s i n  turn u sed a s  an  a nt i ­
gen to produce anti -carboxyl ase  ant i body i n  rabbi ts . 
a ) Av i d i n -Affi n i ty Col umn Synthe s i s 
One gram of Sepharose 48 ( P harmac i a }  wa s swol l en ,  wa shed 
and acti vated wi th  cyanogen bromide  ( CNBr ) by the method of March et  
a l . ( 1 2 5 ) Al l procedures were conducted a t  40C u n l ess  otherwi se  n oted . 
The S ;epharose was s uspended i n  an  equa l vol ume of 2M sod i um ca rbonate . 
(Th i s  procedure i s  bas ed on the vol ume of the S 'epharose whi c h  i s  
approx i mately l Oml i n  thi s prepara ti on . ) A s toc k sol u t i on of f i ve  
mi l l i g rams of cyanogenbromide  (Al dr ich ) was m ixed w ith  2 . 5  ml  of  
aceton i tr i l e  a nd  s tored a t  40C for further u se . A vol ume of the  CNBr­
aceton i tr i l e  sol u t i on , equa l  to approximately 0 . 1  vol ume of the 
S epharose sol uti on ( l ml ) ,  wa s add ed to the Sepharose a n d  s t i rred 
v i gorou s l y  under the hood for 2 m i nutes at 230C .  The m i x ture wa s 
fi l tered on a s i ntered g l ass  fi l ter and was hed with  10 vol umes of 0 . 1 -
M sod i um b i carbonate pH 4 . 5 ,  2 0 vol ume s d e i o n i zed wa ter , and  1 0 
vo l umes of a O . lM s od i um b i carbona te -0 . 5M sod i um ch l or ide  so l u t i on a t  
p H  9 . 0 .  The res i n  wa s then s t i rred overn i ght i n  0 . 5  vol umes o f  O . lM 
sod i um b i ca rbon a te - 0 . 5M s od i um chl or ide  sol u ti on ( pH 9 . 0 )  conta i n i ng 
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I Omg av i d i n  ( S i gma ) . The preparat i on was f i l tered and the fi l trate 
wa s saved for ana lys i s .  The res i n  was wa s hed and resuspended i n  one  
vol ume of the  b i ca rbona te-NaC l  buffer and  pl aced on  i ce .  Excess  
ethano l ami ne was added to the  res i n  s u spen s i on to  g i ve a f i na l  conce n ­
tra ti on o f  1 M .  Thi s was st i rred overn i ght to  b i nd any rema i n i ng 
unreacted CNBr-act i v e  s i te s .  
b ) Character i zati on of the Av i d i n  Affi n i ty Col umn 
An est imat i on of the amo u n t  of  av i d i n  bound to the 
col umn and i ts a b i l i ty to b i nd b i ot i n were a s se s s ed by u s i ng two pro­
cedures . Fi rst , the concentrat i on of a v i d i n  removed i n  the fi l trate 
wa s measured by a s en s i t i ve method devel oped by L i n  and Ki rsh  ( 1 2� i n  
wh i ch the u nknown c oncentra tion of av i d i n  i s  t i trated by a known con­
centra ti on of b i ot i n .  The ti tra ti on , performed a t  230C ,  was fol l owed 
at 350nm on an Ami no-Bowman Spec trophotofl uorometer wi th an exc i ta t i on 
wave l ength of 290nm so  a s  the b i oti n b i nd s  to a v i d i n ,  a r ed s h i ft 
occurs  due  to the i n teracti ons  of b i oti n w ith  the tryptophans  i n  the 
active s i te .  The quanti ty of b i oti n requ i red to compl ete thi s s h i ft 
i s  determi ned by the concentrati on of av i d i n  i n  the unknown sol u ti on . 
(Method i n  Append i x  I I I )  The amou n t  of a v i d i n  bound to the col umn 
equa l s the i n i t i a l  amoun t  of av i d i n  m i n u s  the amoun t  unreacted i n  the 
f i l tra te . 
The second method determ i ned the a bi l i ty of the av i d i n -coupl ed 
sepharose to b i nd b i oti n .  As  wel l as bi nd i ng b i oti n ,  av i d i n  a l s o  
reversab ly  bi nd s  2 - ( 4 -hydroxya zobenzen e )  benzo i c  a c i d  ( HABA , S i gma ) 
wh i c h  i s  a ye l l ow dye that t u r n s  magenta when bound to a v i d i n . ( 124 ) 
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The add i t i on of the dye through  the col umn and i ts a l tered col or  is a 
qu i c k  way to demonstrate the a bi l i ty of av i d i n  to b i nd l i g i nds . The 
b ind i ng capac i ty of a 0 . 8  X 2 cm col umn can be determi ned by u s i ng 
O . 5ml of a 20  mg/ml sol uti on of HABA standard i zed spectrophotometr i c ­
a l ly  a t  3400nm v i sab l e l i g ht pr i or t o  pa s s i ng over the col umn . After 
col l ecti ng the e l u ate from the col umn , the concentration  of  HABA can  
be determi ned by i ts a bsorpti on and the amoun t  of HABA through  the 
col umn can be cal cul ated after the sampl e is  corrected for vol ume . The 
amou nt  of HABA bound is  then determi ned by the amount  of HABA put on  
the  col umn . The  amount  o f  HABA bound determines  t h e  b i nd i ng capac i ty 
of the col umn . The normal b i nd i ng ca pac i ty of avi d i n  for b iot i n i s  
reduced due to s ter i c  h i nderence from the coup l ed sepharose . 
c ) Prepara t i on of l i ver - Av i d i n -Sepharose Compl ex 
Twenty vol umes of col d d i st i l l ed acetone ( DOC ) was added , 
drop by drop , to one vol ume of l i ver homogena te and  st i rred for 1 5  
m i n u te s  at  40C .  The prec i p i tate was vacuum fi l tered i n  a buchner 
funnel and was hed wi th excess  col d d i s ti l l ed acetone to remove a ny re ­
ma i n i ng acetone so l ub l e materi a l . The acetone was removed by was h i n g  
the prepa rati on wi th severa l vol umes o f  perox i de -free ether and the 
sampl e �/a s a i r  dr i ed . (85 ) Thi s procedure removed l i p i d  ma teri a l  from 
the prepara t i on wh i ch  cou l d  have i n terfered w ith  col umn b i nd i ng a s  wel l 
a s  denatu r i ng l arge quant i t ies  of prote i n  wh i l e  l eav i ng propi onyl CoA 
ca rboxyl a s e  6 -methyl crotonyl CoA and pyruvate carboxyl a s e  act ive  
after t he  procedure . T he  l i ver acetone powder wa s d i s so l v ed i n  100mM 
Tri s -Hel  buffer ( pH (l , 0 ) by vortex i ng for 1 0  m i nutes and cen tr i fuged 
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at  1 0 , 000xg for 20 m i n u te s  at  1 50C to remove und i s so l ved acetone 
powder . Thi s so l u t i on was appl i ed to a 0 . 8  X 2 . 0  cm av id i n  affi n i ty 
col umn unti l the b i nd i ng s i tes on the col umn were determi ned to be  
saturated a s  determ ined by the appearance of i ncreased prop i onyl eoA 
carboxyl ase  acti vi ty i n  the el uate . A sol u t i on of l mM b i oti n ( S i gma ) 
was a ppl i ed next to the col umn to b i nd to any unreacted avi d i n s i te s . 
Propi onyl CoA carboxyl ase  reta i ned acti v i ty whi l e  bound to the co l umn 
matr i x  a s  determi ned by a s sayi ng a su spen s i on of col umn pac k i ng . A 
second col umn wa s prepared i n  an  identica l  manner ; however , thi s 
col umn was saturated fi rst  wi th b i o t i n  and was u s ed as a control . 
d ) Prepara t i on of �pharose -av i d i n -carboxyl a s e compl ex for 
i mmu n i zati on 
The col umn materi a l  was s u s pended in an  equal vol ume of 
5mM pota s s i um phosphate buffer , pH 7 . 0 .  One hal f mi l l i l i ter wa s m i xed 
wi th 0 . 5  ml of Freund ' s  adj u v ant  and emu l s i fi ed by v i gorous  ag i tat i on 
i n  a syr i nge . The emu l s i on was su bsequen tl y  i nj ected i n  two separa te 
a bdom i na l  subcutaneou s  s i tes  i n  two New Zea l a nd whi te ra bb i ts . ( 1 27 ) 
An emu l s i on of the bi oti n-satura ted col umn wi th no mea surab l e carboxy-
7 a se acti v i ty was i njected i nto a th i rd rabbi t as a contro l . The 
ra bbi ts  were g i ven boosters of the same anti gen 1 4  days after the 
primary immun i zati on . B l ood wa s obta i n ed by card i ac puncture a t  each  
anti gen i nj ect i on . The serum wa s prepared by centr i fuga ti ng the  coa g ­
u l a ted bl ood sampl e a t  1200xg for 2 0  mi nutes  at  1 50C and  wa s exam i ned 
for anti body produc t i on by the Ouc hterl ony doubl e d i ffus i on tes t .  
(Method i n  a ppend i x  I V ) A 1 %  agarose gel  i n  0 . 05M sod i um barb i tol 
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bu ffer , pH 8 . 6  was poured i nto a sma l l petri d i s h .  Wel l s  were c u t  i n ­
to the agar u s i ng a temp l a te and 1 00u l o f  serum ; s amp l e s  were tes ted  
aga i n s t  a n  anti gen wh i c h  was p l aced i n  the  center wel l . 
D .  Immunot i trat ion  Experiment 
Sequent ia l  d i l u ti on s  of anti -carboxyl a s e  anti s erum were u sed to 
t i tra te the amoun t  of  cro s s  reacti ng ma ter i a l  present in l i ver  and 
fi brobl a s t  homogenates w ith  equ i va l ent tota l protei n  concentra ti on s . 
F i brob l a s ts and l i ver  homogenates were son i ca ted i n  50mM Tr i s-HCl  
buffer , pH 8 . 0  to prevent i n terference from tr i ton  on anti body-a nti g en 
compl ex formati on . An t i s erum wa s d i l u ted sequen ti a l l y  wi th equa l 
parts of a phopha te bal anced sa l t  sol u t i on , pH 7 . 5  to a d i l u ti on of 1 
to 4096 . The protei n  concentra t i on of the homogenates were s tandard ­
i z ed t o  10mg/ml and that o f  the fi brob l a sts  t o  5 mg/ml a s  determ i ned 
by the method of Lowry e t  a l . ( 123 ) Equa l  vol umes of the d i l u ted ant i ­
s erum and the enzyme-conta i n i ng l i ver or fi brobl a s t  extract were 
i ncubated for 30 mi nutes at 370C and centri fuged at 1 0 , OOOxg for 1 0  
m i nutes  to remove iwmunoprec i p i ta te s . The supernata n twere then 
a s sayed for prop i onyl CoA carboxyl ase  acti v i ty i n  order to determ i n e  
t h e  res i d ua l  acti v i ty .  Serum obtai ned from the s ame rabbi t pr i or to 
i mmun i za t i on was u sed as a contro l . Ident ica l  experiments were per­
formed u s i ng an  ant i body prepared aga i nst  homogeneous p i g  heart 
prop i onyl CoA carboxyl a s e .  Thi s anti s erum ( donated by Dr . R .  R .  Fal l 
from the U n i vers i ty of Col orado ) was prepared aga i ns t  p i g  heart pro­
p i onyl CoA carboxyl a s e  wh i ch wa s i sol a ted from p i g  hea l"t by a procedure 
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s i m i l ar to that u sed for the i sol at i on of the bov i n e  kidney enzyme . 
( 1 1 0 ) A rabbi t anti s erum , obta i n ed after s ubcutaneous i nj�cti ons  of · 
the pur i fi ed enzyme i n  i ncompl ete Freund ' s adjuvant , wa s parti a l l y  
puri f i ed by a n  ammo n i um su l fate fracti onati on procedure . ( 1 28 ) The i m ­
munoti tra ti on exper iments wi th  a n t i  bov i ne propi onyl CoA carboxyl a s e  
were u sed t o  confi rm o u r  fi nd ings  wi th hetero l ogou s anti serum . 
E . P ur i fication  of Propi onyl CoA carboxyl a s e  from Normal L i ver 
The enzyme wa s puri f i ed , u s i ng a mod i ficati on of the procedure  of  
Kal ousek  et  a l . (83 ) whi c h  i nvol ves three bas i c  col umn procedures . Al l 
procedures  were conducted a t  40C u n l ess  otherwi se  noted . 
a ) Ion  Exchange Col umn C hromatogra phy 
Four hundred g rams of  l i ver from a 28 year o l d  ma l e  who 
d i ed of congesti ve heart fa i l ure wa s homogen i zed in 300m l  of 40mMKC l -
1 0mM pota s s i um phosphate buffer , pH 7 . 5  and centr i fuged for 60 m i nu te s  
a t  2 5 , 400xg at  1 50C .  The superna tant  was p l aced o n  a 2 . 5  X 44 cm 
col umn of DEAE Sephacel cel l u l os e  ( Pharmac i a ) whi c h  had been prev i ou s l y  
equ i l i brated wi th the same KC 1 -KP04 bu ffer . After add i t i on  o f  the 
l i ver su pernant , non -bound prote i n  was removed by washi ng wi th  1 0  
vol umes of the same buffer unti l l es s  than 0 . 1  0 0  wa s recorded spectro­
pho tomete r i ca l l y  at  2800nm .  Fol l owi ng remova l  o f  non-bound prote i n ,  
the enzyme was e l uated u s i ng a pota s s i um ch l or i d e  grad i en t  between 
40mM to 1 90mM in lOmM pota ss i um phosphate bu ffer , pH 7 . 5  ( 800 ml  of 
each ) . Fract i o n s  of approx i mately  24 ml were col l ected and  a s sayed 
for prop i onyl CoA carboxyl ase  act i v i ty .  The pea k conta i n i ng acti v i ty 
was l oca ted i n  the f i nal  vol umes of the grad i en t  wh i c h  wa s fo l l owed by 
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excess  190mM KC 1 - l OmM pota s s i um phosphate buffer t o  remove a ny res i d­
ual  prop ionyl CoA carboxyl a s e  acti v i ty .  The fractions  conta i n i ng a 
h i g h  rati o of prop ionyl CoA carboxyl a s e  act i v i ty rel at ive to prote i n  
concen tration  were pool ed and concentra ted i n  an  Ami con u l traf i l tra ­
ti on cel l wi th a PM 30  D i afl omembrane , then equ i l i bra ted aga i n s t  lOmM 
pota s s i um phosphate buffer , pH7 . 5 ,  and s tored at -80oC .  
b ) Affi n i ty Res i n  
The concentrated enzyme-conta i n i ng sol u t i on from the 
DEAE col umn was pa ssed over a 2 . 5  X 7 . 0 cm B l u e  Sepharose  col umn 
( Pharmac .i a ) wh i c h had been equ i l 'i brated wi th 5mM pota s s i um pho s p ha te 
bu ffer , pH 7 . 5 .  B l u e  Sepharose i s  a commerc i a l ly  p repared affi n i ty 
res i n  i n  wh ich  b l ue  dextran i s  coupl ed to Sepharose  4B . After prote i n  
add i ti on , the col umn was washed wi th 1 5mM potas s i um phosphate bu ffer 
( pH 7 . 5 ) unti l no prote i n  wa s detected s pectrophotometr i ca l l y  at 280nm 
i n  the e l uate .  The enzyme was sel ecti ve ly  removed from the col umn by 
3mr1 ATP i n  5mM pota s s i um pho s phate buffer , pH 7 . 5 .  Enzyme acti v i ty 
was determi ned i n  the e l uate immed i a tely  after ATP add i ti on . The 
fracti ons  wi th acti v i ty were pool ed , concentrated and equ i l i b ra ted 
aga i n s t  50mM pota s s i um p h o s p ha te b u ffe r - 2 00mM KC 1 , O . 5M sucrose and 
1mM EDTA u s i ng the Ami con system . Thi s step resu l ted in a major pur i ­
fi cation  of  approx i ma tely  a 1000-fo l d .  
c ) Gel F i l trati on 
Further puri ficati on to remov e  l ow mol ecul ar we i g h t  p ro ­
tei ns wa s obta i ned by runni ng the sampl e on  1 . 1 X 1 1 5  cm col umn o f  
Sephacryl -200 superfi n e  ( Pharmac i  a ) whi c h  was equ i l  i bra ted wi th  50mM 
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pota s s i um phosphate buffer- 200mM KCl -O . 5M s ucrose- lmM EDTA . P ro ­
p ionyl CoA carboxyl ase acti v i ty was detected i n  the el ut i on  vol ume . 
These sampl es  were pool ed , concentra ted and s to red i n  2M sucrose- lOOmM 
Tri s -HC1 -l mM EDTA- lmM gl u ta th i one at -BOoC .  No  l os s  of acti v i ty was 
de tected during  s torage of the puri fi ed enzyme over several mon th s . 
F .  Puri fication  o f  the �Iu tan t  Enzyme from L i ver 
A 200-fol d pur i fication  of the mu tan t  enzyme from fi brob l a s ts h a s  
prev i ou s ly  been reported but  the process  was  hampered by the  i nstabi l ­
i ty o f  the enzyme and the l ac k  o f ma teri a l . (Bl) Twenty-seven grams o f  
l i ver  from a prop i o n i c  ac i dem ia  patient  in  the pcc -BC compl ementat i o n  
grou p w a s  homogeni zed i n  50ml of 40mM KC1 - I 0mM pota s s i um phosphate 
buffer , pH 7 . 5  i n  a s imi l ar manner to that u sed to puri fy the norma l 
enzyme . The su pernant so l ut ion  wa s pa s s ed over a 2 X 2 5  cm DEAE 
col umn and the fractions  were col l ected , fol l owing  the i n i ti at i on of 
the 40mM to 1 90mM KCl grad i en t  in l OmM pota s s i um phosphate . The  
fracti ons  were assayed for acti v i ty ,  pool ed , concentrated and equ i l i ­
brated i n  a sol u t i on o f  5mM pota ss i um phosphate- O . 5M sucrose , pH 7 . 5 .  
Hal f mol ar s ucrose was u sed through  the remai nder of the pur i f i cati on 
i n  order to stabi l i ze the enzyme . I t  cou l d  not  be u sed i n  the DEAE 
col umn procedure because  the presence of the sucrose i n h i b i ted the 
as soc i ation  of the mu ta nt enzyme wi th the DEAE col umn . 
The pool ed DEAE pea k was p l aced on a 2 X Bcm B l ue  Sepharose  col umn 
wh i ch was equ i l i brated wi th 5m i 1 Pota s s i um phosphate-O . 5M sucrose and 
non -a s soc i at i ng prote i n s were removed a s  before . The enzyme wa s d i s ­
l odged by 3mM ATP - 5mt'l pota s s i um phos phate - O . 5M sucrose , pH7 . 5 ,  and  
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concentra ted ten -fo l d  in the 50mM pota s s i um phosphate -200mMKC 1 - 0 . 5M 
sucrose- 1mM EOTA buffer . The concen tra te was passed through a 1 . 1 X 
1 1 5  cm Sephacryl -200 superfi ne  col umn and the mutant  enzyme was col ­
l ec ted i n  the el uti on vol ume . The enzyme \-Ias concentrated and stored 
in 2M sucrose-l00mM Tr i s -HC1 -1 mM EOTA - l mM g l u tathi one , pH7 . 5  a t  -800C .  
G .  Sod i um Oodecy1 Su l fate -Polyacryl am i de Gel  E l ectrophore s i s  
Pur i fi ca t i on o f  these enzymes was determi ned by SOS-po1 yacryl a ­
m i d e  g e l  e l ectrophores i s .  S i nce  the mol ecu l ar  wei ght o f  the nat i ve 
prote i n  has  been s hown t o  b e  ap prox ima te l y  550 ,. 000 , the nati ve enzyme 
wou l d  be exc l uded from mos t  polyacryl amide gel s .  Therefore , SOS -po ly­
acry1 amide gel  e 1  ectrophore s i  s �Ias chosen for  identi fi ca  t i on of the  
enzyme by i ts subun i t s . The  enzymes were denatured to subun i ts w ith  
s od i um dodecy1 s u l fate and  mercaptoethano1 . The  mol ecul ar wei ght  o f  
t h e  subu n i ts of propi ony1 CoA carboxyl ase  cou l d  b e  compared wi th that 
whi c h  has  been  reported by other i nvest i ga tors and wi th that of  pur i ­
fi ed bov i ne kidney propi onyl CoA carboxyl a s e . 
A sampl e from each  of the puri f ica t i on steps was run on a 7 . 5% 
polyacryl amide horizontal slab gel ( 2 5cm X l l cm X Imm) wi th 0 . 1% SOS 
u s i ng an LKB-Mu l ti phor un i t . ( 1 2 9 ) The gel con ta i ned a f ina l  concentra ­
t i on of 0 . 1 2 5M g lyc i ne wh i c h  was adj u sted to pH 8 . 3  wi th  Tri s .  The 
e l ectrode bu ffer \'Ia s 0 . 5  M g l yc i n e -Tri s buffe r ,  pH 8 . 3 .  (Append i x  V) 
The prote i n  sampl es  were d i l u ted in the same buffer wi th  0 . 2% SDS  
and were boi l ed for 3 m i nutes  to i ns ure denaturation  of the  mol ecu l e 
and max i mal assoc i at i on w ith  SOS . I n  addi t i on , 5 u l  of  mercap toetha n -
0 1 a n d  5 u l  o f  a 5 %  sol u t i on o f  bromthymol b l u e  tracki ng  dye was 
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added to the sampl e .  F i fteen u l  of  sampl e whi c h  gave between 0 . 1  -
0 . 003 mg of prote i n  cou l d  be run  on eac h  l an e  of  the ge l . Eac h  ge l  
wa s  r u n  a t  a constant curren t of  80 rnA for a pprox imate l y  3 hours  u n t i l 
the track i ng  dye reached the end of the ge l . 
The ge l  wa s i mmed i a te l y  fixed i n  1 0% tri ch l oroaceti c ac i d  a nd 
s ta i ned for prote i n i n  50% methanol - 5% acet i c  ac id - 5% Cooma s s i e b l u e  
overn i g h t  and desta i n ed i n  50% methano l - 5% Aceti c a c i d . ( see Append i x  
V )  
H .  I soel ectri c Focus i ng 
The i soel ectri c po i nt for prop i onyl CoA carboxyl a s e  was deter­
m i ned in  severa l norma l t i ssues  i nc l ud i ng 8 l i vers , 1 k idney ,  1 
p l acenta and 2 fi brobl a s t  l i nes , and from 3 l i vers and  1 pl acenta from 
pa ti ents w ith  propi onyl CoA carboxyl ase  defi c i ency . T i s sues  were 
homogen i zed in l OmM Tr i s -HCl  buffer and s on i ca ted . These i soe l ectr i c  
poi nts  were confi rmed by focu s i ng the pur i f i ed norma l and pccBC! enzyme . 
Th i s procedure was performed on a 1 1 0ml  capac i ty lKB -preparatory i so ­
el ectri c focu s i ng col umn , u s i ng a sucrose  dens i ty grad i ent  rang i ng from 
o to 1 M  wi th 2% amphol i nes  ( lKB ) ran g i ng i n  pH from e i ther 3 . 5- 10 or 
4 -6 , depend i ng on the  experiment .  Temperature of - lOoC was  ma i nta i ned  
throughou t the run . ( 130 ) (Append i x  V I ) For i soel ectr i c  foc us i ng  of t h e  
pur i f i ed en zymes ,  0 . 2% ampho l i ne s  wa s u s ed s i nce  t h e  h i g her c oncen tra­
tion  caused a decrease  i n  enzyme acti v i ty and  the i nc rea sed bufferi n g  
capac i ty wa s n o t  neces sary t o  ma i nta i n  t h e  pH grad i en t .  I n  add i t i o n , 
1 mg of bov i n e  hemogl ob i n  was focu sed a s  a v i s i bl e  s tandard to i nd i ca t e  
that focu s i ng wa s compl eted . The co l umn wa s run  a t  a con stant  o u tput 
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of  6 0 0  vol ts  for 4 8  hours or unti l t h e  curren t became zero . Two mi l l i ­
l i ter fracti ons were col l ected and a s sayed for propi onyl CoA 
carboxyl ase  acti v i ty and the pH grad ient  was determi ned from these 
fracti ons .  The i soel ectr i c  poi nts  of  pyruvate carboxylase  and 
8 -methyl crotonyl CoA carboxyl a s e  from norma l f i brobl a sts  and l i ver , 
were s i mi l arly determi ned . 
I .  Heat Denaturati on Experiments 
Homogenates from 5 normal l i vers , 1 norma l  p l acenta , 3 PCC de­
f ic i ent l i vers and  1 P CC  defi c i en t  p l acen ta a nd  t he  two puri f i ed 
enzymes  were s tud i ed for thermosta bi l i ty .  The enzyme-conta i n i ng 
homogena tes , prepared a s  descri bed prev i o u s l y ,  were d i a l yzed aga i n s t  
50mM Tr i s -HCl buffer ( pH 8 . 0 ) overn i ght t o  remove any smal l mol ecu l es .  
These homogena tes were i nc uba ted a t  e i ther 450C or 520C and the res i d ­
ual  a cti v i ty was determi ned over t ime . The prote i n  concentrat ion  was 
determi ned and s tandard i zed to 1 0mg per m l . The samp l e s  were i ncuba­
ted with  e i ther 10mM Tr i s -HCl  buffer , pH  8 . 0  a l one or wi th 5mM ATP o r  
0 . 5H s ucrose  i n  a l OmM Tri s -HCl  buffer , p H  8 . 0 ,  for 1 5  m i nutes a t  230C . 
The samp l es  were then i ncuba ted i n  e i ther a 450C or  520C waterba th  for 
l engths of time vary i n g  between 0 and 30 m i n u tes  and assayed for re­
ma i n i ng prop i onyl CoA carboxy l a s e  act i v i ty .  The resu l ts  a re expres s ed 
a s  the percent of the i n i t i a l  acti v i ty and p l otted vers u s  time . 
J .  Determi nation  of Km ' s  for Vari ous  S ub strates 
The a pparent  Km ' s  for ATP , prop i onyl CoA , pota s s i um and b i carbo ­




enzyme and the homogena tes from the pccCI l i ver and the pccBC2 
p l acenta . The homogenates �Iere d i a l yzed a ga i n s t  1 0m�1 Tr i s -HCl  buffe r . 
pH 8 . 0 ,  prior to assay a nd the pur i f i ed enzymes were d i a lyzed for the 
pota s s i um Km determi nation . Dur i n g  these exper imen ts . a l l a ssay con ­
d i t i ons  were kept constant  whi l e  the stud i ed s u bs trates concentrati on 
wa s var i ed . Al l Km ' s  were determi ned at  pH 8 . 0  wh i ch i s  the reported 
pH optimum for the enzyme . The a s say conta i ned 50mM Tri s -Hc l , lOmM 
MgC 1 2 , 2mM sod i um adeno s i n e  tri phosphate , 100iTIM KC1 , l m�l propionyl CoA . 
5mM reduced g l utathi one and l OmM sod i um b i carbonate . For the deter-
mi nati on of potass i um ,  ATP , and propi onyl CoA , the concentrati ons  of 
these substances were vari ed as fol l ows : pota s s i um between 5mN and  
200mt1 , ATP between 0 . 25mr1 and 5mt1 and propi onyl CoA between 0 . 5mM a n d  
5mM . Each a s say was run for 1 0  m i n utes  i n  order  to ma i nta i n  the con ­
centra ti ons of the substrates near the i n i t i a l  concentrat i on s  except i n  
the puri fi ed mutant wh i c h  was run for 3 0  m i n utes bu t forms s o  l i ttl e 
product that i t  probab ly  d i d  not a pprec i ab ly  a l ter the i n i ti a l  concen ­
tra ti ons . I n  the ATP Km determ i nat i on , magnes i um i s  known to i nteract 
wi th  ATP and was ma i nta i ned a t  a two -fo l d  excess even at the h i g her 
concentr a t i ons of ATP . When the Km for b i ca rbonate wa s determi ned , 
the tota l u C i  of l 4C -b i carbonate per a s say was kept constant whi l e  the 
concen trat i on of col d sod i um bi carbona te �Ja S var i ed . Thi s resu l ted i n  
a d i fferen t spec i fi c  acti v i ty correcti on for each a s say cond i t i on .  
The Km va l ues were ca l cu l a ted by l i nea r regres s i on s  of a doub l e rec i p ­
rocal L i n eweaver-Burk p l o t . ( 1 3 1 ) 
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CASE REPORTS 
Pat ient  1 
A whi te fema l e  presented a t  3 days of age wi th  metabo l i c  ac idos i s .  
hepa tomegl y  and hypog lycemi a .  She was the fu l l term product  of a n  un ­
comp l i ca ted pregnancy and was breas t  fed for the fi rst  days of  l i fe . 
Metabol i c  testi ng revea l ed the presence of ketones i n  the uri n e .  a n  
ani on gap  of 39mmol /L i n d i ca ti ng severe metabol i c  a c i dos i s .  a nd  a l l  
ami no a c i d s  wi th i n  normal l imi ts . 
On day 4 , the baby became i ncrea s i n g l y  hypoton i c  wi thout evidence 
of  i nfecti on . B l ood ammon i a  was s hown to be  e l evated a t  1 50ug/dl (n l = 
50ug/1 00ml ) . Thi s l evel i ncreased on 5 to 3 50ug/dl produc i ng coma . 
Peri toneal  d i a l ys i s  wa s begun to reduce  the hyperammonemi a .  Duri ng 
the course of the d i a l ys i s , her ammon i a  l evel s reached 1350ug/d l . She 
experi enced a respi ratory arres t and responded to resu s c i ta t i on . She 
was  ma i n ta i ned on a resp i ra tor for approx imate l y  27 hours u nt i l her 
bl ood ammon i a  l evel s returned to 1 5 0ug/d l and  spontaneous breathi ng 
resumed . 
On day 8 ,  she  was begun o n  a l ow prote i n  d i et .  Prop i on i c  a c i d­
emi a was  d i agnosed , fo l l owi ng t he  demon strati o n  of 3 - hydroxyprop i o n i c  
ac id , methyl c i tra te , t i g lyg lyc i ne a n d  prop i onyl g lyc i n e  i n  the uri n e  a s  
determi ned by GC/MS . S he ga i n ed we i g h t  a n d  surv i ved s everal bout s  o f  
v i ra l  i l l ne s s  whi ch prec i p i ta ted ketoti c cr i ses . At t h e  a g e  of 20  
months , the pati ent devel oped severe metabo l i c  a c i dos i s  a s  a resu l t  of 
a vi ral gastroen teri ti s and d i ed .  
The pat i en t ' s  fi brobl a s ts were compl emented and determ i ned to 
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bel ong to the  pccA group and a l i ver sampl e wa s obta i ned a t  a u topsy . 
(Thi s pa ti ent was reported by M .  F .  Roberts , D .  J. Schu l tz ,  B .  Wol f ,  
W . D .  Cochran and A .  L .  Schwartz . Arch . of D i seases i n  C h i l d hood , 
54 : 962 -964 , 1 97 9 . ( 132 ) 
Pati ent 2 
A bl ack  ma l e  presented at  1 1  days of  age wi t h  vomi t i n g , hypoton i a  
a nd apparent  seps i s .  T h e  pat ient  responded t o  ant i boti cs and  i n ter­
venous  fl u i d s ; however , he  devel oped meta bol i c  a c i dos i s when  fed  mi l k . 
The pa ti ent was rel eased on a l ow prote i n  d i et after a repeat hosp i ta l ­
i zat ion . Severe neutropen i a  was noted a t  thi s time . 
At 5 months of age the pa t ient  wa s admi tted wi th symptoms of  
Kwa s h i orkor . T he  pat ient  wa s  rel eased on  a rev i sed d i et ,  on  wh i c h  he 
began to ga i n  wei g h t .  At the age of 1 0  months , hyperglyc i nemi a  and  
hyperammonem i a  were noted and propi on i c  ac i dem i a  was suspected . The 
d i agnos i s  was confirmed by assay of the pat i en t ' s  fi brobl a sts . The 
pa t ient  d i ed at  4 years , 7 months after a bout of acute pancreati ti s 
and pneumon i a  wh i ch resu l ted i n  ketos i s  and coma . The pati en t ' s  f i bro­
b l a sts  were compl emented and determi ned to be i n  the pccC g rou p . A 
l i ver sampl e was obta i ned and frozen a t  a utopsy whi c h  i s  des i gnated 
pcc CI i n  thi s s tudy . 
(Th i s  pa ti ent wa s prev i ou s ly  stud i ed by Lande s , R .  D . ,  G .  B .  Avery , 
F .  A .  Wa l ker and Y .  E .  H s i a . Ped i a t .  Res . 6 : 394 , 1 97 2 . ( 3 2 »  
Pati ent  3 
A whi te mal e presented at  2 weeks of age wi th vomi t i ng , l ethargy 
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and hypoton i a  whi c h  progressed to coma . The pa t i en t  showed no  ev i ­
dence o f  keto s i s and responded to I V  fl u i d s . At th i s  time , the 
d i agnos i s  of dysautonom i a  was cons i dered . The pa tient  was readmi tted 
wi th i n  3 days w ith  vom i t i ng and l ethargy . A pl a sma ammon i a  l evel of 
1 , 1 00ug/100ml was obta i ned and g l yc i ne was a l so e l evated . A l i ver  
b i opsy was  performed to determ ine  the acti v i ty of urea cycl e enzymes  
and carbamyl phosphate syntheta se  acti v i ty was found  to  be 20% of  
norma l . The pati ent  was  ma i nta i ned on 1 g o f  prote i n/ kg body we i g ht/ 
day a nd the hyperammonem ia  abated . Neutropen i a  wa s a l so n oted at  th i s  
t ime . Decreases i n  pl a sma val i ne ,  p henyl a l a n i ne and tyros i ne l evel s ,  
suggested ami no ac i d  depl eti on and a ketoac i d -am i n o  ac i d  nu tri t iona l  
suppl ementa ti on d i et was  begun .  Th i s l oad of  prote i n  i n i ti ated a keto­
ac i doti c cri s i s  w ith  l ethargy , neu topen i a  and  hypogl ycem i a  wh i c h  
suggested t h e  d i a gnos i s  o f  an  orga n i c  aci demi a .  T h e  acti v i ty o f  pro ­
p i onyl CoA carboxyl ase  i n  l eu kocytes was found to be approx imate ly  2% 
of normal , confi rmi ng the d i agnos i s .  The pati ent  wa s ma i n ta i ned on 
1 . 4 g of protei n/Kg body wei ght/day . The pati ent  d i ed at  2� years  o l d 
a s  a resu l t of the d i sease . The stud i es of pa tient ' s  fi brobl a sts . re­
sul ted i n  thei r a s s i gnment to the pccC  complementation group . A l i ver 
samp l e  wa s obtai ned and frozen at au topsy whi c h  i s  des i gna ted � i n  
thi s s tudy . 
(Thi s pa ti ent was prev i ou s l y  reported by D .  J .  Harri s ,  B .  I .  Y .  Yang , 
B .  Wol f ,  P .  J .  Snodgra s s . Ped i atr i c s  65 : 1 07-1 1 0 , 1 980 . ( 2 2 »  
Pat ient  4 
A b l a c k  fema l e  presented a t  2 days of age w ith  ton i c -c l on i c  
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se i zures a nd progre s s i v e  l ethargy wh i c h  wa s present from b i rth . She  
was worked u p  for seps i s  and started on ant i b i o ti c s . Marked hyper­
ammonem i a  and ketos i s  were observed on day 7 wi th el eva ted serum 
prop i ona te reach i ng 6800uM . The pat ient  was treated wi th e l even 2 -vo l ­
ume exchange tran sfu s i on s  over a 48 hour peri od wi th the add i t i on of 
I V  g l ucose and ass i s ted venti l at i on . The d i agnos i s of  prop i on i c  a c i d ­
em i a  via s  confi rmed by enzyme a s say of cu l tured fi brobl a s ts . The 
pat i en t  was hos p i ta l i zed four t imes for refu s i ng formu l a  and  for dehy ­
drati on . She d i ed a t  4 1/2  months of men i ng i ti s .  The pati en t ' s  
fi bro bl a sts were compl emented and were determi ned to be i n  the pccBe . 
g rou p .  A samp l e  of l i ver , obta i ned at autopsy , was frozen and  sub s e ­
quentl y ,  pur i f i cat ion  o f  the mu tant  enzyme i n  th i s  study was des i g na ted 
pccBe . 
Pat ient  5 
A wh i te fema l e  was d i a gnosed prenata l l y  to have prop i o n i c  a c i demi a 
a s  a resu l t  of a bn orma l  metabol i tes i n  the amn i on i c fl u i d . The mother 
had a prev i ou s  c h i l d  I'li th prop i on i c  ac idem i a  who d i ed a t  the age  of  8 
days . Thi s pati ent  wa s started on a l ow protei n  d i et from b i rth . She  
had  hypoton i a  from b i rth and had  i n termi ttent  ep i sodes of keto s i s  and  
hyperammon i a .  The pat ient  i s  a l i ve a t  14 mon ths and s h ows some del ay 
i n  gros s  motor s k i l l s  as a resu l t of severe hypoton i a . Stud i es of the  
pati en t ' s  fi brob l a sts  resu l ted i n  the i r  a s s i gnment to  t he  pccBe comp l e ­
menta t i on g rou p . The pl acenta from thi s pregnancy was frozen after 
de l i very and i s  des i gnated pccBC2 i n  th i s s tudy . 
(Thi s pa t i en t  was reported by L .  Sl'leetman ,  W .  Weyl er , T .  S hafa i , P .  E .  
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Young and W.  L. Nyhan . J. Am . Med . A s s o c . 242 : 1 048- 1052 , 1 978 . ( 6 6 )  
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RESULTS 
A .  Propi onyl CoA Carboxyl a se  Acti v i ty i n  N orma l  T i ssue  a nd Ti ssue  
from Propi o n i c  Aci d em i s Pati ents 
B i ochemica l  character i zati on of normal and mutant pro p i onyl CoA 
carboxyl ase  from var i ous  human ti ssues  was underta ken to g a i n  i n s i g h t  
i n to t h e  b i ochemica l  defect cau s i ng the defi c i ency i n  these pati ents . 
I t  was necessary to b i ochemica l ly  charac teri ze normal pro p i onyl CoA 
carboxyl ase  i n  var i o u s  ti s sues  i n  order to determ i n e  wh i c h  were appro -
pr i a te for s tudy .  The spec i fi c  a cti v i ty of sampl es of  thi s enzyme , 
from several human ti s sue  homogena tes , are s hown i n  Ta bl e I V .  L i ver 
a nd k idney ti ssue demons trated comparabl e and h i g h  s pec i f i c  acti vi ti e s . 
S i nce norma l a nd muta nt  l i ver ti s su e  was read i l y  ava i l abl e ,  i t  was 
c hosen a s  a source  of enzyme for mos t  of thi s s tudy . The donors of  
the  fi fteen control l i vers u sed i n  th i s  s tudy , ranged i n  age from new­
borns to a 55  year o l d ,  bu t most of the l i vers were from i nfants . 
T here was n o  s i g n i f i cant  corre l a t i on between the age of the don or and 
the spec i fi c  a cti v i ty of propi onyl CoA carboxyl ase . However , the t ime 
the l i ver was obta i ned after death , d i d  i nfl uence the spec i fi c  acti v ­
i ty of  the enzyme and a l so i ts subcel l u l a r  d i stri buti on . In genera l , 
the l onger time before obta i n i ng and freez i ng the ti ssue  resul ted i n  a 
l ower spec i fi c  acti v i ty .  A sca tter p l o t  of the spec i fi c  a c ti v i ty of 8 
l i vers s howed a correl a t i on of - 0 . 8 3  between spec i fi c  act i v i ty and  
t ime before freezi ng of the  l i ver . Earl y a ttempts to l ocal i ze pro p i o ­
nyl CoA i n  i so l a ted mitochondr i a  from both l i ver a nd p l a centa , 
demons tra ted o n ly  3% of the pro p i onyl CoA carboxyl ase  a c t i v i ty i n  th i s  
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TABLE I V  
PROP I ONYL CoA CARBOXYLASE ACT IV ITY I N  NORMAL T I SSUE 
AND T I SSUE  FROM PROP I ON I C  AC I DEM IA  PAT I ENTS 
T i s sue  Mean Spec i fi c  Jl.ct i v i ty Rang e 
nmol es/mi n/mg 
Norma l L i ver (n =9 )  6 . 97 0 . 8-16 . 1  
Mutant  L i ver ( n= 3 )  0 . 26 0 . 23 -0 . 36 
F i brob l ast  Norma l ( n= 5 )  0 . 49 0 . 3 -0 . 7 
F i bro b l a s t  Mutant  ( n=8 ) 0 . 0045 0 . 0022-0 . 056  
Pl acenta Normal ( n=3 ) 0 . 49 0 . 41 -0 . 56 
P l a centa Mutant ( n= l )  0 . 1 7 
Ki dney Normal ( n=2 )  8 . 67 7 . 6 ,  9 . 7 
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frac ti on as wel l a s  on ly  3% of another m i tochondri al enzyme acti v i ty ,  
g l u tami c  dehydrogenase , suggest i ng  the brea kdown o f  mi tochondri a  dur­
i ng  l i ver autolys i s .  The percentage of prop i onyl CoA and g l utam i c  
dehydrogenase acti v i t ies  was found t o  b e  parti cu l ar ly  l ow i n  the m i to ­
c hondr i a l  fracti on of  l i vers wh i c h  were obta i ned a l on g  time a fter 
dea th .  Thi s f i nd i ng was con fi rmed by a con trol s tudy i n  fresh ly  ob­
ta i ned p i g  l i ver wh i c h  moni tored the  l ea kage o f  propi onyl CoA a nd 
g l u tami c dehydrogenase . I n  th i s  experiment ,  p i eces  of l i ver , ma i n ­
ta i ned o n  i ce ,  were proces sed 1 ,  4 and 7 hours a fter death and demon­
s tra ted 1 5% decrea se i n  mi tochondr i a l  propi onyl GoA carboxy l a s e  
a c ti v i ty .  Becau se of  the l os s  of  propi onyl CoA carboxyl a s e  acti v i ty 
i n  i so l a ted mi tochondri a ,  whol e cel l homogenates were u sed a s  the 
source of human enzyme in  most exper i men ts . 
The three l i vers and one p l a centa from pa ti ents  i n  the pccC a nd 
pccBC compl emen ta ti on groups  a l l reta i ned res i dua l  prop i onyl CoA car ­
boxyl ase  acti v i ty of l es s  than 4% of  norma l acti v i ty .  The compl ementa ­
t i on c l ass  was determi ned i n  f i brobl a s t  cu l tures obta i ned from these  
pat i ents p r i or  to  dea th . Two of these  l i vers , des i g na ted pecCI and 
� bel ong to the subgroup  pccC , whereas the other l i ver and pl acen­
ta  bel onged to the  s u bgroup pcc B C , des i gna ted pcc B C1 and pccBC2 
respect ivel y .  
The acti v i ty o f  g l u tami c  dehydrogenase was u sed a s  a n  i nd i ca tor of 
tota l mi tochondr i a l  enzyme acti v i ty i n  the mutant  l i ve rs becau se  i t  
corre l a ted wi th propi onyl CoA carboxyl ase  a c ti v i ty i n  norma l l i vers . 
As s hown i n  Tabl e V ,  the mu tant  l i vers have g l utam i c  dehydrog enase  
TABLE V 
THE SPEC I F I C  ACT I V ITY OF PROP I ONYL CoA CARBOXYLASE AND GLUTAM I C  
DEHYDROGENASE I N  L I VERS FROM NORMALS AND PROP I ON I C  AC I DEMIA PAT I ENTS 
Propi onyl CoA Carboxyl a s e  Act i v i ty 
nmo l es/m i n /mg 
Normal L i ver ( n=9 )  
Mutant L i ver ( n=3 ) 
Mean 
6 . 97 
0 . 2 55  
Range 
0 . 8  -16 . 1  
0 . 23 -0 . 36 
G l u tami c Dehydrogenase Ac t i v i ty 
umo l e s/mi n/mg 
Normal L i ver ( n=7 ) 
Muta n t  L i ver ( n=2 ) 
Mean 
1 . 06 
1 . 7 
Range 
0 . 4 - 1 . 98 
1 . 38 ,  2 . 02 
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acti v i t i es wi th i n  the  range obta i ned i n  norma l l i vers i nd i cati ng tha t  
the d i fferences i n  prop i onyl CoA carboxyl ase  acti v i ty a re not l i ke ly  to 
be caused by vari ati on i n  time before these t i ssues  were frozen . The 
res i d ua l  acti v i ty in both the mutant l i ver and pl acental tissues  para­
l l el s  that observed in mu tan t fi brobl ast  cel l l i nes exhi b i t i ng 0 . 5- 10% 
of the spec if i c  acti v i ty found i n  normal t i s sue . Al though the probl em 
of a u to lys i s i s  c i rcumvented u s i ng fi brobl a st  c u l tures , the d i sadvan ­
tage i n  worki ng wi th fi brobl asts  i s  that they have on ly  1 0% of 
propi onyl CoA carboxyl ase  acti v i ty fou nd in l i ver , therefore , requ ir ing 
more materi a l  to obta i n  adequa te acti v i ty for exper imenta ti on . 
The other two mi tochondr i a l  carboxyl ases , pyruva te carboxyl a se and 
S -methyl crotonyl CoA carboxyl a se are l ess stabl e than propi onyl CoA 
carboxyl ase . So the i r  acti v i ty i s  found i n  reduced amounts  i n  most  
l i ver sampl es . Both  enzymes can be read i l y  a ssayed in  f i brob l a s t  
homogena tes , even thoug h  they are approx imate l y 1 /2 a nd 1 /4 the act i v ­
i ty o f  propi onyl CoA carboxyl ases , respect ivel y .  Pyruvate and 
s -methyl crotonyl CoA carboxyl ase  acti v i t i e s  have been s hown to be  
equ iva l ent  in  both  normal  and propi onyl CoA carboxyl a se  defi c i en t  l i nes  
except for the  b i o  compl emen ta ti on group .  The b i o  group represents 
ce 7 7  7 i nes w ith  defi c i enc i e s i n  a l l three carboxyl ase enzyme acti v i ti es 
when i ncuba ted i n  med i um not suppl emen ted wi th b i o ti n .  The add i t i on of 
5 ug/ml of b i ot i n  to the cel l cu l ture med i um res tores the act i v i t i e s  of 
these carboxyl ases  to near norma l l evel s .  Defi c i ent  a ct i v i ty of  a l l  
three carboxyl ases  i n  the b i o  mu tant  and a b i l i ty to correct th i s defi c ­
i ency wi th  excess b i o t i n  suggests that the defect i s  the resu l t of 
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e i ther a bnormal i n tracel l u l ar b i ot i n transport o f  a defec t i n  a commo n  
ho l ocarboxyl ase  syn theta se , the enzyme wh i c h  cova l ent ly  b i n d s  b i o ti n to 
the apocarboxyl a se . 
B .  Immunoti trat ion of  Propi onyl CoA Carboxyl ase  i n  Normal  and Mutant 
Ti s sues  
To determine  if  prop i onyl CoA carboxyl ase  defi c i ency was  the re­
su l t of a normal quant i ty of l e ss  acti ve  defec t ive  enzyme or a 
d ecrea sed synthes i s of a s tructura l ly  normal enzyme , immuno l og i c  
method s were empl oyed . Anti serum aga i n st  puri fi ed p i g  heart  prop iony l  
C o A  carboxyl a se , when added t o  f i brobl ast extracts , i n h i b i ted prop i o ­
nyl CoA carboxyl a se  act i v i ty ,  bu t d i d  not  i nh i b i t  the activi ty of 
pyruva te carboxyl a s e , nor gl utam i c  dehydrogenase . The acti v i ty of  
human 8 -methyl crotonyl eoA carboxyl ase  was s l i g ht ly  i n h i b i ted by i nc u ­
ba t i on wi th the ant i serum . 
A prec i p i tated comp l ex c ou l d  read i l y  be removed from so l u t i o n  by 
centr i fuga ti on a t  5000 X g for 5 mi n .  Non-centri fuged anti body-Pee 
compl exes  reta i ned acti v i ty comparab l e to that of extracts to whi c h  
a n ti body was not added . I n  add i ti on , the a n ti serum on ly  comp l exed to 
pee , s i nce the acti v i t i e s  of the other three carboxyl ases  were u n ­
changed i n  the su perna ta nt  fol l owi ng centr i fugati on . 
Ouc hterl ony doub l e-d i ffu s i on stud i e s  of  extrac ts of normal  and  
pee -defi c i en t  l i vers aga i n st  ant i - p i g  heart pee yi e l d ed s i ng l e prec i p ­
i ti n  a rc s  for each preparat i on  ( F i g . 6 ) . I n  add i t i on , these s tud i e s  
revea l ed patterns o f  i denti ty between the mutant pee a nd norma l pee , 
wi th no evi dence of spurri ng . S i nce the prec i p i t i n  arcs were a bou t a n  
Fi gure 6 .  Doub l e d i ffu s i on o n  Ouc hterl ony p l a te s  of crude 
extracts of norma l l i ver ( N ) and l i ver from the pee-def i c i en t  pati e n ts 
( 1 0  mg/ml ) bel ongi ng to the pccA ( A ) . pccBe ( Be ) and pcce (e )  geneti c 
compl emen ta ti on groups  aga i n s t  undi l u ted anti serum to p i g  heart  pee i n  
the center wel l ( Ab ) . Var i ab l e dark ly  s ta i n i ng reg i on s  around extra c t  
wel l s  a ppear to be d u e  t o  l i p i d  mater i a l . 
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equa l  d i s tance from eac h  of  the l i ver ex tract  wel l s con ta i n i ng equ i va l ­
ent  prote i n  concentrat i ons , the cros s -react i ng  materi a l  (C RM ) i n  eac h  
l i ver  sampl e appears to b e  a bout the same concentra ti on . 
To mea sure the amoun t  of the CRM i n  these l i ver  extracts  more 
accurate ly , we ti trated P CC acti v i ty in ex trac ts of normal and PCC-de­
fi c i ent  l i vers by determi n i ng t he  res i dua l  PCC  acti v i ti es i n  the 
su pernatant  sol ut ions  of extracts  fol l owi ng i ncubat i on wi th decrea s i ng 
ti ters of ant i serum ( Fi g . ? ) . The resu l ts s tri k i ng ly  reveal ed the d i f­
ference i n  the acti v i t ies  of normal ( 2600-41 00 pmo l /mi n/mg prote i n ) 
and mu tant  PCC ; act i v i ty of the �l i ver wa s 67 pmo l /m i n/mg ( 2 . 1% o f  
norma l ) and that of the pccBC�] i ver wa s 13 . 5  pmol /mi n /mg ( 0 . 4% of nor­
ma l ) . PCC acti v i ty i n  extracts i nc u bated wi thout a nt i serum was 
s i mi l ar to that of extracts i ncubated wi th 1/2048 to 1 /4096 d i l u ti ons  
of  a n ti serum . The  shapes of the hepa t i c  immunot i trati on curves for 
the two mutant  extracts corresponded c l ose ly  to eac h  other and to those 
for norma l l i ver extracts wi th 50% of the maxi mum PCC a c ti v i ty i nact i ­
va ted a t  anti serum ti ters of a bout  1/64-1/128 . Ex tracts o f  the l i ver  
of  the  pccA group coul d not be t i tra ted because  the res i du a l  a c ti vi ty 
was so l ow ,  because of i ts reduced thermo sta b i l i ty ,  tha t i t  wou l d  
not  be l i near wi th respec t to the l eng thy time o f  i ncubati on  neces sary 
under  the a s say cond i t i on . 
To compare the C RM i n  fres h t i s sues  deri ved from i nd i v i dua l s 
a s s i gned to the major c omp l ementa t i on g rou p s , we t i trated extracts of 
f i brob l a sts  from normal and PCC -defi c i ent i nd i v i dua l s  wi th  ant i - p i g  
heart P C C  i n  t h e  same ma nner a s  we  t i tra ted t h e  l i ver extract s . A s  
Fi gure 7 .  I n h i b i t i on of PCC act i v i ty by i ncrea s i ng d i l u t i ons  o f  
a nt i serum t o  p i g  heart P C C  i n  normal  l i ver extracts  a n d  i n  extracts  
from PCC-def ic i en t  pat i ents bel ong i ng to the pccBC  and  pccC  compl emen ­
ta ti on groups . The extract  prote i n  concentra ti on s  were adj u s ted to 
10 mg/ml . Ex tracts were i ncuba ted wi t h  the severa l  d i l u ti on s  of a n t i ­
serum a t  370C for 30 m i n . The sampl es  were then centr i fuged a t  5000 X 
g for 5 m i n .  and the s uperna ta n t  so l u t i ons  a s sayed for PCC act i v i ty .  
Shaded a rea s i nd i cate the range  o f  f i ve n orma l ex tra c ts ; pccC  a n d  pccB C  
extracts  a r e  i nd i cated by ( e )  a nd ( . ) ,  respec t i vel y .  PCC-spec i f i c  
act i v i ty i s  p l otted aga i n st  the t i ter o f  ant i serum . The a rrows i nd i ­
ca te t i ters of ant i serum a t  whi c h  50% of max imum PCC act i v i ty i s  
i na c t i vated . Note the d i fferent ord i na te sca l e s  of  PCC act i v i ty for 
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s hown i n  F i g . 8A , t h e  res i du a l  P C C  acti v i ty i n  t h e  superna ta n t  s o l u ­
t i o n s  of mutant fi brob l a s t  extracts va ri ed from 2 . 2  to 56  pmol /mi n/mg 
prote i n  ( normal = 500 -700 pmo l /mi n /mg ) or from 0 . 4% to 9 . 3% of norma l . 
As i n  the hepa t i c  i mmunoti trat i on stud i e s , the  t i trat i on c urv e s  of 
mutant fi brobl a s ts from eac h  of  the compl ementat i on groups  were compar­
ab l e to those o f  n orma l f i brob l a sts , with 50% i nh i b i ti on of PCC 
a c t i v i ty at  an anti s erum ti ter of  1/256  to 1 /51 2 .  The fi brob l a s t  l i ne 
( F i g .  8A ) and the l i ver ( Fi g .  7 )  of the pccC  compl ementa ti on group  
were from the  same pati en t .  Immunoti trat i on o f  another pccC  fi b rob l a s t  
l i ne (data not g i ven ) gave s im i l ar resu l ts . Two o ther pccA l i ne s  and a 
pccBC  l i ne were a l s o  t i trated , but  the  PCC act i v i ty was  heat  l a bi l e  
u nder the cond i t ions  o f  the t i tra t i on a s say .  
PCC acti v i ty i n  f i b robl a s t  c u l tures o f  the  bio mutant i ncubated i n  
med i um wi thout su ppl emental  b i ot i n ( bi ot i n  i n  unsupp l emen ted med i um 
2 ng/ml ) was 36 pmol /mn/mg . Acti v i ty i n  the same cel l s  i ncuba ted i n  
med i um su ppl emented wi th  bi ot i n  ( 1  ug/ml ) wa s s i x teenfo l d h i g her  ( 6 1 0  
pmo l /mi n/mg ) and wi th i n t h e  normal range of  acti v i ty .  Immunot i trati on 
of  PCC  acti v i ty in  f i b robl a s t  extracts of  the b io  mutan t i ncu ba ted i n  
med i um wi thou t supp l emental  b i ot i n gave c urves s i m i l ar to those  of  
norma l extracts  ( 50% of  maximum acti v i ty i nacti vated a t  1 / 2 56  to 1/5 12  
d i l u t i on of anti serum ) . T hu s , not  on ly  do PCC-def i c i en t  l i ver  a nd 
fi brobl a sts  ev i dent ly  conta i n  CRM to the ant i s erum , bu t ,  based on un i t 
prote i n  concentra t i on , each mutant  l i ver or  fi brob l a s t  extract has  a 
concentrat ion  of CRM s i mi l a r  to tha t of  norma l extracts . 
I n  order to obta i n  an ant i body to human prop i onyl CoA carboxyl a s e , 
Fi gure 8 .  I n h i b i t ion  of PCC  act i v i ty by i ncrea s i ng d i l ut i ons  o f  
a n t i serum t o  p i g  heart P C C  i n  normal f i brobl a s t  extracts a n d  i n  
extracts from PCC-defi c i ent  pa ti en ts bel ong i ng t o  t h e  vari ous  compl e­
menta t i on groups . T i trat i on  cond i t i o n s  are  a s  descri bed i n  F i g . 7 ,  
except that the extract  pro te i n  concentra t ion s  were adj u s ted to 6 mg/ml . 
Shaded area s i nd i ca te the range of three normal extracts . PCC - s p ec i fi c  
act i v i ty i s  pl otted versus  the t i ter of  ant i serum . The arrows i nd i c ate 
t i ter of anti serum a t  wh i ch 50% of max imum PCC act i v i ty i s  i nact i v a ted . 
N ote the d i fferent ord i nate scal es of PCC  acti v i ty for the vari ous  
fi brobl a s t  l i nes . (A ) Immu noti tra t i on of  PCC  act i v i ty i n  representa ­
ti ve f i brobl a s t  l i nes  of  the pccA ( . ) and pccC ( 4t ) compl emen ta t i o n  
groups . T he  pccC fi brobl a s t  l i ne s hown i n  th i s  fi gure and the l i ver of 
the pccC compl ementa ti on group s hown in Fi g .  7 were from the same 
i nd i v idua l . ( 8 )  I mmunoti trat ion  of  PCC  acti v i ty in the b i o t i n -respon ­
s i ve f i b robl a s t  l i ne of  the bi o compl ementat i o n  group w ith  s u ppl emental  
b i ot i n (4t : 1  ug/ml ) and wi thout  added  b i o t i n  (. ; b i oti n in  unsu ppl e �  
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we  d evel oped a s impl e method to prepa re ant i bod i es to  the  human carbox­
yl a ses . Expl o i t i n g  the b i oti n - b i n d i ng property of  av i d i n ,  an  avi d i n  
affi n i ty col umn was syn thes i zed t o  reta i n  carboxyl a se  from human l i ver 
homogenates . Ev idence tha t the b i ot i n -conta i n i ng enzymes d i d  i n  fac t  
b i nd t o  the col umn i s  prov ided by the fol l owi ng  observati ons : 1 )  l es s  
than one percent o f  the l i ver su pernant  prote i n  whi ch  was pas sed 
throug h  the col umn ad hered to the co l umn ma trix ;  2)  the l os s  of th i s 
sma l l quant i ty of prote i n  was a s s oc i a ted wi th a c ompl ete l os s  of pro ­
p i onyl CoA carboxyl a s e  a c ti v i ty i n  the el uant  whi l e  g l utam ic  dehydrog ­
enase  a c ti v i ty rema i ned ; 3 )  saturab i l i ty of the coi umn for propi onyl 
CoA carboxyl a se  c ou l d  be demonstra ted , i nd i ca t i ng s pec i fi c  b i nd i ng 
s i tes  for the enzyme , and 4 )  prop i onyl CoA carboxyl ase  a cti v i ty cou l d  
be demon stra ted o n  the col umn fo l l owi ng exten s i ve wa sh i ng . S i nce 
enzyme act i v i ty cou l d be detected in  the enzyme-av i d i n -Sepharose com ­
p l ex ,  one o r  more u n bound s i tes  o n  the enzyme mol ecu l e  mu s t  reta i n  
the i r  a cti v i ty fol l owi ng b i nd i ng to the col umn ma tri x .  
When s erum , obta i n ed from ra bb i ts  o n  days 0 and  1 4  after i nocu l a ­
t i on wi th th i s enzyme-avi d i n -Sepharose compl ex , was d i ffused a ga i ns t  
tota l l i v er homog e n a te , n o  prec i p i ta n t  a r c s  wh i c h  i nd i ca te the presence 
of a n t i body were vi s i bl e .  However , prec i p i tant a rcs were observed when 
the serum obta i ned s even days a fter the seconda ry i mmun i za t i on was 
tested in the s ame manner . The control ra bbi ts d i d  not demons tra te 
any prec i p i tant  arcs . When serum from rabb i ts trea ted w i t h  carboxyl a s e ­
satura ted col umn was i nc u ba ted wi th l i ver homogenates a n d  centri fuged , 
the  a c t i v i ty of propi onyl CoA carboxyl a s e , pyruvate carboxyl a se , a n d  
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8 -methyl crotonyl eoA carboxyl a s e  was i n h i b i ted . I n h i b i t i on  of these  
enzyme acti v i ti es , fo l l owi ng t he  add i t i on  of ant i serum , appears to  b e  
rel a ted to  a s pec i fi c  anti gen-anti body react ion  s i nce t he  acti v i ty o f  
g l u tam i c  dehydrogenase was n o t  i nhi b i ted by the ant i serum . A preci pi ­
ta bl e compl ex cou l d readi ly  be removed from sol ut i on  by centr i fugati o n  
a t  5000xg for 5 m i nutes . Non -prec i p i ta ted c ompl exes reta i ned enzyme 
act i v i ty .  The prec i p i tat ion  reacti on  wa s temperature dependent and  
was s u bstanti a l l y  i nh i b i ted by i nc u bat i on  a t  40C .  I n  addi t i on , 
Ouchterl ony doubl e d i ffu s i on s tudi es i n  agarose s ho�/ed a broad prec i p i ­
ti n reg i on between ant i serum and  the supernatant from no rma l l i ver  
extrac ts wh i ch reta i ned fl uorescami ne-tagged a v i d i n ,  i nd i cati ng  the 
presence of  b i ot i n -conta i n i ng prote i n .  When sera from i nocul a ted 
ra bb i ts were passed over an a v i d i n -ca rboxyl ase  saturated col umn , both 
the ab i l i ty to i n hi b i t prop iony l  CoA carboxyl ase  acti v i ty and  to form 
prec i p i tant  arc s  on  Ouc hterl ony dou b l e d i ffu s i on s tud i e s , was removed . 
The prec i pi tat ion  of propi onyl CoA carboxyl ase  by ant i -carboxyl a s e  
a n t i s erum was compared wi th the anti serum prepa red aga i n s t  puri f ied p i g  
heart  prop i onyl  eoA carboxyl ase . Both anti sera s i mi l arl y  i nh i b i ted 
pro p i o nyl CoA c a rboxyl a s e  a c t i v i ty a l mo s t  to ta l l y  in huma n fi brobl a s t  
a nd l i ver homogena tes . ( Ta bl e V I ) T h e  ant i body aga i n s t  p i g  heart pro­
p i o nyl eoA carboxyl ase  was s hown to c ro s s  react  s l i g htly wi th  human 
8 -methyl crotonyl CoA carboxyl ase  but  not wi th human pyruvate carboxy­
l a se . S i nce  the  s tructures of 8-methyl cro tonyl eoA  carboxyl ase  and  
prop i o nyl CoA  carboxyl a se  are probab ly  s i mi l ar ,  some degree of  cro s s  
reacti v i ty a t  h i g h  a nti body ti ters i s  n o t  surpri s i ng . T h e  a n ti serum 
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TABLE  V I  
Compar i son o f  Percent I n h i b i t i on of Anti -porc i ne Propi onyl CoA 
and Anti -human Carboxyl a se  Anti s erum 
Anti -porc i ne 
Anti -human prop ionyl CoA 
carboxyl ase  carboxyl a s e  
F i brobl a s t  anti serum anti serum 
Propi onyl CoA carboxyl ase  95% 83% 
S -Methyl crotonyl CoA 62% 28% 
carboxyl a se  
Pyruvate carboxyl ase  7 1%  0% 
L i ver Homogenate 
Propi onyl CoA carboxyl ase  80% 60% 
S -Methyl crotonyl CoA 59% 43% 
carboxyl ase  
Pyruvate carboxyl ase  73% 2% 
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prepared aga i nst  the human carboxyl a ses , a s  expected , i nh i b i ted both 
pyruvate carboxyl ase  a nd 8 -methyl crotonyl eoA carboxyl ase , bu t not a s  
d rama t i ca l ly  a s  i t  i n h i b i ted propi onyl eoA carboxyl ase . 
Further compari sons of the ant i sera by Ouchterl ony doub l e d i ffus ­
i on , demonstra ted tha t both ant i sera prec i p i ta ted puri fi ed p i g  heart  
prop i onyl eoA carboxyl ase . ( Fi gure 9A ) The spur  observed , i n d i cates 
that the anti - p i g  heart propi onyl eoA carboxyl ase  recog n i ze s  d i fferent  
ant igen i c  determi nants  i n  thi s prepara ti on  than  those  recogn i zed by 
the human anti -carboxyl ase . There are several po s s i bl e  exp l a nat i on s  
for the observed spur . There i s  a poss i b i l i ty that there i s ,  i n  the 
pur i fi ed pig heart preparati on , a con tam i nant  not observed by gel  e l ec­
trophores i s  to  whi c h  an anti body has  been  made , or tha t the human 
ant icarboxyl ase  serum may be m i s s i ng some anti geni c determi nants whi ch 
are covered by the av i d i n  b i nd i ng . However , the mos t l i ke ly  pos s i b i l i ­
ty i s  that th i s  spur res u l ts from d i fferent determi nant  i n  the p i g  
heart enzyme a s  opposed t o  the human enzyme . Whatever the correct 
expl anati on , the ant icarboxyl ase  a nti serum preci pi tated the pur i fi ed 
p i g  heart prop i onyl eoA carboxyl a s e  a s  s hown by the p rec i p i ta n t  arc . 
F i gu re 98 shows the prec i p i tant  arcs formed when the ant i -carboxyl a se 
anti serum a nd the anti - p i g  hea rt prop i onyl eoA carboxyl ase  ant i s erum 
were d i ffu sed aga i n s t  norma l l i ver homogena te wh i ch conta i ned measur­
abl e a cti v i ty of prop i onyl eoA , pyruva te and  8 -methyl crotonyl eoA 
carboxyl a se  acti v i ty .  The fi gure s hows the same spurr i n g  pattern 
observed i ·n the prev i ou s  pl a te and , in add i t i on , a s pur  by the a n ti ­
carboxyl ase  anti serum . Th i s  spur i s  proba b l y  caused by prec i p i ta t i o n  
F i gure 9 .  Doub l e d i ffu s i on on Ouch terl ony p l ates  of  ant i -human 
carboxyl ase  ant i s erum ( 1 )  and ant i - p i g  heart pro p i onyl CoA carboxy l a s e  
ant i serum ( 2 )  aga i n s t  p ur i f i ed p i g  heart propi onyl CoA carboxyl a s e  ( A )  
and  human l i ver homogenate ( l Omg/ml prote i n  ( 8 » . 
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of the other carboxyl a ses i n  the  l i ver homogena te whi ch  are not  reco g ­
n i zed by the anti - p i g  heart propi onyl CoA carboxyl ase  anti serum . 
Immu nod i ffu s i o n  s tud i e s  revea l ed a pattern of i denti ty when the 
ant i -huma n  carboxyl ase  anti serum was tes ted aga i n s t  crude l i ver homog ­
ena tes from both prop i onyl CoA carboxyl ase  def i c i en t  and  non -defi c i ent  
s u bjects . ( F i gure 1 0 )  The a bsence of  prec i p i ti n  spurs i nd i cate no  
d i fferences i n  ant i gen i c  s i te s  between mutant and norma l t i s s ue  ex­
tracts . These  a re i denti cal  to those observed wi th anti - p i g  heart 
propi onyl CoA carboxyl ase  ant i serum . Prop i onyl CoA carboxyl a se  acti v i ­
ty wa s ti tra ted i n  fi brobl a s t  extrac ts from a n o rm a l  l i n e , a pccA l i ne 
a nd a pccC l i ne . Each  l i ne has equ i va l ent tota l prote i n  concentra­
t ions  ( 5mg/ml ) and comparab l e pyruvate and S -methyl crotonyl CoA 
carboxyl ase  acti v i ty .  The t i tra t i on curves were s im i l ar i n  each of  the  
l i nes  tested , i nd i cat i ng equ i va l ent  prop i onyl CoA  carboxyl a s e  cros s ­
react i ng ma teri al . ( F i gure 1 1 )  
F i na l l y ,  prop i onyl CoA carboxyl ase  act i vi ty wa s measured i n  super­
nant sol ut i on s  of norma l , pcc Cl and pccBC1 l i ver extracts conta i n i ng 
ident ica l  total prote i n  concentrat i on s . These were ti trated wi th anti ­
serum and s ubsequently cen tr i fuged . ( F i gure 1 2 )  The resu l ts  i nd i c a ted 
tha t a 1 : 2 d i l u t i on of anti serum i n h i b i ts 59% to 63% of the maximum 
propi onyl CoA carboxyl a se  acti v i ty i n  both n ormal a nd mutant extracts . 
The i mmunoti tra ti on curves for the mutant  extracts a re s im i l ar to each  
other and to those  for norma l l i ver extrac ts . These curves are a l so 
s im i l a r to those obta i ned u s i ng the ant i -prop ionyl CoA carboxyl a s e  
ant i serum . Thu s , n o t  o n l y  d o  the muta n t  l i ver s ev ident ly  conta i n  
F i g ure 1 0 .  Doubl e d i ffus i on on Ouc h terl ony p l a te s  of ex trac ts of 
norma l l i ver and l i ver from the PCC-defi c i en t  pa ti ents aga i n s t  a nt i s erum 
to human carboxyl ases . 1 and 4 ,  norma l l i ver ; 2 and  5 ,  l i ver of 
pa ti ent �1 and 6 ,  l i ver of pati en t  RCCSC! . The prote i n  concen tra ­
ti ons of extracts i n  wel l s  1 ,  2 ,  and 3 were 1 0  mg/ml and 5mg/ml i n  
wel l s  4 ,  5 ,  and 6 .  
8 3  
F i g ure 1 1 .  Ti tra t i on curve of PCC act i v i ty i n  n orma l fi brob l a s t  
extracts  (. ) and "i n  extracts from PCC -defi c i en t  pat i ents bel ong i ng 
to the pccA ( � )  and pccC « »  compl emen tat ion  g roups ( 5mg prote i n/ml ) 
i n h i b i ted by i ncrea s i n g  d i l u t i on s  of ant i sera to human carboxyl a ses . 
Extracts  were i n cubated wi th each d i l uti on of ant i serum at  370C for 
30  mi n .  and centri fuged at  5000xg for 5 mi n .  PCC acti v i ty was then 
determi ned in the supernata nt  sol u t i on s .  
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F i gure 12 . I n h i b i ti on of PCC acti v i ty i n  a norma l l i ver extra c t  
( e ) a nd i n  extracts from PCC -defi c i e n t  pat i e nt  P�l ( 0 ) a n d  � 1  
( 0  ) by i ncrea s i ng d i l u t i on s  of ant i serum to  P CC  and  other acyl -carboxy­
l a ses . The extrac t prote i n  concen trat ion s  were adju s ted to 14mg/ml . 
Ex trac ts were i ncubated wi th the severa l d i l u t i on s  of a n ti serum a t  3 70C 
for 30  mi n .  The s ampl e s  were centri fuged a t  5000xg for 5 mi n .  and  the 
su pernatant  sol u t i on s  a s sayed for PCC act i v i ty .  
8 5  
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cro s s -reacti ng ma teri a l  to  the ant i serum , but  based on u n i t prote i n  
concentrat i on , eac h mutant l i ver ex tract  has  a concentra ti on o f  cross -
reacti ng ma ter i a l  c omparabl e to tha t i n  the normal l i ver extracts . 
Furthermore , the resu l ts demonstrate that the heterol ogous ant i serum 
gave s i mi l a r  resu l ts  to those deri ved from puri fi ed p i g  heart a n ti s erum . 
C .  I soe l ectr i c  Focus i ng of Propi onyl Cop.. Carboxyl a s e  from Norma l 
T i s s ue  
S i nce  the  i soel ec tri c po i nt i s  a val uabl e i nd i ca t i on of  mi nor 
d i fferences between enzymes from d i fferent  sources , and s i nce  i t  had 
not  been prev i ou s l y  u sed in the i nves t i g a t i on of prop i onyl CoA carboxy­
l a se , the i soel ectr i c  po i n t  of prop i onyl CoA carboxyl a se  from four 
d i fferent  human t i s s ue  homogenates , l i ver , k i d n ey ,  p l acenta and f i bro -
bl a s t ,  was determ i ned and compared i n  order t o  l ook for d i fferent  
i sozymes of t he  enzyme . S tud i e s of seven norma l l i vers , s howed t ha t  
the enzyme had an  i soel ectr i c  po i nt o f  4 . 66� 0 . 2 .  S im i l ar profi l es 
were obta i ned u s i ng homogena tes  of k i d n ey ,  p l acenta and f i brob l a s ts 
and a representa t i ve profi l e  of each t i s sue  i s  shown i n  F i gure 1 3 . 
I n  add i ti on , cel l mi tochondr i a l  fracti on s  from several l i ver 
samp l es  were compared by i soel ec tr i c  foc u s i n g  to determi ne  if there are  
mu l t i p l e  i sozymes of prop i onyl CoA  carboxyl ase . These  compari sons  i n  
three d i fferent  l i vers fa i l ed to show any d i fference between mi tochon ­
d r i a l  prop i onyl CoA carboxy l a s e  and  that found  i n  whol e t i s s ue  
homogena tes .  Al l m i tochondr i a l  fract i on s  demons trated a p I  for  t he  
enzyme of  about  4 . 7  a s  s hOl'/n i n  t he  repre senta ti ve  profi l es i n  F i gure  
14 .  From these  da ta , n o  i soel ectr i c  focu s i ng  d i fferences i n  prop i onyl 
F i g ure 1 3 .  I soel ectr i c  focu s i ng profi l es o f  p e e  i n  l i ver , k i d ney ,  
p l a cen ta a nd f i brobl a s t  extracts  on a l5 - 10 . 0  pH g rad i en t  for 48 
hours . pee acti v i ty ( 0 ) and  pH ( .  ) were determ i ned i n  eac h  2ml 
fract i on co l l ected . 
87 
>- �r L I V E R  ds:::]� !:::: > pH i= u <t W � (f) :3 
>-
�1 ;�� f� X B. 0 CD cr p H  <t u <t 0 U ...J >- 40 7 z C. F I B RO B LAST 0 30 6 a:: 0 20 5 pH cr Cl. 
...J 1 0 4 
� 0 0 I-
u.. 40 D. PLAC E NTA 7 0 30 6 I- pH z 20 5 w u 1 0 4 a:: w Cl. 0 5 10 1 5  20 25 
FRACTION N U M B ER 
Fi gure 14 . Compar i son of i soel ec tr i c  foc u s i ng profi l es of PCC  
from l i ver homogenate and  from the mi tochondr i a l  fract ion  i so l a ted by 
centri fugati on a t  7200xg  for 20 mi n .  PCC a c t i v i ty ( 0 ) and pH ( .  ) 
were determi ned i n  each 2 ml fract i on . 
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CoA carboxyl a se s  from d i fferen t  ti s sues  or  d i fferent s u bcel l u l a r  
fract ions  were observed , suggest i ng the a b s ence  o f  d i fferent i sozyme s . 
The i soe l ectr i c  po i nt  of pro p i onyl CoA carboxyl ase  wa s a l s o  
compared t o  the other two mi tochondri a l  carboxyl ases , pyruvate carbox­
yl a s e  a nd 6 -methyl crotonyl  CoA carboxyl ase  in a fres h ly  obta i ned human  
l i ver wh i c h  had been  s tored i n  s ucrose to preserve both pyruvate 
carboxyl a se  and 6 -methyl crotonyl CoA carboxyl a s e  acti v i ty .  I s oel ec ­
tr i c  po i nts for these enzymes have not been prev i o u s ly  reported i n  
human ti s sue . Al though a l l  three enzyme s gave d i fferent pea ks ,  t he  
pea k s  for prop i onyl eoA ca rboxyl ase  and pyruvate carboxyl a s e  wel'e  over ­
l ap p i n g  wi th p I  v a l ues  of 4 . 9  a nd 5 . 3 ,  respecti ve l y .  6 -�lethyl cro tonyl 
CoA carboxyl a s e  had a p I  of a bout  6 . 4 . ( Fi gure  1 5 )  S im i l a r  profi l es 
were obta i ned when the i s oel ectr i c  po i nts of these enzymes  were deter­
m i n ed in  norma l fi brobl a s ts . 
D . Character i z i ng the Mu tant En zyme 
Prop ionyl CoA ca rboxyl a s e  from three l i vers  (pecCI ' � a nd 
pccBC1 ) and from one pl acenta (pCCBC2 ) of pati ents  wi th prop i on i c  a c i d ­
emi a  i n  the pccBC compl ementati on group were c haracteri zed by s tudy i ng 
three ba s i c  b i ochem ica l  propert i e s : i s oel ectr i c po i nt , thermos ta bi l i ty ,  
and b i nd i ng affi n i ty for the var i ou s  enzyme s ub strate s . The i soe l ec ­
tri c  po i nts  of these  enzymes  i n  t i s s ue  homogenate s  from the pecCI ' 
� and pccBC2 mu ta n ts demonstrated a p I  wi t h i n the norma l range , 
whereas  the enzyme from the pccBCI l i ver  homogenate had a p I  of 5 . 3 . 
( F i g u re 1 6 )  Th i s  a l tered p I  wa s observed even when equa l  amounts of  
l i ver homogenates , a s  determi ned b y  prote i n  concen tra t i on of pccC1 
F i g u re 1 5 . I soel ectr i c  focus i ng profi l e  of the t h l'ee mi toc h o n ··  
dria l  carboxyl a ses  was  determi ned by foc u s i ng a normal l i ver homogenate 
on a 3 . 5  - 1 0 . 0  pH grad i en t  and ana lys i ng the 2 ml fracti ons  for per­
cent tota l PCC acti v i ty ( 0 ) .  S MCC  acti v i ty (� ) .  P C  acti v i ty ( . )  a nd 
pH ( . ) . 
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F igure 1 6 .  The i soel ec tr i c  foc us i ng pattern of pee from l i ver ( 3 )  
and  pl acentru ( 1 )  homogena tes from Pee -defi c i en t  pati ents wa s determ i ned 
by pee acti v i ty ( 0 ) a nd pH ( e ) in ea ch  2ml fract i on . 
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a nd pccBCl ( a l  tered p I ) , were pre i ncuba ted for 30  mi nu tes a t  230C a nd  
t hen  focused . T he  profi l e  demons tra tes t he  presence of d i fferent  
enzymes by the b i phas i c  pea k at  p H  4 . 9 a nd 5 . 4 0  ( Fi gure 1 7 )  A s i mi l ar 
profi l e  was obta i ned when a ten -fo l d excess  of th i s  mu tant l i ver  homo g ­
enate wa s i ncubated �, ; th a norma l l i ver homogenate . 
I n  order to s how that the pI s h i ft i n  the pccBC1 mutant was not  
the  resu l t of a non - s pec i fi c  i nterac t ion  wi th some extraneous  s u b stance  
w i thi n t he  homogenate as  suggested by  Ka l ou sek  e t  a l . ( 83 ) , t he  enzymes 
from a normal l i ver and from the pccBCl l i ver  were pur i fi ed . The pur i ­
f ica t i o n  of the mu tan t e n zyme was made pos s i bl e  by the add i t i on o f  0 . 5M 
sucrose  wh i ch s tab i l i zed the enzyme duri ng mos t  puri f icat ion  procedure s . 
The extent of puri f i c at i o n  and y i e l d s  are s hown i n  Tabl e V I I .  The 
apparent l ow pur i fi ca t i o n  of the pccBCl enzyme i s  the resu l t of  i ts 
i n stab i l i ty througho ut  the proced ures , espec i a l l y  OEAE col umn c hroma ­
tography where sucrose had to be omi tted because  i t  i n terfered wi th 
enzyme-col umn i n teract i o n s . A l os s  of 98% of the enzyme ' s  acti v i ty 
occurred fo l l owi ng thi s s tep . The puri ty of the normal enzyme was 
determi ned by SOS -po l yacryl am i de gel  e l ectro phores i s .  The separa t i o n  
on  t h e  ge l  showed t h e  presence of  three bands , two of whi ch r a n  i den­
t i ca l l y  to  a puri fi ed p i g  heart  prop i o nyl  CoA  carboxyl ase  s tandard 
wh i c h  s howed mol ecu l ar wei ghts of 76 , 000 and 62 , 500 was determ i ned by 
compar i ng them to known s tandard s . ( F i gure 1 9 )  The th i rd band may be 
a degrad a t i on product  of one of the s ubun i ts or a contami nant  i n  the 
prepa rat i o n . The muta n t  enzyme cou l d not  be v i sua l i zed on e l ectro­
phores i s  becau se  of the l ow y i e l d after pur i fi cat ion  and the l imi ted 
F i gure 1 7 . I s oel ectr i c  focu s i ng profi l e  of the pccCI and pccBCI 
l i ver P C C .  The percen t tota l PCC a ct i v i ty ( 0 )  and pH ( . ) was deter­
m i ned on an  i soel ectr i c  focu s i ng grad i en t  where equa l vol umes of ( 10mg 
prote i n/ml ) l i ver homogenates der i ved from pat i ents  from the pccCI and  
pccBCI compl emen tati on group  were i ncu ba ted a t  23
0C for 30 m i n .  p r i or  
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TABLE  V I I 
PURl  F l CAT I ON OF THE N ORt·1AL AN D MUTANT ENZYr1E 
Step S pec i fi c  Pur i fi  ca t i  on 
Acti v i ty 
nmol /mg/ml -fol d 
Norma l 
Homogenate 3 . 64 x 1 01 1 . 0  
DEAE 3 . 9 1 x 1 02 1 1  
B l u e  Sepharose 5 . 27 x 1 04 1447 
Sephacryl 6 . 02 x 1 04 1654 
Mu ta n t  
Homogenate 0 . 1 037 1 
DEAE 0 . 037 0 . 36 
B l u e  Sepharose 1 . 53 1 1  
Sephacryl 3 . 56 34 
Y i e l d 
% 
1 00 




2 . 2  
2 . 6  
0 . 6  
F i gure 1 8 .  The e l ectrophoret i c  profi l e  of four  steps  of the 
pur i fi cat ion  compared on  a 7 . 5% pol yacry l am i de - 2% SOS gel under red u -
c i ng cond i t i on s . Lan e  Pur i f i ed pee After Sephacryl , Lane  2 - After 
B l u e  Sepharose , Lane 3 - After OEAE-cel l u l ose , Lane 4 - Whol e l i ver 
homogenate , La ne 5 - S tandards  ( from top to bottom ) : bov i ne serum 
a l bum i n , g l utam i c  dehydrogenase , a l cohol  dehyd rogena s e , and  a v i d i n .  
c , ,) -C ---
" .:r 
<jO . ..... 
i' , �  "",,jt 
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9 5  
.. .  1* 
C ·  ) i 
F i gure 1 9 . Determi nat i on of mol ecu l ar we i g h t  of propi onyl CoA 
carboxyl a s e  s ubu n i ts by SDS-po lyac ryl ami de  gel e l ec trophores i s .  The 
fol l owi ng s ta ndard s were u s ed : bov i ne serum a l bum i n  68 , 000 , g l u tami c 
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amount  of  l i ver ava i l a bl e for pur i fi cati o n . 
I soel ec tr i c  foc u s i n g  of the p ur i fi ed enzymes  ( Fi g u res  20  & 2 1 )  
demon s trates a s imi l ar profi l e  to those  observed i n  crude l i ve r  prepara ­
ti ons  w ith  a p I  of 4 . 7  for the norma l e nzyme and S . 3 for the  muta n t  
enzyme . A n  expl anat ion  was sought  for the p I  s h i ft reported by 
Ka l ou sek  et a l . ( 8 3 )  dur i ng puri f i ca ti on of the  n orma l e n zyme from 4 . 7  
to S . 2 .  S im i l ar s h i fts  were observed i n  both the crude and  pur i f i ed 
normal enzyme upon i ncubati on wi th Smf'l ATP pr i or  to focu s i ng . S i nce  
Ka l ou sek  et  a l . (83 ) observed the i r  p I  s h i ft after the e l u ti o n  of  the 
enzyme from the B l ue  Sepha rose  col umn \>li th 3mM MP , the add i t i on of 
th i s  nuc l eotide cou l d eas i l y  account  for the apparent s h i ft .  e s pec i a l ­
l y  i f  the ATP i s  not comp l etely removed from the system . A s h i ft to a 
s l  i g ht ly  h i g her p I  �Ja S observed when the pccBCl 1 i v er homogenate wa s 
pre - i ncubated wi th ATP . The demon stra t i on of a n  a l tered p I  i n  one  
pccBC mutant  demonstra tes heterogene i ty wi th i n  the mu ta n t  comp l ementa­
t i on c l a s s  a s  wel l a s  prov i d i ng the f irst  defi n i t ive  ev i dence of  a 
s tructu ra l  a l tera t ion  i n  a prop i onyl CoA carboxyl a s e  defi c i en t  muta n t .  
Prev i ou s  s tud i e s  have demonstrated d i fferences betwee n  normal a nd  
pro p i onyl CoA carboxyl a se  defi c i en t  fi brob l a s ts wi th respect  to the i r  
thermos ta b i l i ty . ( 3 )  I n  order to fu rther i nvest igate the thermos ta bi l ­
i ty i n  the mutant  pccBC comp l ementati on " group , the s tudy was extended 
to i nc l ude the i n teract i o n s  of sucrose or ATP wi th the enzyme and  
the i r i nfl uence on thermo sta b i l i ty .  Thermo s ta b i l i ty of  prop i onyl CoA 
carboxyl ase  act i v i ty 'lIa s determ i ned by i ncubati on of  d i a l yzed t i s su e  
homog ena tes con ta i n i ng l Omg o f  prote i n  p e r  m l  at  4SoC fo r var i ou s  
F i g ure 20 . The i soel ectr i c  foc u s i ng  profi l e  of the norma l enzyme 
wa s d eterm i ned i n  a norma l l i ver homogena te in a 3 . 5  - 1 0 . 0  ( to p )  and 
a 4-6 pH grad i ent  ( mi dd l e )  and compa red to t h e  h i g hl y  pur i f i ed samp l e 
focu sed on a 4-6 pH grad i en t  ( bottom ) w i th pH ( .  ) and  perc en t tota l 
p e e  a c t i v i ty ( 0 ) be ing  determi ned i n eac h  frac t i on . 
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F i gure 21 . The i soel ectr i c  foc u s i n g  profi l e  o f  the h i g h ly  pur i ­
fi ed mu ta n t  ( bel ow )  wa s compared w i t h  the pccBel l i ver homogenate 
( a bove ) on a 3 . 5  - 1 0 . 0  pH gra d i en t  wi th the pH ( .  ) a nd  percent  Total  
pee act i v i ty ( (» ) be i ng d eterm i ned in  every fracti on .  
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l engths  of t ime between 0 and 3 0  m i nutes . The  s haded area i n  F i gure  
22  represents the n orma l range  d etermi ned from the data on  f ive  n orma l 
l i vers . Under these  cond i t i on s , the  en zymes  from the � and pccBCl 
were con s i derabl y more l ab i l e than the  enzyme from homogenates o f  
e i ther n orma l l i ver o r  m u tant  pccCI or pccBC2 ti s s u e . Both  the  � 
a nd pccBCI mu ta n t  had a h a l f - l i fe of a pprox i mately  2 -3 m i n u te s  a t  450C . 
wherea s the enzyme i n  the  pccCI and  
pccBC2 ti s s ue  homogena tes had a 
ha l f- l i fe of grea ter than 1 5  m i nutes . 
Fu rther d i fferences  were observed by s tudyi n g  thermos ta b i l  i ty i n  
homogenates v/i th  5mM ATP or 0 . 5M s u c r o s e  added d u r i n g  experimen ts . 
T i s su e  homogenates were i nc u ba ted for 30 mi nutes  a t  230C pr i or  to  heat 
dena tura t i on exper imen ts . Sucrose  was tr i ed b ecau se  it  wa s d emons tr a -
ted to s tab i l i ze t h e  enzyme by H s i a  et  a l . (8 1 )  and  ATP w a s  u sed  a s  a 
meas u re of s ub strate s tab i l i za ti on . Both  of  these  reagen ts  stab i l i zed 
prop i onyl CoA carboxyl a se  in a representa t i v e  norma l l i ver homogena te ; 
however , the mutant enzymes  demon s tra ted a heterogeneous respon s e . 
( F i g u re 23 ) Propi onyl CoA carboxyl a s e  i n  the  pccCI l i ver homogenate 
gave  a s imi l ar heat denatu ra t i on profi l e  to the  normal enzyme be i ng  
s ta b i l i zed by  ATP  or  s ucrose a t  450C .  ( F i g ure 23B ) The  pccBCl muta n t  
homogenate wa s s tab i l i zed d rama t i ca l l y  b y  the add i t i on o f  s ucros e ; how­
ever , the  add i t i on of ATP had l i tt l e or no effect .  ( Fi gure  23C ) T h e  
pccBC2 mutant  homogenate \�a s stab i l e  u p  to 3 0  m i n u te s  u nder a l l con ­
d i t i o n s  a s  wa s the  normal  p l acenta l  control . ( Fi gure  23A & D )  
I n  a further attempt  t o  d i s t i ngu i s h bet\oJeen t h e  pcc CI mu tan t  and  
the normal l i v er en zyme by  thermo stab i l i ty ,  the  exper i men t was repea ted 
F i g ure 22 . Heat denatura t i on c urves for norma l and P C C - d ef i c i en t  
l i vers . Res i du a l  PCC act i v i ty was determi ned i n  d i a l yzed homogen a te s  
from n orma l l i vers ( 5 ) ( range i n  s haded area ) and l i vers from PCC­
defi c i ent  pa ti ents ( 3 )  after i ncubati on at  450C for vari ou s t i mes  
between 0 - 1 5  m i n u te s . 
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F i gure 23 . Compar i son of  hea t denaturat i on profi l es of d i a lyzed 
1 i ver homog enates ( c l o s ed symbo l s )  and p l acental  homogenate s  (open  
symbol s )  ( 1 0 mg prote i n /m l ) after a 3 0  mi n .  i nc u ba t i on at  4SoC i n  
e i ther l Omt� Tr i s -HCl buffer , pH 8 . 0  ( .) .  SmM ATP - lOmM Tri s - HCl  
buffer , pH 8 . 0  (� ) ,  or O . SM sucrose- 1 0mM Tr i s -Hcl  buffer , pH 8 . 0  
( . ) .  Norma l range  of l i ver homogenate heat denatura ti on i s  s hown by 
s haded area . 
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a t  52oC .  ( F i gure 24 )  E ven  a t  t he  h i g her  temperature , t h e  pecCI mutant  
behaved s im i l a r ly  to the  n orma l enzyme . Both the pecCI mutant  and the 
norma l l i ver homogenate were s tab i l i zed by sucrose and  s l i g ht ly  by ATP . 
The puri f i cat i on of the n orma l  enzyme d i d  not  a l ter i ts s ta b i l i ty 
a s  determi ned at  450C i n  l OmM Tr i s -HCl buffer , pH  8 . 0 ,  from tha t  i n  
n ormal l i ver homogenates . However , the enzyme was n o  l onger  s ta b i l i zed 
by the add i t i on of  e i ther 5mt1 ATP or 0 . 5M sucrose . ( Fi g u re 25A )  The 
pur i f i ed pccBCl mutan t enzyme s howed i ncrea sed thermosta bi l i ty of the 
enzyme over that in the pccBC
I 
l i ver homogenate d emons tra ti ng a ha l f­
l i fe of 1 7  mi nutes  bu t the enzyme rema i ned l e s s  s ta b l e than t h e  norma l 
enzyme . ( F i gure 25B ) I n  con tra s t  to the norma l enzyme , the  p ur if i ed  
pccBCl enzyme conti n ued to be stab i l i zed fol l ow i n g  the add i ti on of  
sucro se . Sucrose  was a l so  noted to stab i l i ze both  enzymes when  s to red 
a t  -80oC .  The add i ti on of ATP fa i l ed to stab i l i ze  e i ther enzyme . 
I n  summary , pccC2 and  pccBCl mu tants  demons trated d i fferences  i n  
the thermosta b i l i ty .  The pccBCl homogenates a l so s howed a dramat i c  
s tab i l i zat i on o f  enzyme acti v i ty by the add i ti on of sucrose to both 
crude and  pur i f i ed preparat i on s . Mutant pecCI amd pccBC2 gave  s i m i l ar 
profi l es to the normal con trol s .  I n  general , thermos tabi l i ty has  been  
a u sefu l parameter for d emon strat i ng heterogenei ty between the  mutants  
i n  the pccBC g rou p ; however , thermosta b i l i ty seems to be  a funct i on of  
the mo l ecu l ar  env i ronment of the enzyme a s  wel l as  the enzymes '  s truc-
ture . 
A th i rd parameter u sed to compare the proper t i e s  of the mutant  a nd  
normal enzymes i n  t i s sue  prepara t i on s  was to d ete rm i ne t he  a pparent 
F i g u re 24 . Heat d enaturat i on prof i l e . Res i dua l PCC a cti v i ty wa s 
determi n ed for d i a l yzed norma l and pccCI l i ver homogenates ( 1 0  mg pro­
te i n/ml ) after  i nc ubat i on i n  a 520C wa terbath for var i o u s  per i od s  of 
t i me between 0 - 15  mi n .  Prior to heat denatura t i on s  samp l e s  were i n ­
cu ba ted a t  230C for 3 0  m i n .  i n  e i ther 10mM Tri s -HCl  buffer , p H  8 . 0  
( .  ) ,  5mM ATP - 1 0m�1 Tr i  s -HCl buffer . pH 8 . 0  (A ) ,  o r  0 . 5M sucro se­
I OmM Tr i s -HCl buffer , pH  8 . 0  (. ) . 
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Fi gure 2 5 .  Heat dena tura t i on profi l e  of res i dua l  PCC acti v i ty o f  
pur i fi ed n orma l enzyme a n d  h i g h l y  pur i f i ed pcc SCl enzyme after i nc u ba ­
t i o n  i n  a 450C wa terbath for va r i o u s  per i ods o f  t i me . Pr i o r  to hea t 
denatura t i on pur i f i ed norma l enzyme ( d i l u ted 1 : 1 00  w i t h  1 ot�M Tri s -HC1  
bu ffer , pH 8 . 0 )  and d i a l yzed h i g h l y  pu r i f i ed pcc B C! enzyme were i nc u ­
ba ted a t  23°C for 30  m i n .  i n  e i ther 1 0mM Tri s -HCl  buffer pH 8 . 0  ( 4t ) .  
5m�1 ATP- 10m�' Tri s -HCl  bu ffer . pH 8 . 0  (& ) or 0 . 5  M sucro se- 1Om�' 
Tri s -HC1  buffer , pH 8 . 0  C .  ) .  
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Km ' s  of  t he enzyme for i ts s u bs tra tes . An  i ncrea sed Km for a ny s ub­
strate cou l d affec t the a b i l i ty of  t he  enzyme to  funct i o n  and  ex pl a i n  
the d efect i n  these cases . The  Km val ues  for the subs tra tes were 
d eterm i ned wi th both of the puri fi ed enzymes a nd wi th homogenates of 
pccCI a nd pccBC2 ti ssues . The a p parent Km ' s  were determi ned for ATP , 
pro p i o nyl CoA , b i carbonate a nd potass i um i o n s . Al l other s u bstrates 
were hel d con stant  a t  standard a s say cond i t i on s  whi l e  the s u b s trat e  of 
i n terest  wa s vari ed . The Km ' s  fo r the four  reactant s  are reported i n  
Tab l e V I I I  a nd the i nd i v i d u a l  graph s  fol l ow i n  f i gures  26 to 2 9 . There  
is  good  ag reement between the  va l ue s  obta i ned for the puri f i ed norma l 
and  m u tant  enzymes . The val u e s  obta i ned i n  ti s su e  homogena te s  s howed 
a p prox ima tel y a two-fo l d  i ncrea se  over the val ues  obta i ned i n  the puri -
fi ed  e n zyme ; howeve r ,  th i s var i a t i on s hou l d  be expec ted i n  crude  
preparat i o n s . The Km val ues  obtai ned i n  the d i a l yzed homogenates  were  
in  good  agreement wi th  va l ue s  obta i ned i n  both the pur i fi ed e n zymes 
and  tho s e  reported by other i nves  ti  ga to rs . T he 1 a rg e s t  dev i  a t i  on from 
the norma l enzyme Km val u e  �Ia s observed i n  the Km for prop i  onyl CoA i n  
the pccBC2 ti ssue  homogenate . T h i s va l ue was not  dramat i c a l l y  d i ffer­
ent from the Km observed in  the pccCI 
homogena te or the  va l ue obta i ned 
by Hsi  e t  a l . ( 8 1 ) in  crude f i brobl a s t  extracts . I n  genera l , no  
heterogene i ty was fou nd i n  the s tudy o f  Km ' s  e spec i a l l y  among  the  
val u e s  obta i ned for  the pur i fi ed enzyme . The  Km va l ues  s eemed to be  
compa rab l e between  homogenates a s  wel l as between normal  enzymes . 
A s umma ry of the data compari ng the norma l a nd mu ta n t  enzymes 
from the pccBC t i s s u e  s tud i ed i s  g i ven in  Ta bl e I X . Al l o f  the 
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TABLE  V I I I 
COMPARI SON OF  APPARENT Km ' s  OF P ROP I ONYL  CoA CARBOXYLASE 
SOURCE 
Pur i f i ed Normal 
P ur i f i  ed pccBC1 
pccC 1 L i ver 
pccBC2 P l acenta 
Prev i o u s  
i nvest i ga tors 
norma l mamma l i an 
enzyme 
FRor� VARI OUS SOURCES 
P ROP I ONYL CoA ATP 
(m�l ) 
0 . 424 0 . 1 1 7  
0 . 420  0 . 1 03 
0 . 90 0 . 440 
1 . 67 0 . 4  8 
0 . 2  - 1 . 7 0 . 06 - 0 . 9  
B i ca rbonate Pota s s i um 
1 . 49 4 . 87 
2 . 98 8 . 33 
9 . 09 1 0 . 65 
6 . 30  8 . 5  
1 . 6 - 4 . 5  7 . 0 
Fi gure  26 . A doubl e rec i procal  L i ne weaver- Burk  p l ot  of 
ve l oc i ty aga i n s t  varyi n g  concen tra t i on s  of  prop i onyl CoA between 0 . 5  
a nd 5mt'1 �Ia s u sed to determi ne  a pparen t Km i n  homogena tes  o f  l i ver 
pecCI ( . ) and p l acenta pccBC2 CA ) ( a bove ) a nd h i g h l y  pur i f i ed 
norma l ( 0 ) and  pccBCI ( e ) propi onyl CoA carboxyl a se  ( bel ow ) . 
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F i g ure 27 . A dou b l e reci proca l  L i n e  weaver- Burk  pl o t  of 
v e l oc i ty aga i n st  vary i ng concentra t i on s  of ATP between 0 . 25 a nd 5mM 
wa s u s ed to determi n e  a pparent Km i n  homogen a te s  of l i ver pccCl ( . ) 
and  p l acenta pccBC2 ( .... ) ( a bove )  and h i g h l y  pur i f i ed normal (0) a nd 
pccBCl ( e ) propi onyl C oA carboxyl a s e  ( be l  01'1 ) • 
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F i gure 28 . A doub l e reci proca l L i ne wea ver - Bur� p l o t  o f  
ve l oc i ty aga i n s t  varyi ng concen tra t i on s  o f  tota l b i ca rbona te between 
0 . 5  and 2Omr� by vary i ng  co l d sodi um bi carbona te a nd keep i n g  tota l e pms 
per a s s ay con stant �Ia s u s ed to determ i n e  apparent Km in  homogena tes  of 
l i ver pecCl ( . ) a nd p l acenta peeBC2 ( .. ) ( above ) and h i g h l y puri f i ed 
norma l ( 0 ) a nd peeBCl ( . ) prop i onyl CoA carboxyl a se  ( bel ow ) . 
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F i gure  2 9 . A doubl e reci proca l  L i ne weaver- Burk  p l ot  of 
ve l oc i ty aga i ns t  vary i n g  concen trat i ons  of the act i vator , pota s s i um 
between 5 and  lOOmM was u s ed to determi ne a pparent Km i n  homogena tes 
of l i ver pccCl ( . ) and p l acenta pccBC2 (�)  ( a bove )  and  h i g h ly  pu r i ­
f i ed n orma l ( 0 )  a nd pccBCl ( ct ) propi onyl CoA carboxyl a se  ( be l ow) . 
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TAB LE I X  
COMPAR I SON OF  PROPERT I ES OF  PROP I ONYL  CoA CARBOXYLASE 
FRor� NORMAL AND f>iUTANT T I SSUE  
Sourc e  CRM p I  Thermosta bi l i ty a t  45°C ( t1/2 ) m i n 
Buffer w/ATP w/Sucrose 
Norma l L i ver + 4 . 7  9 > 30 > 30 
pccCI L i ver 
+ 4 . 7 > 3 0  > 30 >30 
pccC2 L i ver + 4 . 7  3 NA NA 
pccBC 1 L i ver + 5 . 4 2 2 > 1 5  
Norma l P l acenta + 4 . 6  > 30 > 30 > 30 
pccBC2 P l acen ta + 4 . 6  
> 3 0  > 30 > 3 0 
1 1 3  
var i a n ts tha t were s tud i ed represent  CRM-po s i t ive  mu tan ts , sugges ti ng  
that  the mu ta ti on  causes  a s tructural  a l tera ti on . The data demons trate 
heterogenei ty wi thi n the pccBC group i n  two of  the parameters tes ted 
wi th mutants pccCI and pccBC2 be i ng i nd i st i ngu i shab l e from the enzyme 
i n  the norma l t i s su e . Mutant  pccBCI enzyme demon strated d i fferences  i n  
thermostab i l i ty and  i soel ectr i c  po i n t .  Muta n t  pccC2 s howed a d i ffer­
ence i n  thermosta bi l i ty bu t n ot in  i soel ectri c po i n t . Unfortunatel y ,  
there wa s not enough samp l e for further s tudy . The d i fferences o b -
served a re  suggest ive  of  further heterogenei ty i n  t h e  s truc ture of  t h e  
enzyme �l i th i n  the pccBC compl ementati on  g ro u p . 
1 1 4  
D I SCUSS I ON 
The  prop i on i c  a c i dem i a s  are a group of  genet i c  defects that 
demon strate a s im i l ar c l i n i ca l  p henotype . T h i s d i sord er has  been 
d i v i d ed i n to three grou ps : pccA , pccBC a nd b i o ,  on the bas i s  of 
geneti c compl ementa t i on s tud i e s of fi brob l asts  der i ved from pati ents  
wi th  pro p i on i c  a c i dem i a . Prev i ou s  ev i dence has  sugges ted that the 
defects  in  eac h c ompl ementat i on group a re cau sed by a s tructu ra l l y  
a bnorma l enzyme . I n  order to prov i de  add i ti onal  ev i dence for de l i nea ­
t i ng these defects  i n  t i s s ues from prop i onyl CoA carboxyl a s e defi c i ent  
pa ti ents , b i ochem i cal  character i za ti on of  prop i onyl CoA carboxyl a s e  i n  
norma l t i s sues  wa s req u i red . F i brobl a s t  l i nes  and t i s sues  from fou r 
pat i ents wi th prop i onyl CoA c a r boxyl a s e  defi c i ency , represen t i n g  each 
of the comp l ementat i on  g rou p ,  \�ere s tu d i ed u s i ng immunol og i c  tech ­
n i qu e s  t o  demon stra te the pre sence o f  equa l  amou nts o f  cro s s -rea c t i n g  
mater i a l  i n  norma l a n d  mu tant  t i s sue  homogena tes . These  exper iments  
prov i ded ev i dence tha t prop i o n i c  a c i d emi a i s  caused by a structural  
a l tera t i on wh i c h  res u l ted in  a l es s  acti ve  enzyme . 
I n  order to fu rther c haracter i ze the s truc tu ral  a l terati on , 
t i s s u e s  from pa ti ents bel ong i ng to one compl ementat ion  grou p , pccBC , 
were s tud i ed .  One s u c h  mu tant  enzyme from th i s g rou p wa s pur i f i ed a nd 
compared to normal  enzyme . The fi nd i n g s  suggested the presence of  
mu l t i p l e mu tat i on s  wi t h i n the  pccSC g rou p .  
I n i ti al l y , the a c t i v i ty o f  prop i o nyl CoA carboxyl a s e  \'1a s deter­
mi ned i n  fou r n orma l hum a n  t i s s ue s : f i bro b l a s ts , l i ver , k i d ney a n d  
p l a centa . T h e s e  d e t e rm i n a t i o n s  prov i d ed i nforma ti on about  the 
1 1 5  
d i s tr i but ion  o f  p rop i onyl CoA carboxyl a s e  i n  the vari ous  body t i s s u e s . 
As expected , k i dney and l i ver demonstra ted the h i ghest  spec i f i c  a cti v i ­
ty , wi th l i ver be i ng the t i s su e  of c ho i c e  for fu rther study beca u s e  o f  
the ava i l a bi l i ty of both  normal a n d  prop i onyl CoA carboxy l a s e  defi c i ­
ent sampl es . The  d i s tr i bu ti on o f  prop i onyl CoA carboxyl ase  between 
m i toc hondr ia  and su pernatant frac ti ons wa s a l s o i nvest i gated i n  severa l  
normal  l i vers . T he  grea test  percentage  of prop ionyl  C oA ca rboxyl a s e , 
a s  �Ie 1 1  as g l  u tamate d ehyd rogenase , a m i  toc hondri  a 1 mar ker enzyme , wa s 
found i n  the su perna tant  sol ut i on ; a f i nd i ng that contrad i c ts i nforma­
ti on from an imal s tud i e s  i n  o ur  l a bora tory , a s  wel l a s  i n  o thers , 
s h owi ng that these enzymes are 1 oca ted i n  m i toc hondri a .  I t seems  
l i ke ly  tha t t h e  human l i v er samp l e s  h a d  undergone  a u to l ys i s  wi th t ime . 
�Ih i c h  caused mi tochondr i a l  matr i x  enzymes to be rel eased i nto the 
s u perna tant  fract i on . The l oca l i zat i on of propi onyl CoA carboxyl a se 
was s tu d i ed i n  porc i ne l i ver wh i c h  wa s obta i ned immed i a te l y  a fter d ea th .  
The same phenonenon of  rel ea se of GDH and p c e  i nto the su perna tant  
frac t i on wa s  observed over a s i x  h o u r  peri od . That confi rmed the c on­
c l u s i on that t he  p henomenon wa s not an  a rt i fact  of t he  m i tochondr i a l  
i so l a t i on procedure . The brea kdown o f  m i toc hondr i a  cou l d a l s o  expl a i n  
the f i nd i ng s  o f  G i org i o  and  H h i ta ker ( 1 1 1 )  who reported tha t the enzym e  
i so l a ted from human l i ver m i tochondr i a s howed grea tl y reduced a cti v i ty 
a fter one  hour  po stmortem . A l though  pro p i onyl CoA acti v i ty was s hown 
to d ecrea se �I i th time postmortem , the enzyme a c ti v i ty wa s detectab l e u p  
to e i g h t  hours po s tmortem , i n  c o n f l i c t  w i th the observa t i o n s  o f  G i org i o  
a nd Wh i ta ker ( 1 1 1 ) . The rel ea s e  o f  bo th  GDH and pee from the 
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m i toc hondr i a  wa s ,  however , found  t c  occur  d ur i ng th i s t ime peri od . 
The decrea s e  i n  p e e  act i v i ty reported by G i org i o  and Whi ta ker proba b l y  
represents  the rel ease  of  pee from the m i tochondr i a  whi c h  occurs  rap i d ­
l y  after death and resu l ts i n  a n  apparent decrea s e  i n  the enzyme i n  
i so l a ted mi toc hondr i a . Beca u se o f  the ra p i d  d ecrea se  i n  p e e  i n  l i ver  
m i toc hondr ia  over  t i me , and the t iMe el apsed d ur i ng the  course of ob­
ta i n i ng ti s sue , who l e l i ver homog enate s were u sed for  most  experiments  
in  t h i s  s tudy . 
Propi onyl eoA carboxyl ase  act i v i ty was compared i n  normal ti s s u e  
a nd t i s su e  from pati ents wi th  prop i onyl eoA carboxyl a s e  defi c i ency . I n  
l i ver , p l a centa and f i bro b l a s t  t i s s u e  o bta i ned from prop i o n i c  aci demi a 
pat i ents , l e s s  than 5% of normal prop i onyl eoA carboxyl ase  ac ti v i ty was 
found  in homogenates of each  ti  s s u e  type . I n agreement  �I i th s i mi l a r  
fi nd i ng s  for fi brobl a s ts by H s i a  e t  a l . ( 8 1 ) and Wol f et  a l . ( 3 )  the 
mu tant  en zyme from these  ti s su e s  Via s g enera l l y  l es s  s tabl e tha n the 
enzyme from norma l t i s sue . The  o b servat i on that the g l u tami c dehydrog ­
ena s e  a c t i v i ty i n  the mu tant  l i vers i s  comparab l e to tha t of the 
con tro l s a l s o  i nd i cates that there wa s no  s i g n i f i ca nt  a u to lys i s  i n  
these l i vers and , therefore , the dramat i c  decrea se  i n  p e e  acti v i ty re­
su l ts from the mu tant  en zyme . The re s i dual  p e e  a c ti v i ty found in  the 
mutant  l i vers corresponds  to the defi c i ency observed i n . f i brobl a st s  i n  
wh i c h  the  t ime requ i red to obta i n  and proce s s  ti s su e  i s  constan t .  The 
acti v i ti es of the other two m i toc h o n d r i a l  carboxyl a s es , pyruvate car­
boxyl a se  and jJ -methyl  cro tonyl eoA carboxyl ase  �Iere more 1 ab i l e i n  
l i ver than wa s pee , a nd were g r ea t l y  red uced i n  mos t  l i ver samp 1 e s  
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obta i n ed one hour postmortem . Both of these enzymes cou l d  b e  s ta b i l ­
i zed by 2M sucrose and c ou l d  be a s sayed i n  f i brobl asts . PCC def i c i en t  
fi brobl a s t  l i nes  demonstrated normal ft· MCC and  PC acti v i ty except  
f i brob l a s ts l i nes  bel ong i ng to the  b io  c ompl ementat i on group had re­
duced acti v i ty of a l l three m i tochondr i a l  carboxyl ases . The a c t i v i ty 
of these carboxyl a se s  returned to normal when c e l l c u l ture med i a  wa s 
su ppl emen ted w ith  l Omg/L b i oti n .  
Further proof \'Ia s o bta i ned tha t pro p i o n i c  a c i dem i a  i s  the resu l t 
of a s tructural  a l tera t i on of the enzyme a s  studi ed i n  l i vers and  
f i brobl a st  l i ne s  from pa t i ents  wi th pro p i on i c  a c i dem i a  bel ong i ng to 
the var i o u s  genet i c  compl ementa ti on grou ps \'Ihen s tud i ed by i J11llu n od i f­
fu s i on a nd immu not i trat i on . Compar i sons  between the a nti -huma n  
carboxyl ase  anti serum and the ant i -porc i n e PCC ant i serum demonstra ted 
tha t the anti - human ca rboxyl ase  ant i serum prec i p i tates the a c t i v i ty of 
the three carboxy l a ses , wherea s the ant i -PCC  serum i n h i b i ts the a c ti v i ­
ty o f  PCC and , to a m i nor degree , that o f  f' MCC . Thi  s cro s s -react i o n  
wi th MCC i s  not surpr i s i ng s i nce f3 t1CC i s  very s im i l a r  i n  s tructure  
to PCC a s  demon stra ted \'Ihen both  enzymes \'Iere pur i f i ed  from bov i n e  
k i dn ey ( 1 1 0 ) . 
D i fferences bet\'leen bov i n e  and human prop i onyl CoA carboxyl a s e  
were d emons tra ted by t h e  Ouchter l ony doub l e d i ffu s i on  tec h n i qu e . B o t h  
ant i sera formed prec i p i tant  a r c s  when d i ffu sed aga i n s t  p ur i f i ed p i g  
heart PCC bu t a s p ur  wa s o bserved between the two a nt i sera . The 
presence of the spu r s uggests s ome d i fferences  i n  a n t i g en i c  d eterm i ­
n a n t s between human a nd porc i ne PCC . When both ant i sera were d i ffu sed 
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aga i n s t  a l i ver homogena te conta i n i ng act i v i ty for the three carboxy­
l ases , a second spur s i g na l ed the d i fference betl'/een the two ant i  serums . 
The non- i denti ty spurs  i nd i cate that  d i fferent  ant i gens were recogn i zed 
by the ant i -human carboxyl a se ant i serum whi c h  were not recog n i zed by 
the a nt i -porc i ne PCC a n t i serum . T h i s spur proba b ly  resu l ts from the 
presence of )!MCC a nd PC , wh i c h  were prec i p i tated by the a nt i - human 
carboxyl a se a nt i serum a nd not by the a n i t-PCC  a nt i serum . 
The a nt i -huma n carboxyl a s e  ant i serum demonstra ted the presence of 
CRM in  l i ver ex tracts  of PCC -defi c i en t  pa t i ents i n  blo �/ays . F i r st , 
p rec i p i ti n  arcs were observed s i g n i fyi ng  i dent i ty between the  a n t i ­
serum a nd normal extracts a s  we l l a s  bet�/een the a nt i serum and mu tan t  
ex trac ts . F l u orescense  i n  these arcs , when trea ted w i th a v i d i n -f l u o ­
ra scam i ne , confi rmed t h e  presence o f  b i ot i n -con ta i n i ng prote i n .  The  
absence of spur forma t i on on dou b l e d i ffu s i on p l a tes  suggested that  
norma l t i ssue  ex tract  has no  a nt i gen i c  s i tes  tha t are l ac k i ng i n  
mu ta n t  t i ssue  ex tract . Second , Vie demon s tra ted that  the  b i nd i ng  of  
c ro s s -react i ng mater i a l  i n  muta n t  ex tracts to a nt i bod i es i n  the ant i ­
serum prevented the i n h i b i t i on of PCC  act i v i ty i n  norma l l i ver extracts . 
These fi nd i ngs are s im i l a r  to those observed wi th the ant i -p i g heart 
PCC . 
The i mmunoti trat i on resu l ts further c onfi rmed the presence of CRM 
i n  mu ta nt  l i ver  extracts , bu t revea l ed that  the same d i l u t i on of ant i ­
serum i n h i b i ts PCC a ct i v i ty i n  both  norma l and PCC -defi c i en t  l i ver 
extrac ts at equ i va l ent  tota l prote i n  concen tra t i ons  to the  same per ­
centage  of i n i t i a l  act i v i ty .  T h e  immu nod i ffu s i on curves obta i ned for 
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both mu tant  extracts  c l ose l y resembl ed the c urve  o f  norma l  extract . 
Thu s , the quant i t i es of CRr·1 i n  eac h  extract ,  when extract prote i n con­
centrat i on i s  hel d con stant ,  are a pprox imate l y equal . The  fi nd i ng 
presented here , therefore , confi rms the fi nd i ng s  wi th p i g  heart PCC  
that  the two PCCs s tu d i ed from l i ver , i nc l u d i n g  one  from a pa t i e nt  
a s s i g ned t o  t he  pccC  compl emen ta ti on su bgroup  (�) ,  and one  from 
the pccBC s ubgrou p (pCCBCl ) . represent  CR�l pos i  t i v e  mu tants , synthe­
s i z i ng a pproxima te ly  norma l quanti t i e s  of s tru ctura l l y  a l tered PCC . 
I n  add i t i o n , th i s  tec hn i qu e  demons tra tes tha t hetero l ogou s a nt i ­
human  a n t i s erum produced a g a 'i n s t  va r i ou s  ca l'boxyl a ses , by a s i mp l e 
tec hn i que , can a l s o  be u sed to d eterm i n e  CR�l i n  i rrmu noti tra ti on tec h ­
n i ques  where the concentra t i on o f  other carboxyl a ses  a r e  known to b e  
con sta n t .  T h e  a ct i v i ty o f  M C C  and  PC  i n  fi brobl a s t  l i nes  were 
a s s ayed and were s hown t o  be s im i l ar in the ce l l l i nes u sed . S i nce  t he  
prote i n l evel s i n  t h e  l i ver homogenates a r e  k e p t  consta n t , t h e  acti v i ­
ty of the other carboxyl a se s  s hou l d  con s ti tu te a s im i l ar percentage o f  
the tota l prote i n  resu l ti ng i n  s i m i l ar concentrat ions  i n  these homog ­
enate s . Therefore , even i f  the ant i s erum cro s s-reacts wi th the other 
ca rboxyl ases , a ny d i fference in  the amount  of  c ro s s -react i ng prote i n  
wou l d  correspond to  the d i fference i n  the concentra ti on o f  P C C  and 
wou l d  s h i ft the equ i va l ence po i nt of  the curve . The irrmunoti tra t i on 
prof i l es of PCC act i v i ty s hO\� s im i l ar amou nts  of PCC prote i n  u s i ng 
e i ther a nt i serum . The fac t  that these curves  correspond to those ob­
ta i ned wi th  the  a nt i - p i g  hea rt PCC , demonstrates the i r  va l u e i n  
i mmu n o t i tra t i o n  e x p e r i m e n t s . The resu l ts of the i mmuno t i tra t i on  
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exper iments u s i n g  both a n t i s era are cons i s tent  �li th near norma l qua n ­
t i t i es o f  a n  i nact i ve en zyme i n  a l l three compl emen ta ti on grou p s , b i o , 
pccSC a nd  pccA . I n  add i t i on ,  CRM I'/a s d emonstra ted i n  a l l l i vers  by 
Ouc hterl ony dou bl e d i ffu s i on . I n  the b i o  grou p , the i na ct i ve en zyme 
i s  proba b ly  the resu l t  of the i na b i l i ty to b i nd b i oti n ,  wherea s , i n  
pccA a nd pccSC , i t  suggests  a structura l  mu ta t i on . 
Th i s study has prov i ded further ev i dence for a s tructural  muta ­
t ion  by b i ochem i ca l l y  character i z i ng the normal  enzymes and the  enzyme 
from a s i ng l e mu tant  compl ementa ti on g rou p ,  pccSC . The pccSC grou p i s  
espec i a l l y  i nteres ti ng s i nce  there ex i s ts three su bgrou p s  wh i c h  are  
des i g na ted pccBC , pccC and pccS  becau se  of  the i r  comp l emen ta t i o n  prop ­
ert i es . When pccS  cel l s  a re  fu sed t o  pcc C  ce l l s , there i s  a s l i g h t  b u t 
reproduc i bl e  i ncrea se  i n  P C C  act i v i ty wh i c h  i s  approx imately 1 0% of  
tha t seen  i n  compl ementa t i  on between e i ther group a nd pccA ce  1 1  s .  Pre­
v i o u s  i nve st i ga t i o n  of the  k i net i c  propert i e s  for  the sma l l i ncrea s e  i n  
a c ti v i ty dur i ng c ompl ementat i on a nd the  s i m i l ar i ty i n  the b i ochem i ca l  
proper t i e s  between pccS  and  pccC  have  suggested tha t  th i s  i s  the  res u l t  
of i n tera l l e l i c  compl ementat i on ( 6 ,  1 22 ) . The mu tants  i n  th i s s tudy 
compr i sed two of these s ubgroups , pccC and  pccSC . The i denti f i c a t i o n  
of  b i ochem i ca l  heterogene i ty i n  t h e  i soel ec tr i c po i n t  a n d  the thermo ­
s ta b i l i ty of the enzyme among these mu tan ts i n  th i s  s tu dy s uggests that  
the  compl ementati on w i t h i n th i s group  i s  i ntera l l el i c .  
D i fferences were obs erved i n  the  p I  of one mutant  enzyme , pccSC1 , 
a s  compared to n orma l a nd other mu tant  pc e s . The i soe l ectr i c  po i nt o f  
human pee via s  determ i ned t o  be 4 . 7  for the n orma l  enzyme from seven  
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d i fferent l i ver homogenates ( 1 33 ) . Th i s wa s the f i r s t  determi na t i o n  
of  t h e  p I  for t h e  human enzyme a l thou g h  t h e  p I  o f  6 . 1  was reported pre­
v i ou s l y  for bov i n e  l i ver . (8D ) The i nves t i ga t i on of norma l enzyme from 
d i fferen t subcel l u l ar frac t ions  a nd d i fferent t i s sue  s howed no  normal 
var i a n t  or i soenzyme of  pee . The p I  of the enzyme deri ved from l i ver 
mi toc hondr i a  preparati ons  was c ompared wi th the tota l  cel l homogenates 
and  these profi l es were a l most i dent ica l  prov i d i ng further ev i dence 
that  there ex i sts on l y  a s i ng l e subcel l u l ar enzyme wh i ch is  l oca l i zed 
in both fract ions  due to mi toc hondri a l  l ea kage  dur i ng l i ver a u to lys i s .  
The p I  o f  pee from l i ver , k i dney , p l acenta and  fi brobl a s t  homogena tes 
are i n  the same range a s  the n orma l enzyme from l i ver . 
I n  a dd i ti o n , the i soel ectr i c  po i nts for the other two m i tochon ­
d r i a l  carboxyl ases  had not  been prev i ou s l y  reported and  they were 
d etermi ned for the purpose of  pu r i f i cat i on of th i s  enzyme . The p I  of 
6 . 2  for ji' Mee , \�h i c h  i s  s tructura l l y  s i m i l ar to pee , is qu i te d i ffer­
en t from tha t of pee and  th i s was u sefu l for separa t ion  of the two 
enzymes  duri ng the pur i f i ca t i on procedure by i on exchange c hroma tog ­
raphy and  e l imi na ted the poss i b i l i ty of res i du a l jBMCC  or PC  acti v i ty 
con tr i bu ti ng  to the determ i na t i on of  mu tant pce acti v i ty i n  the 4 . 7  
pea k .  
Al thoug h  other i nvest i ga tors have prov i ded ev i dence suggest i ng 
that  the  defect i n  prop i o n i c  a c i d em i a  i s  due  to struc tura l mu ta ti on s , 
the f i r s t  d i rect  ev i dence wa s the i den ti f i ca t i on of a mu tant  enzyme 
wi th an a l tered p I  of 5 . 3  i n  the pceBC1 mutant . From the s tud i es i n  
the normal t i s su e , i t  i s  u n l i ke l y  tha t t h i s a l tered p I  represen ts a 
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normal  v a r i a n t  of pee . T he other  three  mutants had p I ' s  in  the  norma l 
range , demonstra t i ng  the heterogene i ty wi t h i  n the pecBe grou p . The 
pccBel mu tant  enzyme and the n orma l enzyme were puri f i ed from l i ver i n  
order t o  confi rm the f i nd i ng o f  a n  a l tered p l . 
The pu r i f i ca t i on of the norma l enzyme was accompl i s hed by a mod i ­
f i c a t i o n  of the procedure  of Ka l ou sek  et a l . ( 83 ) The  extent of 
pur i f i c a t i on was compara b l e to tha t reported , a l though  the yi el d wa s 
l ower . Th i s  wa s probab ly  because  on ly  the cen tra l reg i ons of the pea k 
were pool ed dur i ng the co l umn procedures . The 50S -po lyacryl ami de ge l  
s h owed three ba nds  wi th  mo l ecu l a r  we i g hts of  58 , 500 , 62 , 500 a nd 7 6 , 000 . 
The l oca t i on of the 7 6 , 000 and 62 , 500  mol ecu l a r  wei ght  bands corres ­
ponded to the bands obta i ned wi th a sampl e of pur i fi ed p i g  heart pee 
( 61 , 500 and 7 6 , 000 ) . These two bands a re of  equa l i n ten s i ty whi c h  
wou l d  b e  ex pec ted for two su bu n i ts �Ih i c h  are  i n  equal  proport i ons i n  
the enzyme mol ecu l e .  The sma l l er band may be e i ther a con tami nant or 
a d egra da t i on product  of one of the pee s u bu n i ts s i m i l ar to that 
observed in  puri f i ed bov i ne k i d n ey pee , s i nce  it  became more prom i nent  
a s  the  prepara t i on aged . These  mol ecu l ar weig h t  va l ues  are s imi l ar to 
those  o b ta i ned by Swac k  et  a l . ( 1 6 7 )  for c h i cken  p e e  and Ka l ou sek  et  
a l . ( 83 )  for  huma n pee . 
The  s trongest  ev i dence i n  favor of a s tructura l l y  a l tered mu tan t  
enzyme �Ja S prov i d ed by the pu r i f i ed mutant  enzyme . The enzyme from a 
Pee -defi c i en t  huma n l i ver has  not  been prev i ou s l y  pur i f i ed becau se  of 
the d i ff i c u l ty in  obta i n i ng enoug h  mater i a l  a nd t he i ns ta b i l i ty of the  
enzyme . The p u r i f i ca t i o n  of the mu ta n t  was on ly  accompl i s hed by 
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cond uct i ng most procedures i n  O . 5H sucrose wh i c h  had been s hown pre­
v i ou s l y  to stabi l i ze the part i a l l y  puri f i ed mu tant enzyme from 
f i brobl a s ts . ( 8l ) The dramat ic  s ta bi l i za t i on effect of sucrose on th i s  
mu tan t  wa s demonstrated i n  the hea t dena tura t i on ex per iments where the  
s ta b i l i ty of the mu ta n t  becomes comparab l e to  norma l wi th the add i t i on 
of O . St-J sucros e .  The presence o f  5mM ATP s l i g htl y decrea sed the  s ta ­
b i l i ty o f  the mu tant  i n  the thermosta bi l i ty experiments and  d ecrea sed  
i ts s ta b i l i ty dur ing  the  pur i f i ca t i on procedure when 3mM A T P  wa s u sed 
to e l u te the enzyme from the B l u e  Sepharose co l umn . HO�lever , the add i ­
t i o n  of sucrose to the 3mM ATP sol u t i on s ta b i l "ized the enzyme , even i n  
the presence of ATP . The spec i f i c  a c t i v i ty of the mu tan t  i s  a pprox i ­
ma te ly  1 000 t imes  l es s  than tha t of the pur i fi ed norma l enzyme , 
i nd i ca t i ng the mu tant  enzyme i s  structura l l y  a l tered , s i nc e  a regu l a ­
tory mu tant  wou l d  resu l t  i n  l ow y i e l d s  but  a s im i l ar s pec i f i c  a cti v i ty 
to the  nonna l  enzyme . The 1 0�1 spec i f i c  act i v i ty i s  d ue  to the i n s ta ­
b i l i ty o f  the enzyme dur i ng the i so l a ti on procedures , espec i a l l y  the 
DEAE co l umn step where s u crose  had to be omi tted . The pur i fi cat i ons  of  
the  mu ta nt  and  the norma l en zyme were comparab l e beyond  th i s  s tep wi th 
the mu tant  bei ng puri f i ed gO-fol d over the next two s t e p s  a nd the 
norma l l 50-fol d .  These da ta suggested that  the mu ta n t  enzyme actua l l y  
wa s pu r i f i ed around l 500-fo l d l i ke the norma l  enzyme , bu t the  fol d i n ­
crea se  �/a s obscu red by l os s  of act i v i ty .  
The  i s oel ec tr i c  po i nts i n  the pur i fi ed enzymes supported the d ata 
obta i ned wi th  the  crude  homogenates . The p I  s h i ft , d u r i n g  the  pu r i f i ­
cati on repor ted by Ka l ousek  et a l . (83 ) , �/a s not  observed i n  e i ther 
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pu r i f i ed e n zyme . A s h i ft a p p ro x i �a t i n g tha t reported cou l d  be pro ­
du c ed i n  bo t h pu r i f i ed a n d  c ru d e  enzyme preparat ions  by prei ncu bati ng 
wi th 5mM ATP . S i nce  the s h i ft o cc u r s  a fter the e l ut i on from the  B l u e  
S e p ha ro s e  c o l umn wi th  3mt·1 ATP a n d  a prop orti on o f  t h e i r p u r i f i ed 
enzyme s t i l l  focu s e s  a t  t h e  l ower p I , t h i s o b s erva ti o n i s  c on s i s ten t  
w i th  the  b i n d i ng o f  ATP t o  the maj o r i ty o f  the enzyme , cau s i ng a p I  
s h i ft .  The rea s on why a s h i ft i s  n o t  observed i n  our pre para t i on i s  
p ro bab l y d u e  t o  the h i g her sa l t  conc en tra t i on s empl oyed dur ing  the  
S ep ha c ryl co l umn proced u re wh i c h  �/ou l d  m i n i m i ze the  enzyme-ATP i n ter -
a c t i on . 
S evera l pos s i b l e e x p l a na t i on s  f o r  the a l tered p I  i n  the pCCBC1 
en zyme c a n  be i nv o ked . T h e  p I  of the pccBC
l 
mu ta n t enzyme i s  s h i fted 
a pp rox i ma tel y 0 . 6  of pH u n i t s wh i c h  p r o b a bl y c a n n o t  be ex p l a i n ed by 
o n e  c ha r g e  d i fferenc e .  S i nc e  p e e  i s  a tetramer , any c harge d i fference 
wou l d  occur  i n  a l l four  s ubu n i ts cau s i ng a fou r -fo l d effect on the  p I  
o f  t h e  e n zym e . One obv i ou s  exp l a n a t i o n for a c ha rge d i fference wou l d  
be the  s u b s t i tu t i o n  of a n  am i no a c i d  i n  t h e  p o l ypep t i de c ha i n  o f  the 
s ubu n i t .  Such  a su bs ti tu t i on c ou l d  e i ther a l ter the p I  d i rect ly  by 
c h a n g i ng t h e  c ha r g e  of t h e  mo l o cu l e  or i nd i rect ly  by a l ter i ng the  c on ­
forma t i on of the e n zym e . A subs t i tu t i on i n  the  am i n o  a c i d  sequ ence 
c ou l d  a l ter the po s t - tra n s l a t i on a l  mod i f i ca t i on of the enzyme , poss i b­
l y  c a u s i ng t h e  a dd i t i o n  o r  d e l e t i o n  of c harged mo i ety .  Al s o ,  a 
su b s t i tu t i o n c ou l d  cau se  l oc a l c o n forma t i o n a l  c h a n g e s  c a u s i ng expo s u re 
of prev i o u s l y  i n te r na l i z ed g r o u p s . T h e  d a ta on sucrose  stab i l i za ti on 
ha s a l r e a d y  s u g g e s ted t h a t  s u c h a c h a n g e may o c c u r  i n  th i s  muta nt . 
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Severa l  o r  a l l o f  these phenomenon may i nteract t o  a l ter t h e  p I  o f  
th i s enzyme . 
Another expl anati on for the  a l tered p I  i s  the t i ght  b i nd i ng of 
some l i gand such  a s  ATP to the mutant  enzyme . The presence of 5mN ATP 
ha s been s hown to s h i f t  the  p I  of the mu tan t  enzyme i nd i cat i ng that i t  
i s  not  respons i bl e  for the p I  a l terat i on  ori g i na l l y  observed i n  t h i s 
mu ta n t . I n  add i ti on , the Km of the pur i f i ed pccBC
1 
mu tan t  en zyme fo r 
ATP i s  not d i fferent  from that obta i ned for the normal enzyme v/h i c h  
suggests  s im i l ar affi n i ty for ATP . The presence of some other t i g h t l y  
bound l i gand rema i n s 3 po ss i bi l i ty .  
Compari sons o f  the property of thermos ta bi l i ty a l so demo n s tra ted 
d i fferences  bet\�een the mu tant  enzymes . Two of the fou r mu tan t  enzymes , 
� and pccBC1 , had a ha l f - l i fe of a p prox i ma te l y  3 mi nutes a t  4 50C ,  
whereas , the  other blo mutants , pcc CI and pccB C2 , demons tra ted ha I f­
l i fes of over 3 0  m i nu tes , wh i c h  i s  wi th i n the n ormal range . The 
dramat i c  s tab i l i zat i on  of the pccBC1 mu tan t by sucrose may g i ve a c l u e  
t o  the nature  o f  the  defect  i n  th i s mutant  and suggests a defect i n  t he  
ou ter structure of t he  mo l ecu l e  wh i c h  i s  i nvol ved i n  hydrophob i c  i n ter­
act i on s .  Sucrose , a t  the concentrat i ons  requ i red to s tabi l i ze th i s 
enzyme , ha s been s hovm to s trengthen hydrophob i c  i n teract i ons  between 
grou ps  and reduces  the dr i v i n g  force for the tran sfer of a hydrop hob i c  
group t o  a non -po l a r  env i ronment . ( 1 34 ) From the data , a subst i tu t i o n  
of a hydropho b i c  group  on t h e  o uts i d e  o f  t h e  mol ecu l e  m i g h t  be sugge s -
ted . 
T h e  Km val ue s  f o r  prop i onyl CoA , ATP , b i carbonate , and pota s s i um 
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were compared i n  t h e  norma l a nd t h e  mu tant  enz)wes and no maj or d i ffer­
ence s  �/ere found . The 1 ack  of 1 arge d i fferences in  the Km I S for the 
enzJme s ub strates s i mi l ar to that o bs erved  in s tud i e s  of fi brobl a s t , 
su g ge st s  the defect i n  these enzJmes does  not  i n terfere wi th subs trate 
b i nd i ng . ( 3 ,  82 ) The Km va l u es  ca l cu l a ted for the pur i fi ed normal e n ­
zyme i s  w i t h i n  t h e  range  reported for mammal i a n  PCC  by other i nvesti ­
gator s . Surpri s i ng l y , none of the mu tant s  s howed a dev i at i on from 
the s e  va l u es  of more than 6 -fol d .  The Km for prop i onyl CoA i n  the 
pcCBC2 mu tant wh i c h  i s  approx ima te ly  fou r t imes  normal i s  s ti l l  l es s  
than t h e  Km ca l cu l ated for n orma l human fi brobl a s t  extracts  by H s i a  e t  
a l . ( 81 ) a nd i s  proba b ly  not s i g n i f i can t . The crude cel l h omogenates 
gave a g ood approx i mat i on of the va l u e s  determ i ned in the pur i f i ed 
normal en zyme al thou gh  more var i a t i on was observed among the Km va l u e s  
from t h e  homogenates . I n  the s tudy by !�o l f et  a l . ( 3 ) , fi brob l a st s  
were s e parated i n to d i fferen t compl ementat i on g roup s ; the pccA group  
d emons tra ted an  i ncreased Km for  pota s s i um bu t the  pccBC  grou p wa s the  
same a s  the norma l . The i r  f i nd i ng in  the pccBC  g roup wa s confi rmed i n  
the mu tants  s tud i ed . 
Thi s s tudy has demonstra ted the heterogenei ty wi thi n one mu tant 
compl ementa t i on g roup , pccBC . Al l of the enzymes  demonstra ted normal  
quan t i t i es of C R�l and Km va l ue s  for  s u b s trates . Mu tant  pcC BCl had a n  
a l tered p I on a b normal  hea t dena tura t i on  profi l e ,  a n d  �/a s n o t  s tab i l ­
i zed  by ATP . Mutant  pccC2 h a d  a s i mi l ar heat dena tura t i on profi l e  b ut  
a normal p I . The d emonstrati on of  three d i fferen t pa tterns  i n  these 
mu ta nts  suggests tha t eac h  repre sents  a d i fferent s truc tural  mu tati on  
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vl i t h i n a s i ng l e  s ubun i t .  S i nc e  mu tants pecCi and � c ompr i s e  one 
su bgrou p and pccSCl and pccSC2 another , there i s  no pattern of beha v ­
ior  c ommon to a ny one subgrou p .  I f  there ex i sts many poss i bl e  
structural  mu tat i ons  wi th i n  a compl ementat i on  group , some mutat i ons  
may i nterfere wi th the  a b i l i ty to parti c i pa te in  i n tera l l el i c compl e ­
men ta t i on by i nterfer i n g  w i t h  s tab l e tetramer ic  form . The var i ed 
a bi l i ty of cel l s  wi th i n the pccSC compl ementat i o n  g roup to part i c i pate 
in  c ompl emen ti ng one a nother may be j u s t  another exampl e of  hetero-
genei ty wi th i n  the pccSC grou p .  
The  heterogene i ty observed wi th i n  th i s  compl ementat ion  group  par ­
a l l e l s  the c l i n i c a l  heterogenei ty observed i n  th i s  d i sorder . No 
d i fference in severi ty of the d i sorder ha s ever been o bserved between 
the two major compl ementa t i on grou ps and great heterogenei ty has  been 
observed wi th i n  the grou ps . (  Of course , no conc l u s i on s  can be  
reached wi th  such  a smal l sampl e ;  however , i t  i s  i nterest i ng to  note  
that the pccBC2 pl acenta i s  the on l y  one of the sampl es from a pat i e n t  
s t i l l  l i v i ng wi th P C C  def i c i ency and  i s  one  of t h e  two samp l es  whi c h  
d i d  not  show any d i fferences from normal  i n  the  parameters tested . 
The pa t i ent  whose l i ver enzyme ( pccSC! ) Via S dev i a n t  i n  these tests , 
d i ed a t t h e  you n g e s t  a g e  of those i n  th i s  study .  I t  i s  poss i bl e  tha t 
i n  the  future , pa rame ters such  a s  the  ones  u s ed i n  t h i s s tudy , c ou l d  b e  
u sed t o  pred i c t  t h e  c l i n i ca l  course  for these  pat i ents . 
Al tera t ion  of enzyme s ta bi l i ty ,  i f  i t  occurs  i!!. v i v o , wou l d  
represent a severe prob l em to these  pa t i ents . However , t h e  d i scovery 
that o t he r  mo l ec u l e s i nfl u ence the stab i l i ty of th i s enzyme suggests  
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a nother p o s s i b l e  a p proa c h  to trea tm e n t  of th i s d i s order .  I nvest i ga ­
ti ons  are needed to e l u c i date s u b s ta n c e s  wh i ch wou l d  i ncrea se  the 
sta b i l i ty of the enzyme . I t  i s  poss i b l e that a s u b stance cou l d  be 
found �Ih i c h  cou l d  be u s ed to i nc rea se t h e  s ta b i l i ty of muta n t  PCC  
l ead i ng to a trea tmen t for  th i s  d i s o r d e r . 
I n  summa ry , the data presen ted demonstra ted tha t the defec t i n  
mu ta nt pc c BCZ i s  the resu l t of a s truc tu ra l mutat i o n  whi c h  i s  s ta b i l ­
i zed  by t he add i t i on of 0 . 5t·1 su crose . Add i ti ona l l y ,  the i mmunoti tra ­
t i on  experiments su pport the hyp o t h e s i s th a t the defect i n  the  other 
mu tan t s  s tud i ed from t h e  o t h e r  two compl ementat i on  grou p s  are a l s o  the  
r e s u l t s of a s tructural  mu tat i on . The fi nd i ng tha t none  o f  t h e  b i nd ­
i ng con sta nts for the pcc BCZ mutant  Vlere a l tered a nd tha t sucrose  
s t a b i l i z e s  t h e  e n zyme , h i n t s  t ha t  t h e  d efec t i nvol ves  the hyd rophobi c 
outer a r e a  of the mol ecu l e ra ther than the s u b stra te b i nd i ng s i tes . 
The demons tra ti on of b i oc hem i c a l  heterogenei ty i n  the pc c B C  grou p 
suggests tha t th i s grou p repr e s e n t s  a col l ect i on of  d i fferen t s tructur­
a l  mu ta ti ons . I f  d i fferen t mu ta t i ons  resu l t i n  s l i g htl y d i fferent  
propert i es ,  the i ntera l l e l i c compl emen ta t ion  observed in  some of these  
mu tant s  m a y  be i n terfered w ith  in  other  mu tan ts such  a s  those  compri s ­
i ng t h e  pccBC su bg rou p .  
C l ea rl y ,  th i s s tudy i s  on l y  a beg i n n i ng i n  the  u ndersta nd i ng of 
the mol ecu l ar defec t in  prop i o n i c  a c i d e m i a .  �1a ny q u e s t i o n s  on the 
rel a t i on s h i p bet�leen t h e  b i oc hemi c a l a n d  c l  i n i ca l  h eterog ene i ty i n  
th i s  d i sorder rema i n  to be a n sVier e d . H o p e fu l l y ,  a better u nderstand ­
i ng of t h e  n a t u r e  of the d e fe c t  w i l l  i n i t i a t e  i nnova ti ons  i n  t h e  
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trea tment  of prop i on i c  a c i dem i a  wh i c h , a t  present ,  i s  so  d eva s tat i ng 
to the affected c h i l dren a nd the i r  fam i l i es . 
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1 4 1  
RELEASE  OF ORGANS AT POSTf10RTEM EXAMI NAT I ON 
I ,  ___________________ , a s  the parent  
a nd/or guard i an of ______________ , g i ve perm i s -
s i on to D r .  ___________________ to remove a ny 
organs  necessary for med i ca l  i nvest i gat i on a t  the pos tmortem exam i n a -
t i on of  my c h i l d .  T h i s perm i s s i on and au thor i ty i s  g ranted s u bj ect  to 
the fol l owi ng res tr i c t i on s :  ____________________ _ 
Phys i c i a n :  S i gned : 
( S i gnature of phys i c i an obta i n i ng 
-----------
perm i s s i on ) 
S i gned : __________ ___ 
Date : __________ ___ 
House  and attend i ng staff to be cal l ed :  
Dr. ______________ __ P hone : ____________ __ 
Dr . 
_______________ __ 
P hone : ___________ __ 
Human Autopsy L i ver : I denti f i ca t i on No . :  -----
Date of  B i rth : / / Gestati onal  Age : wks . Sex : M F 
Mode of Del i very : V C -S Bi rthwe i g ht : ______ gms . Race : C N M 
Maternal  Compl i cat i on s : 
B i rth  Compl i cati on s : 
Date of Death : / / T ime of Death : ____ a- .m .  p .m .  
Body Wei ght  a t  Dea th : gms 
Postmortem handl i ng of body : 
T ime a t  �Ih i c h  1 i ver removed 
and i ced down : a .m . /p . m . : 
Cause of Death : 
Thera py preced i ng death : 
Ass i s ted Venti l a ti on : Yes  No  
Hypera l imentati on : Yes No 
Date : / I 
O2 Thera py : ___ -:% 
Hypera l imen tat i on  fl u i d : 
1 .  V .  Fl u i d s : 
Med ica l  Therapy : 
Ant iconvu l sants : 
Antimi crob i a l  Agen ts : 
D i ureti c s : 
Card i ovascu l ar Agents : 
Hormones : 
Other : 
Abnorma l F i nd i ng s  a t  Autopsy : 
Abnorma l F i nd i ng s  at Au top sy ( Con t ' d . ) 
L i v er Stud i e s : 
We i g ht  at Autopsy : g . 
Appearance : 
H i  s tol  ogy : 
L i ght  r4 i c roscopy : 
El ectron �li croscopy : 
B i ochem ica l  F i nd i ng s : 
Prote i n  Content : mg . /g .  l i ver 
Prote i n  D i s tr i bu t i on : 
Nuc 1 ea r Frac t i on :  mg . / 9 . 1 i ver 
Mi toc hond r i a l  Fracti on :  mg . /g .  l i ver 
M icrosoma l Fract i on : mg . /g .  l i ver 
Sol ub l e Frac t i on : mg . / g .  l i ver 
B i l e  Ac i d s : 
Enzyme Conten t :  Tota l M i tochond r i a l  
Branc hed -Cha i n  o(-Ketoac id  Dehyd . 
Prop �onyl CoA Carboxyl a se 
G l utam i c  Dehydrogenase  
�c i d  Phosphatase  
G l ucose-6-Phos pha tase  
Mi cro soma l Cytosol  Nuc l eu s  
A P P EN D I X  I I  
ENZyt�E ASSAYS 
a )  Propi onyl C oA Car boxyl a s e  
b )  j? -Methyl cro tonyl CoA car boxy l a s e  
c )  Pyruva te Carboxyl a se 
d )  G l u tam i c  D e hydrogen a s e  
e )  LmJrY Protei  n Determ i  n a  t i on 
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T he  As say for Propi onyl CoA carboxyl a s e , )$-Methyl crontonyl 
CoA ca rboxyl a se , and Pyruva te Carboxyl a s e  
A .  Reagents 
1 .  Magnes i um Ch l or i d e , Ana l yti ca l  Reagent  
2 .  Sod i um B i carbonate , Ana l yt i ca l  Reagen t 
3 .  Pota s s i um C h l or i d e , Ana l yti ca l  Reagent 
4 .  G l u ta thi one , Red uced form , �ll'J = 307 . 3 ;  S i gma Chem i c a l  
Grade I I I ,  cat . # G4501 . 
C o . ,  
5 .  Adenos i ne -, 5 ' -tr i phos pnate , d i sod i um sa l t ,  MH = 5 5 1 . 2 ;  S i gma 
Chem ica l  Co . , cat . # A3127 . 
6 .  Tr i s  ba se , MW - 1 21 . 1 ;  Ca l b i ochem , grade A ,  meta l i on free , 
cat . # 64831 1 .  
7 .  Ethyl ened i ami netetraaceti c a c i d , d i sod i um  sa l t ,  MW = 336 . 2  
S i gma C hem ica l  Co . ca t .  # ED2SS . 
8 .  Propi onyl CoA , �'W = 823 . 6 ;  S i gma Chemica l  C o . , Grade I I ,  
l i th i um sa l t ,  ca t .  # P4386 . 
9 .  )1-Methyl crotonyl CoA , l i t hi um s a l t ,  NW = 849 . 7 ( free a c i d ) ; 
S i gma C hemi ca l  Co . , cat . # M9507 . 
1 0 .  Pyruvic  a c i d , s od i um s a l t ,  MyJ = 1 10 . 1 ;  S i gma Chem i c a l  Co . , 
cat .  # P2256 . 
1 1 . Acetyl CoA . 
1 2 .  Tri ch l oroaceti c ac i d , Ana lyt ica l  Reagen t .  
1 3 . NaH14CO::1' 40-60 mC i /mmol e ,  MI1 = 84 . 0 ;  New E ng l a nd Nuc l ear , 
cat . # NEC-086H . 
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B .  So l u t i on s  
1 .  40mM ATP 
0 . 1 1 9  gm ATP-Na2 wa s d i s so l ved i n  3 . 0  m l  of de i on i zed water . 
ti trated to pH B . O  w ith  NaOH and mad e  to a fi na l vo l ume of 
5 . 0  ml . 0 . 1 ml  of th i s  so l ut i on was d i l u ted to 100 m l  i n  
de i on i zed wa ter and the a bsorbance o f  the f ina l  sol u t i on wa s 
determi ned through a 1 . 0  cm l i ght  path at  259nm . The concen­
trati on of the i n i t i a l  so l ut i on was determi ned u s i ng a 
mi l l imol ar  a bsorpti on coeffi c i ent  for ATP of 1 5 . 4 .  The con­
centration  was adj usted to 0 . 040N . 
2 .  1 0mr� Prop i onyl CoA 
0 . 01 gm of propi onyl CoA was d i s so l ved i n  0 . 5  m l  of d e i o n i zed 
wa ter . The f i na l  concentrat i on wa s determi ned by u s i ng a 
m i l l imo l a r a bsorpti on coeff i c i ent  of 1 6  a t  a wa vel eng th of 
2 60nm throug h a 1 . 0  cm l i g htpath . 
or 30MM j3 -�'ethyl crotonyl  CoA 
0 . 003 gm of -methy l  crotonyl CoA �/a s d i sso l ved i n  0 . lm1 
d e i on i zed �Ia ter and standard i zed as above . 
or a )  60m�1 Pyruvate 
0 . 33gm pyruvate wa s d i s so l ved in 5 ml of de i o n i zed water . 
b )  1 5mM Acetyl CoA 
3 .  200mt� MgC 1 2 
4 . 066  gm of MgC 1 2-6H20 wa s d i s so l ved and brought to a fi na l vol ume of 1 00ml . 
4 .  2 . 5M KC l 
1B . 6  gm of KC l was d i sso l ved and  brought u p  to a fi na l  vo l ume 
of 100 ml . 
5 .  1 M  Tr i s -Hc l , pH 8 . 0 ,  1 00mM g l u ta th i one , O . l mtl EDTA . 
a )  H 1  Tr i s -HC l  
1 2 . 1  gm of Tr i s  wa s broug ht u p  to a vol ume of 50 m l  and  pH 
w ith  HCl to  8 . 0 .  
b ) 3 . 07 gm of g l u tath i one were added to the so l u t i on . 
c )  0 . 0037 gm EDTA \�ere added and the f i n a l  vol ume wa s broug ht 
u p  to 100ml . 
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6 .  50mf" Sod i um B i carbona te - 14C _ l a bel l ed 
a )  1 00mf� Sod i um B i carbonate 
0 . 084 gm of Sodi um b i ca rbona te was d i sso l ved and made u p  to  
a f i na l  vol ume of  l Oml . 
b ) One ml of 14C l a bel l ed b i carbonate conta i n i ng 1 mC i was 
d i l uted wi th 0 . 64 ml of the 1 00mM s od i um bi carbonate so l u t i o n . 
7 .  1 0% Tr i c hl oroaceti c ac i d  
1 0  gm o f  Tri c h l oroaceti c a c i d  were made u p  to a fi na l  vo l ume 
of 1 00ml w i t h  d e i o n i zed wa ter . 
8 .  Reacti on M i x tu re 
0 . 5  ml of so l u t i on s  1 ,  3 ,  4 and 5 are m i xed together the d ay 
of the a s s ay .  
C .  Assay Sys tem 
B l a n k  
1 0 u l  o f  de i on i zed water or  5u l of  d e i o n i zed wa ter and 5 u l  of  
acetyl CoA ( for pyruva te ca rboxyl a s e )  
20ul  o f  reac ti on m i x ture 
50  u l  of samp l e 
20 u l  of b i carbonate i s  added to beg i n  the a s say 
Compl ete sys tem 
1 0  u l  of e i ther prop ionyl CoA or -methyl crotonyl CoA or  5 u l  of 
acetyl CoA and 5 u l  of pyruva te for pyruva te carboxyl ase  
2 0  u l  of  react i on  mi xtu re 
50 u l  of samp l e  
20 u l  o f  b i c arbona te t o  beg i n  a s say 
The fi r st  three reagen ts are m i xed together and the s amp l e s  are 
i nc u ba ted at  3 70C for 2 m i n u tes  in  a wa ter bath . The reacti on i s  
begun by the add i t i on of the l a bel l ed b i carbonate and i s  a l l ol-Ied 
to proceed for up to 30 m i n u tes . To s top  as say ,  50 ul of 1 0% TCA 
is added . 100ul a l l i q u ot  i s  removed from each and eva pora ted t o  
d ryness under a hea t l amp t o  vol i ta l i ze any unreac ted 1 4C02 . T he  
res i d ue  �Ia s so l u b l i zed i n  100  u l  of d e i o n i zed water and  d i s so l ved 
i n  4 . 0  ml  of Aqua - so l  and  counted in a Beckman L S 7 500 s c i n t i l ­
l a t i on cou nter . 
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Ana l ys i s of Superna tants of  M i toc hondr i a l  Son i c a tes for Gl u tam i c  
Dehydrogena se : 
1 .  Reagents 
A. Tri ethanol ami ne :  S i gma ,  cat . no . 7 -1377 . l ot no . 120-2290 , 
mol . wt . = 149 . 2  
B .  EDTA : S i gma , ca t .  no . E D , l ot no . 36B 0950 , mol . wt . 
( free ac i d ) = 292 . 2 5  
C .  Ammon i um Aceta te :  F i sher , A . C . S . , ca t .  no . 1 -637 , mol . wt . � 
77  . 08 
D .  -NADH : S i gma , cat . n o . N8 1 2 9 , l ot n o .  , d i sod i um 
sal t wi th 1 . 5 mol es water/mol e ,  mo l . wt . = 736 . 02 
E .  ADP , monosod i um sal t :  S i gma , ca t .  n o . A-01 27 , 1 9t no . 
mol . wt . = 
F .  D<: -Ketogl u tar i c  a c i d , monosod i um sa l t :  S i gma , cat .  no . K1 8 7 5 , 
l ot no . , mol . wt . = 1 68 . 1 . 
2 .  Sol ut i ons  
A .  0 . 067 M Tr i ethano l am i ne-5 . 2mt1 EDTA , pH 8 . 0 : *  
0 . 99964g . tri ethano l am i ne -0 . 1 5I 97 g .  EDTA ( free a c i d ) 
d i ssol ved i n  85 m l . water , then t i trated to pH 8 . 0  a t  
250C and made to  a f i na l  vo l ume of 100  ml . S tore 
frozen when not in u s e . 
B .  2 . 1  M Ammon i um Acetate 
1 . 6187 g .  Ammon i um acetate d i s s ol ved i n  de i on i zed water  
and made to  a f i na l  vol ume of 10 . 0  ml . Store frozen 
when not in u s e . 
C .  1 nt1 NADH : 
Approx i ma te ly  0 . 00585  g .  NADH-Na2 -1 . 5H 20 d i s so l ved i n  
5 . 0  m l . water . 0 . 1  ml . o f  thi s d i l u ted w i th 1 . 9  ml of 
d e i on i zed water . The absorbance of the resu l t i ng  
d i l u t i on determi ned at  340 nm throug h  a 1 . 0 cm . l i g h t  
path . 0 . 0 .  = . 3 6 5 . Ca l cu l a ted conc ' n .  of  t he  u nd i l u -
ted sol u t i on = mM . The  concen trati on of the 
und i l u ted or i g i nal  so l u t i on adj usted to 1 . 0 mM . P re ­
pare fre s h  da i l y .  
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D .  1 2  mr� ADP : 
0 . 02736  g .  monosod i um ADP d i sso l ved i n  2 . 0  ml of wa ter , 
t i tra ted to pH 6 . 8 ,  and  made  to a f i na l  vol ume of 5 . 0  
ml . 
E .  0 . 1 6t'l o(-Ketog l u tara te : 
0 . 1 3448 g .  of the monosod i um sal t of -ketogl u tara te 
i s  d i s so l ved i n  4 . 0  m l  of d e i o n i zed wa ter . The 
so l ut i on i s  t i trated to pH 7 . 0  wi th NaOH . 
Adj u s t  the f i na l  vol ume to 5 . 0  m l . S tore a t  -200C .  
3 .  G l u tam i c  Dehydrogenase Assay : 
0 . 5 ml of 0 . 067M tr i e thano l am i ne-5 . 2  mM EDTA , pH 8 . 0  
0 . 05 ml  of 2 . lM ammon i um aceta te 
0 . 1 0  m l  d e i o n i zed wa ter 
0 . 1 5 ml  of 1 . 0 mM NADH 
0 . 05 ml  of 1 2  mM ADP 
0 . 05 m l  of enzyme-con ta i n i ng so l u ti on ( the m i tochon ­
dr i a l  s upernatant from a m i tochondr i a l  su spen s i on 
conta i n i ng a pprox imate ly  1 0  mg of protei n/ml i s  d i l u ted 
1 : 4 \'li th  i ce-col d d e i o n i zed water i rrmed i a te ly  before 
a s say ) . Fo l l owi ng add i t i on of enzyme , the c hange of 
optical  dens i ty at  340 nm is  fol l owed for 1 -2 mi nutes 
a t  2 50C . , then 0 . 05 ml  of  0 . 16M  sod i um o(-ketog l u tarate 
i s  added and  the  record i ng conti nued . Resu l ts are re­
corded a s  i n i t i a l  rati os of a bsorbance c hange a t  340  nm 
through  a 1 . 0 cm l i g ht  path at 2 50C .  Ful l scal e 
a bs orbance for the i ns trument i s  set  for 0 . 200 . 
I n  order to i nsure compl ete rupture of the m i tochondr i a  i n  order to re­
l ea se  g l u tami c dehydrogenase , the tr i ethano l am i ne-EDTA reagent i s  
proba b ly  best made  conta i n i ng approx ima tely 0 . 1% Tri ton X-IOO .  Thi s i s  
best made wi th Pac kard pur i f i ed Tri ton X -IOO o n  the day of u se . D i l u te 
0 . 01 ml of Tri ton X -100  w ith  tri ethanol am i ne-EDTA reagent to a f ina l  
v o l ume o f  1 0 . 0  m l . Wi thout tr i ton X - 100 , d i l u t i on s  of m i tochondr i a l  
prepara t i on s  when added t o  t h e  a s say sys tem show n on - l i nea r ra tes of 
reacti on wi th a steady decl i n i ng ra te of react i o n  a s  a func t ion  of t ime . 
1 50 
When tr i ton X-IOO i s  present , the rate of reac ti on rema i n s  l i nea r .  
1 5 1 
Mea surement of Prote i n  Concentra t i ons  i n  T i ssue  Homogenates and  T i s s ue  
Extracts : 
A .  Reagents 
1 .  CuS04 -5H20 ,  mol . wt . = 249 . 68 ;  F i s her Cert i fi ed , A . C . S .  
2 .  Sod i um P o ta s s i um Tartra te , Na KC4H406 • mol . \'it . = 282 . 23 ;  
F i s her Cert i f i ed , A . C . S .  3 . Sod i um Hyd rox i d e , mol . wt . = 40 . 00 ;  F i s her  Certi f i ed A . C . S . 
4 .  Na 2 C 03 ' a n hydrou s ,  m o l . wt . = 105 . 99 ; F i s her  Certi f i ed , A . C . S . 
5 .  Fo1 i n -C i oc a l teau Reagen t ;  F i sher  Sc i en t i f i c  Co . 
6 .  Bov i n e  Serum Al bum i n ,  crystal l i zed and  l yoph i l i zed ; S i gma 
C hem i c a l  Co . 
7 .  P h o s p h or u s Pen tox i de , mol . wt . = 141 . 95 ; F i s her Sc i en t i f i c  
B .  So l u t i ons 
1 .  LO�/ry 1 1ethod for Prote i n  Determi na t i o n  
Reagent  A :  
20g . of anhydrous  Na 2C03 d i sso l ved a nd  made to 1 000  m l  
i n  O . lN N a OH . 
Reagent B :  
Thi s i s  prepared by m i xi ng  equa l  vo l umes of 1 . CuS04 5 H20 ( l g .  of CuS04 . 5H20 d i s so l ved and  made to 1 00 m 1  1 n  
�/a ter ) \,l i th 2 sod i um pota s s i um tartra te . ( 2 . 0g .  o f  N aKC4H406 . 
4H20 d i s so l v ed and made  to 100 m 1  wi th wa ter ) 
Reagent C :  
M i x  50 m1 of reagent A wi th  1 ml  of  reagent B .  Use  
fresh ly  made on l y .  
Reagent D :  
Fo1 i n -C i oca1 teu Reagent  ( Phenol  Reagent ) 
The norma l i ty of the c ommerc i a l  prepara t i o n  i s  deter­
m i ned by ti tra ti on u s i ng standard i zed HC1 . Pr i or to u s e , t he 
Fo1 i n -C i oca 1 teu Reagent  i s  d i l u ted  to I N .  
2 .  Prepara t i on of S ta n d a rd Prote i n  
A s toppered we i g h i ng bottl e i s  dr i ed t o  constant  wei g ht 
over P205 i n  a n  evacua ted de s i cca tor a t  room temperature . 
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Then add 0 . 8g .  of purif i ed , lyoph i l i zed bov i ne serum a l bumi n 
and dry i t  to cons ta n t  we i ght  i n  the des i cca tor . F i na l  
s tabl e wei ght  i s  d i s so l ved i n  1 0  ml wa ter a nd  1 . 0 ml samp l e s  
s tored i n  v i a l s at  -200 • Eac h 1 . 0  ml d i l u ted to  1 0 . 0  m l  wi th  
wa ter and  the  resu l tant  u sed for a s tandard i n  the  b i uret 
a s say . 
C .  Ana lyt i ca l  Method s 
0 . 2  m l  of t i s s ue  homogenate or ti s sue  extract ,  conta i n i ng 
2-40 ug protei n ,  i s  mi xed wi th 1 ml of Lowry Prote i n  Reagent 
C and al l cwed to i n terac t for 10  mi n .  a t  room temperature . 
Add 0 . 1  ml of Lowry Prote i n  Reagent 0 to the a bove mi x tu re , 
shake i mmed i ately and wa i t  for 30  mi n .  before read i ng the 
fi nal col or . The a bsorbance of the fi na l  m i xture i s  deter­
mi ned e i ther a t  7 5 0  nm o r  at  500 nm , Co l or devel opment  i s  
compared aga i n st  that yi el ded by bov i ne a l bum i n  s tandard . 
When i t  i s  des i rab l e to determ i ne the prote i n  content 
on prote i n  prec i p i ta tes , these are first  d i sso l ved in  O . l N 
NaOH before a samp l e i s  ta ken for ana lys i s .  I n  some cases  i t  
may be necessary to hea t the prote i n  i n  0 . 1 N NaOH to effec t 
sol u t i on . 
The presence of ur i c  ac i d , guon i ne ,  xonthi ne , sucrose , 
monosac char i des , hexosami ne i n  s i gn i f icant  quanti ti es may 
i n terfere wi th the accuracy of the method . The presence o f  
g lyc i ne ( 0 . 5  ) can cause a decrease  i n  col or by 5 0  ; hydra ­
z i ne at  grea ter than 0 . 5mg/ 10ml i nterferes . P henol s (except 
n i trophenol s ) reduce the rea gent and thereby cause i nterfer­
ence . Ammon i um s u l fate ( at  a concentrat i on grea ter than 
0 . 1 5 ) , s u l fosa l i cyl i c  a c i d  and thymol may i nterfere . The 
presence of i norgan i c  phosphate in t he t i ssue  extrac t or 
homogenate causes prec i p i tat i on of the molybdate reagen t .  
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Append i x  I I I  - Avi d i n  Assay 
S tandard So l u t i ons  
1 .  B i oti n standard - 5mg . d-b i oti n ( S i gma )  in  5ml of 0 . 1 5r� 
sodium phosphate buffer , pH7 . 0 .  Thi s stoc k sol ut i on i s  d i ­
l u ted 1 : 50 ( 0 . 1  m l  i n  5ml ) t o  a concentrati on o f  20ug/ml for 
the a s say .  
2 .  Av i d i n  standard - 1 0ug of av i d i n  ( S i gma ) i s  d i sso l ved i n  
a. 15m s odl um phosphate cuffer , pH 7 . 0 . Thi s sol uti on i s  
standard i zed spectrophotometr i ca l l y  a t  280 nm . 
Procedure 
W i t h  the exi c i ta ti on monochroma tor set  a t  290nm , u s i ng a 
bandw idth of 4nm , the fl uorescence i s  moni tored a t  350nm w i t h  
a ba ndwi dth  o f  1 6nm . For stand ard , 2ml o f  av i d i n  so l u ti on i s  
p i petted i n to the c u v ette a n d  fl uorescence decrea s e  i s  mon i ­
tored after the add i ti on of 20ul  a l i qu ots of the b i oti n  
standard sol u t i on .  T he po i nt where n o  further decrease i n  
fl uorescence i s  observed i s  the poi nt of equ i va l ence between 
avi d i n - b i oti n b i nd .  U nknown a v i d i n  so l ut i ons can be  t i tra ted 
i n  the same manner and compa red to the standard . 
L i n ,  H .  J .  and J .  F .  K irsc h .  Ana l . B i ochem .  81 : 442 -446 , 1977 . ( 1 2 6 )  
APP E N D I X  I V  
OUCHTERLONY DOUB L E  D I F FUS I ON 
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Ouchterl ony Dou bl e  D i ffus i on 
Reagents 
1 .  Barbi tol MW 184 . 2 ; F i s her Co . 
2 .  Sod i um Barbi tol MW 206 . 2 ;  F i s her 
3 .  Nobl e Agar ;  D i fco  
4 .  Sod i um Az i d e  MW 65 . 0 ;  F i s her 
Procedu re 
Grams 
3 . 44 
7 . 57 
1 0  
0 . 1  
D i s so l ve barb i to l  and sod i um barb i tol  i n  900 m l  de ion i zed wa ter . 
Add agar and hea t m i xtu re i n  a n  earl myer fl a s k  wh i l e  swi rl i ng con stan t­
ly over a bunsen burner u nti l bo i l i ng . Heat gentl y unt i l a l l of the 
agar has  d i sso l ved . Add the sod i um a z i d e  a nd bring  up  to 1 000 ml . 
Let cool u nti l l u ke warm and pour 1 0  ml i n  5cm i n  d i ameter petri d i s he s . 
After these cool , refr i gera te overn i g h t . Cut  wel l s  for a n ti body a nd 
ant i gen wi th templ a te and fi l l  �Ie l l s  �/ i t h lOOu l  of sampl e and l et 
d i ffuse for 24 hours . 
APPEN D I X  V 
SDS -pol yacryl am i d e  Gel  E l ec trophore s i s 
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SDS-Arcyl amide  Gel  E l ec trophore s i s  
I .  Reagents 
A .  Gl ac i a l  Aceti c Ac i d , mol . wt . = 60 . 05 ,  Reagent Grade 
B .  Methanol , Reagent Grade 
C .  Acryl amide , mol . wt . 7 1 . 08 ,  el ec trophoreti c  grade , B i o -Rad 
Laborator i es , Cat . No . 1 6 1 -0100 
D .  N , N ' -methyl ene b i sacryl amide , mol . wt . 1 54 . 2 ,  el ectrophoret ic  
grade , B i o -Rad Laborator i es , Cat . No . 161 -0200 . 
E .  N ,N , N ' , N ' -tetramethyl ethyl ene d i am i ne , mol . wt . 1 1 6 . 21 , 
Eastman Organ i c  Chem i ca l s ,  Cat . No . 8178 
F .  Ammon i um Persu l fate , mo l . wt . 228 . 2  el ectrophoreti c grade , 
B i o -Rad La bora tori es , Cat .  No . 1 6 1 -0700 
G .  Sod i um dodecyl su l fa te , mol . wt . 288 . 4 ,  S i gma C hemi ca l  Co . ,  
Ca t .  No . L-57 50 
H .  Coomas s i e  Bri l l i a n t  B l u e  R ,  S i gma Chem i ca l  Co . , C a t  .. No . 
B-0630 
I .  Bromthymol B l u e , Al l i ed Chemical  Co . ,  Cat . No . 241 
J .  
K .  
L .  )9-Mercaptoethanol mol . wt . 78 . 1 3 ,  S i gma Chem ica l  Co . ,  Cat • . 
No . M6250 
M .  Tri s base , mol . wt . 1 2 1 . 1  cal b i oc hem grade A meta l i on free , 
Cat . No . 6483 1 1  
N .  G lyc i ne MW7 5 . 07 ,  Reagent grade 
I I .  Sol u t i ons : 
A .  Acryl amide  - N , N ' -t1ethyl ene B i sacryl amide : 
2 0 . 0g .  Acryl amide  + 0 . 667g . N ,N ' -Methyl ene b i sacryl ami de  
d i ssol ved a nd made to a f ina l  vol ume of 50 ml  in  de ion i zed 
�Iater . Store th i s  sol u t i on i n  a brown bott l e at 0-20 • 
Note : Th i s  m ixture i s  u nstabl e and tends to po lymer i ze -
prevent exposure to l i ght  as much a s  pos s i b l e .  Do not u s e  
thi s sol u t i on after o n e  month of s torage . Warm u p  the 
bottl es to room tempera ture pr i or to open i ng them . These  
compound s are neurotox i n s  - avo i d  exces s i v e  exposure to  them . 
B .  Ammon i um Persu l fate Sol u t i on : 
0 . 56g . of ( NH4 ) 2S208 i s  d i ssol ved and made to a f ina l  vol ume 
of l Om l  i n  d e i on i zed �Ia ter . Ma ke fresh j u s t  before u s e . 
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C .  N , N , N ' , N ' -Tetramethyl ethyl ene d i am i n e  So l u t i on : 
O . 092ml of n , n , n '  , n ' , -tetramethyl ethyl ene d i am i ne i s  d i s ­
sol ved and made to a fi nal  vol ume o f  l O . Oml . i n  de i oni zed 
water . t�a ke fresh  before u s e .  
D .  Tri s -G lyc i ne Buffer : For Gel Preparat i on  ( 0 . 25t1 G lyc i ne ) . 
3 . 7 535g . G lyc i ne d i s s ol ved i n  180ml of d e i on i zed water and 
the pH of the so l u t i on i s  adj u s ted to 8 . 3  wi th tr i s  0 . 4  gm 
of SDS i s  added and f i na l  vol ume i s  made  to 200ml wi th de­
i on i zed wa ter . 
E .  Tri s -G lyc i ne Buffer : For E l ec trode Compa rtment 37 . 53 5g . 
G lyc i n e  i s  d i s sol ved i n  970ml of d e i on i zed wa ter a nd the p H  
i s  adju s ted to 8 . 3  wi th tr i s .  Fol l owi ng the pH adj u s tmen t , 
the vol ume i s  made to 1 00Oml . S tore a t  0-20C .  For u s e  a s  
the el ectrode so l u ti o n  i t  i s  d i l u ted 1 : 5 w ith  d e i o n i zed wa ter 
so  300 m l s i s  made up to 1 4 0 0ml per compartment and 1 5gm SDS 
i s  added . 
F .  Prote i n  Carr i er Sol ut i on : 
502 of r�erca ptcethanol  mixed  wi th  1 . Ornl of Sol u t i on E .  
G .  D i sso l u t i on of Prote i n  for E l ectrophore s i s :  
U p  to 1 00mg of prote i n d i s so l ved i n  O . l Oml  of Sol ut i on F .  
H .  Marker Sol u t i on . 
2 . Orng of Bromthymol b l ue  ( Bromphenol b l u e  may a l so  be u sed ) 
d i s sol ved i n  so l ut i on E .  Th i s so l u t i on can be u s ed i n  p l a ce  
of  Sol ut i on E t o  m a ke  So l u t i on F . 
I .  Methanol -Acet i c  Ac i d  Sta i n i ng Sol ut i on : 
0 . 1 25g cooma s s i e  b l ue  d i sso l ved i n  1 1 3 . 5m l  of 50% methanol  
and the fi na l  vo l ume adj u s ted to  1 2 5m l  by add i t i on of g l ac i a l  
acet ic  ac i d . 
J .  Desta i n i ng Sol u t i on : 
l Ornl of G l a c i a l  Aceti c Ac i d  d i l u ted to 250ml  wi th d e i on i zed 
�Iater and 250ml Methano l . 
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I I I .  Ge l  Preparat i on : 
Gel % m l . So l  I n .  ml . so l I n .  ml . H20 ml . sol I n .  
o A C 
7 . 5  40 1 5  1 5  5 
m l . sol I n .  
B 
5 
The sol ut i ons ( 0  through  C )  are m ixed i n  a vacuum f l a s k  and  
dega ssed 10  mi n .  Then So l ut i on B added , immed i ate ly  m ixed 
and the resu l t i ng so l ut i on u sed i mmed i a te l y  to f i l l  gel  mo l d . 
I V .  E l ectrophore s i s of the Prote i n M ixture 
The prote i n  sampl e was d i s sol ved i n  the Tr i s -HC1 , Mercaptoethano l , 
50S mixture and boi l ed for 3 m i nutes . F i fteen u l  of samp l e i s  
p l a ced i n  eac h o f  the preformed s l ots . U p  to 1 00 ug. of protei n  
c a n  b e  run i n  eac h  l ane ; however , for t h e  mos t  accurate determ i na ­
t i on on ly  1 0ug s hou l d  b e  run . The ge l  i s  run  a t  cons tant  current 
of 80mA whi l e  bei ng cool ed by c i rcu l a ti ng wa ter a t  1 50C ,  for 
approx imately three hours unt i l the trac ki ng dye reaches  the end  
of the gel . 
V .  S ta i n i ng the Gel 
The gel  i s  p l aced in 10% TCA for 1 hour and i s  then s ta i ned i n  
the so l uti on I overn i g h t .  The sta i n i ng sol ut i on i s  then poured 
off a nd the desta i n i ng so l u t i on is added . I t  requ i res severa l 
changes of desta i n i ng sol u t i on to remove a l l of the sta i n  from 
the gel . 
A P P E N D I X  V I  
I SO E L ECTR I C  FOC U S I NG 
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Requ i r ed Reagents : 
Sol uti on D :  Dens e  Sol u ti on : 1 . 5m l  of 40% Amphol i ne ( pH 3 -10 ) + 
28c . sucrose + g l a s s  d i s ti l l ed wa ter to a f ina l  
vol ume of 6Oml . 
Sol u t i on L :  L i ght  Sol uti on : 1 . 5m l  of 40% Amphol i ne ( pH 3 -10 ) + 
wa ter to a f i n a l  vol ume of 6Oml . 
Anode Sol u t i on : 1% H2S 04 i n  dense sucrose . 
0 . 2mT of concen trated su l fu r i c  a c i d  ( 98% ) added 
to 14 . Oml  of  water . 1 4 . 0g of sucrose d i s so l v ed 
i n  the ac i d i c  sol u ti on . 
Ca thode Sol uti on : O . l g .  NaOH + 1 0 . Oml d i st i l l ed wa ter - to g i ve 
a 1% sol u t i on . 
Prepara ti on of the Sucrose Jl.mpholyte Sol u t i on s  Needed to Prepare the 
Sucrose Grad i en t :  
Tu be m1 . ml . Tu be ml . ml . 
# Sol uti on D Sol uti on L # Sol u t i on D Sol u ti on L 
1 4 . 6  - 1 3  2 . 2  2 . 4  
2 4 . 4 0 . 2  1 4  2 . 0  2 . 6  
3 4 . 2  0 . 4  1 5  1 . 8 2 . 8 
4 4 . 0  0 . 6  1 6  1 . 6 3 . 0  
5 3 . 8 0 . 8  17 1 . 4  3 . 2  
6 3 . 6  1 . 0  18  1 . 2 3 . 4 
7 3 . 4  1 . 2  19  1 . 0 3 . 6  
8 3 . 2 1 . 4 20  0 . 8  3 . 8 
9 3 . 0 1 . 6 21 0 . 6  4 . 0  
1 0 2 . 8 1 . 8 22  0 . 4  4 . 2  
1 1  2 . 6 2 . 0  23 0 . 2  4 . 4  
1 2  2 . 4  2 . 2  24 - 4 . 6  
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Prepara t i on of Col l ect ion Tubes : 
60 sma l l g l a s s  tubes ( 1 2  x 1 00mm . ) are ca l i bra ted (wi th 2 . Oml of 
wa ter ) so that they can be u s ed to col l ec t  2 . Oml fract i on s after 
the i soel ectr i c  focu s i n g  run . 
When d es i rabl e ,  mercaptoethanol may be added to So l u t i ons  0 and L to 
prov i d e  s tab i l i ty for certa i n  enzymes . To make these sol u ti ons a pprox ­
imate ly  ImM wi th  respect to mercaptoethanol , add 4 . 2  of mercaptoe­
thanol  16Oml . 
